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A remarkable reduction of the total number of under-five deaths was achieved between 1990 
and 2018 in the African setting, as pre-school mortality fell to 5.3 million deaths compared to 
12.5 million in 1990. The bulk share of this reduction is attributed to the Millennium 
Development Goals (MDGs) era, during which time the under-five mortality rate has been 
declining with an annual rate of 3.8% across Africa. Despite these important achievements, 
the sub-Sahara African region did not meet the fourth target of the MDGs and still has an 
unacceptably high under-five mortality rate. Crucially, limiting the under-five mortality rate to 
a maximum of 25 deaths per 1,000 live births by 2030 lies at the heart of the Sustainable 
Development Goals (SDGs) and a recent report from the United Nations has warned that 
based on current trends, the African continent will not meet the SDG target for under-five 
mortality. Hence, providing useful insights from the associations between under-five 
mortality, the leading causes of disease and preventative or curative health interventions 
could make available valuable information to decision makers in order the African countries 
to achieve the SDGs on pre-school mortality.  
Malaria is a major contributor to under-five mortality in sub-Saharan Africa, accounting for 
400,000 deaths, approximately 60% of which are in children below the age of five. At global 
scale, the disability-adjusted life-years for the malaria disease are 45 million. An important 
aspect of the disease is that infection by malaria parasites does not necessarily lead to 
mortality and it is rather conditions that follow infection or other comorbidities that produce 
severe forms of the disease with increased mortality risk. Apart from malaria, pneumonia 
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and diarrhea account for the most frequent causes of pre-school deaths. An interesting 
feature of all these three leading causes of under-fives in Africa, i.e. pneumonia, diarrhea 
and malaria, is that they share febrile response as their main clinical manifestation.  Against 
the leading causes of under-five mortality, preventative or curative health interventions have 
been widely adopted in Africa, with their spatial coverage being on a significant rise, 
particularly due to the so-called scaling-up of health interventions during the last five years of 
the MDGs. For instance, ownership of Insecticide-Treated nets against malaria rose from 50 
to 80 percent between 2010 and 2015, while their utilization averted 663 million clinical 
malaria cases over the MDGs era. Yet, the coverage of health interventions and the 
subsequent reduction in under-five deaths has happened in an unequal way across sub-
Saharan Africa, raising concerns about health inequities at sub-national level.  
The overall aim of the present PhD thesis is to develop, implement and interpret Bayesian 
geostatistical models with spatially varying coefficients in order to analyze approximately one 
million, cross-sectional mortality related-data in Africa and associate under-five mortality with 
malaria and health interventions. The point-by-point objectives of our work are as follows: 
1. To develop a novel indicator for quantifying malaria-related mortality for children 
under the age of five in sub-Saharan Africa, namely the malaria-anemia comorbidity 
prevalence indicator (chapter 2); 
2. To identify health inequities experienced by sub-national populations due to the 
geographical variation in the association between curative or preventive health 
interventions and under-five mortality in sub-Saharan Africa (chapter 3); 
3. To assess the contribution of the leading causes of under-five mortality in sub-
Saharan Africa on febrile response by associating the prevalence of malaria 
parasitaemia, diarrhoea and ARI with fever. (chapter 4); 
4. To estimate the association between health interventions and under-five mortality on 
changes in mortality risk between two time points across Africa (chapter 5); 
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5. To compare Bayesian variable selection methods for spatially varying coefficient 
models, given that these approaches are at the forefront of analyzing geolocated 
mortality data in Africa (chapter 6). 
 
In chapter 2, we estimated the association of malaria parasitaemia, anemia, and malaria-
anemia comorbidity with all-cause under-five mortality and evaluated the potential of 
malaria-anemia comorbidity prevalence to quantify malaria-related deaths in sub-Saharan 
Africa. Additionally, we estimated within-country variation of the association between 
comorbidity and under-5 mortality, using spatially varying coefficient models. We presented 
our results at high spatial resolution, including model-based risk maps of malaria, anemia, 
and malaria-anemia comorbidity.  
In chapter 3, we modeled the geographical variation in the association between health 
interventions and all-cause, under-five mortality in order to identify health inequities 
experienced by sub-national populations within a given country. To achieve that, we 
developed Bayesian geostatistical Weibull survival models with spatially varying coefficients 
for the effect of health interventions on mortality. Our approach allowed us to calculate the 
number of statistically important associations between interventions and mortality at regional 
level and hence to assess if health equity of interventions exists across the regions of a 
given country. 
In chapter 4, we assessed the contribution of the leading causes of under-five mortality in 
sub-Saharan Africa on febrile response by associating the prevalence of malaria 
parasitaemia, diarrhoea and ARI with fever. Our flexible Bayesian spatial modelling 
approach allowed evaluating the geographical distribution of disease-exposure effect on 
fever in space (Administrative level 1). We also calculated the Potential Attributable Fraction 
(PAF) in order to quantify the contribution of childhood diseases on fever. 
In chapter 5, we developed a novel methodology to statistically model the effect of health 
interventions on the changes in under-five mortality risk between two DHS survey time-
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points for 21 countries in Africa. We used a Bayesian geostatistical Weibull survival 
modeling approach and implemented rigorous Bayesian variable selection procedures in 
order to identify the most suitable set of health interventions for subsequent model fit. 
In chapter 6, we assessed the performance of stochastic search variable selection (SSVS) 
for the fixed effects of geostatistical models, we compared three different Bayesian variable 
selection (BVS) methods for conditionally autoregressive (CAR) structured spatially varying 
coefficient models and finally we assessed the sensitivity of SSVS for the fixed effects when 
is co-implemented with a BVS procedure. We conducted a simulation study and applied the 
methods to the Burundi DHS in order to assess the aforementioned selection procedures. 
The present PhD thesis has contributed to the scientific fields of Epidemiology and Statistics 
by committing to the spatio-temporal modelling of under-five mortality data in the African 
setting, using primarily routinely collected, cross-sectional, household-based survey data 
coming from the Demographic and Health surveys program. The key outcomes of the 
research conducted in this thesis are as follows: 
1. Our work contributed to the development, proposal and validation of a novel indicator 
for quantifying malaria-mortality using survey data, i.e. the malaria-anemia 
comorbidity indicator. Our main conclusions were that malaria burden in sub-Saharan 
Africa is considerably underestimated when anemia in not taken into account and 
that the malaria-anemia comorbidity prevalence provides a useful measure of the 
malaria-related deaths; 
2. We presented the first study to assess sub-national health inequities, across most 
countries in Africa, by employing a spatial statistical modelling approach and 
routinely collected survey data coming from the DHS and MIS. Our results 
demonstrated strong sub-national health inequities across various regions for 28 
African countries; 
3. Our estimates confirmed the strong contribution of diarrhoea and acute respiratory 
infection on febrile response and accounted only one out of five cases to malaria; 
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4. Our work concluded that the health interventions that are mostly associated with 
changes in all-cause, under-five mortality risk in sub-Saharan Africa were Bacillus 
Calmette–Guérin (BCG) immunization, vitamin A supplementation and deworming 
medication; 
5. Our analysis showed that the SSVS method is able to accurately identify the 
statistically important predictors for the fixed effects of geostatistical models and that 
SSVS is not sensitive to co-implementation with a BVS procedure for CAR-
structured, spatially varying coefficients. We also concluded that one of the three 
BVS methods for varying coefficients, namely the Global selection method, is able to 
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1.1 Under-five mortality 
As an integral part of the Convention on the Rights of the Child, the United Nations 
acknowledged the inherent right that every child has to life and all its member states made a 
commitment to initiate all efforts needed for the maximum development and survival of 
children (UNICEF, 2019). To this regard, the under the age of five mortality rate (U5MR) is a 
crucial measure illustrating the health status of pre-school children within a society.  The 
U5MR quantifies the probability for a child to die before its fifth birthday and it is presented 
as deaths per 1000 live births. The definition of live birth describes a conception product, 
which demonstrates evidence of being alive after having being expulsed or extracted from 
the mother (Woods, 2014). As of 2018, 5.3 million children worldwide did not survive their 
fifth birthday and the estimated global U5MR was 39 deaths per 1000 live births (WHO, 
2019c).Yet pre-school mortality rates are unequally distributed across various regions. 
Specifically, sub-Saharan Africa (SSA) is the most afflicted region worldwide, accounting for 
the highest U5MR, i.e. 78 deaths per 1,000 live births and currently experiencing under-five 
mortality levels of developed countries approximately two decades ago (UN IGME, 2019). 
Crucially, the sub-Saharan region is home to the majority of countries exceeding an U5MR 
of 100 deaths per 1000 live births, with its children experiencing an estimated 8-fold chance 
of dying between birth and the age of five, compared to children of similar age residing in 
Europe.  
Despite the unacceptably high, total number of preschool deaths and U5MR, a remarkable 
reduction of both measures was achieved between 1990 and 2018. Specifically, in 1990 the 
U5MR and the number of deaths were estimated at 93 per thousand live births and 12.5 
million respectively, compared to an U5MR equal to 39 deaths and 5.3 million children that 
did not survive their fifth birthday in 2018. Importantly, the major decline of the above metrics 
was achieved between 2000 and 2015, hence during the era of the Millennium Development 
Goals (MDGs). The MDGs were eight goals established by the United Nations that aimed to 
improve global health and well-being, social justice, equality and environmental 
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sustainability. At the heart of these goals was the vision that in 2015, the U5MR would have 
been reduced by two-thirds, compared to 1990 (UN, 2019a). Despite the under-five mortality 
goal not being achieved, the millennium commitment contributed to a more than 50% decline 
in the U5MR. In sub-Saharan Africa, the U5MR fell from 182 deaths per thousand live births 
in 1990 to 78 in 2018. This translates into an annual reduction rate of 3% over these 28 
years, albeit the highest annual rate was observed mostly during the MDGs era with an 
annual reduction rate equal to 3.8%. The global interest for a better, more sustainable life for 
all children was renewed with the introduction of the Sustainable Development Goals 
(SDGs), which now call for a U5MR of maximum 25 deaths per 1000 live births across all 
countries worldwide (UN, 2019b). Despite the considerable decline in U5MR in Africa over 
the past 28 years, a 2017 report from the United Nations projected future reductions in the 
U5MR and concluded that based on historical and current trends, the African continent will 
not meet the SDG target for under-five mortality (United Nations, 2017a). Additionally, under-
five mortality has been unevenly reduced across various regions of Africa, with very few 
studies having assessed the subnational variation in mortality and its main drivers. 
Therefore, the leading causes of under-five mortality need to be studied, together with their 
spatial variation, in order to inform decision makers about the dynamics of mortality and 
diseases and hence to assist the African countries on their efforts to achieve the SDGs, in a 
fair way for all their populations. In addition to the major childhood diseases, other factors 
that influence under-five mortality, for which there is a priority to be studied and assessed at 
local-scale, are health interventions and socio-economic, demographic and environmental 
factors. 
1.2 Childhood diseases 
On a global scale, the distribution of childhood diseases that drive mortality for children less 
than five years of age is investigated separately for children in the first month of life 
(neonatal) and for those aged between one and 59 months. The reason behind this 
separation is that neonatal mortality accounts for a large share of all under-five deaths, i.e. 
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approximately 47% of all under-five mortality and since there are discrepancies between the 
leading causes of neonatal mortality and those for children aged 1 to 59 months (UN IGME, 
2019). The major contributors to neonatal mortality are preterm birth complications, 
intrapartum-related events and sepsis. Conversely, pneumonia, diarrhoea, various injuries 
and malaria lead the causes of mortality for children between 1 and 59 months of age. In the 
African setting, neonatal deaths account only for 36% of total under-five mortality, albeit SSA 
has a neonatal mortality rate of 28 deaths per 1,000 live births, which is currently the highest 
globally. Additionally, due to the indigenous climatic and socio-economic conditions, tropical 
or poverty-related disease such as malaria and diarrhoea are more relevant in Africa than 
other parts of the world (WHO, 2018c). A supplementary but crucial factor underpinning 
under-five mortality is malnutrition, as it generally leads to weak immune systems that pave 
the way for easier development of diseases, and could additionally aggravate the type of 
disease that a child is already afflicted by. In Africa, it is estimated that malnutrition is 
associated with one-third of the total number of childhood deaths (WHO. Regional office for 
Africa, 2019f). Given its historical importance, significant burden and life loss, as well as its 
impact on socioeconomic development, malaria has a prominent role among the leading 
childhood diseases. 
1.2.1 Malaria 
1.2.1.1 Malaria characteristics and transmission 
Parasitic, single-cell eukaryotes of the genus Plasmodium are responsible for the malaria 
disease. Human malaria is an outcome of a Plasmodium infection and specifically by the 
injection of Plasmodium sporozoites to an uninfected person. There are six Plasmodium 
species affecting humans, which are different in geographical distribution and in the severity 
of the malarial disease that they cause in humans (Cowman, 2016). The most prevalent 
Plasmodium species are Plasmodium Falciparum (P. falciparum) and Plasmodium Vivax (P. 
vivax), with P. falciparum claiming the most deaths. Although both species are present 
across different areas of the tropics and subtropics, P. falciparum is predominantly found in 
25 
 
sub-Saharan Africa while P. vivax in the Americas (Ashley, 2018). Plasmodium malariae, 
Plasmodium ovale curtisi and Plasmodium ovale wallikeri are less prevalent than P. 
falciparum and P. vivax and are generally associated with milder forms of disease. 
Plasmodium knowlesi (P. knowlesi) is the last and most recently recognized of the six 
plasmodial species causing human malaria.  
Female mosquitos of the genus Anopheles are the vectors responsible for the carriage and 
transmission of the Plasmodium parasites to humans. In particular, the Anopheles genus 
consists of approximately 460 species, over 100 of which have the capacity to transmit 
pathogens that can lead to human malaria (Wiebe, 2017). Yet, only about 40 species can 
successfully transmit the disease, as a mosquito species needs additional qualities, such as 
long life expectancy, presence in large numbers and parasite carrying capabilities, in order 
to sustain transmission (The Malaria Atlas Project, 2019). In the African setting, the 
Anopheles gambiae complex, consisting of several closely related, indistinguishable species 
and the Anopheles funestus species constitute the cornerstone of malaria transmission 
vectors. From the Anopheles gambiae complex, the Anopheles gambiae sensu stricto is 
considered among the most successful vectors of transmitting malaria, mainly due to its 
preference on feeding on humans (anthropophilic), the very short period in which its larva is 
developed and its generally long life span.  
The malaria parasitaemia life cycle begins in the salivary grands of an infected mosquito, 
where cells, named sporozoites, capable of being infective agents when injected to humans, 
are developed. A blood meal of an infected mosquito will introduce the sporozoites to the 
dermis of the host. The sporozoites will move via the bloodstream into the liver, where they 
target and penetrate hepatocytes and within which they asexually multiply. This process 
results in the production of schizonts, which accommodate large numbers of hepatic 
merozoites. Rupture of schizonts allows the exit of merozoites from the liver and their later 
insertion into the circulatory system, in which the merozoites will use a four-stage process to 
penetrate red blood cells (RBC). Inside the RBC, the parasites de-differentiate into immature 
trophozoites and after a period of enlargement, they mature into schizonts. As before, the 
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schizonts are ruptured, resulting in the lysis of the RBC and the subsequent release of 
merozoites, which the schizonts contained. The released merozoites further penetrate 
uninfected RBC. The products of the rupture of RBC are the stimulants of the clinical 
manifestations of malaria. The continuation of malaria transmission occurs as some of the 
merozoites remain inactive and transform into micro- and macrogametocytes, which are later 
picked up by a mosquito during a blood meal. Inside the mosquito’s gut, the gametocytes 
are transformed into gametes, which after fertilization form a zygote. Subsequently, the 
zygote forms an ookinete, which invade the gut walls and become  an oocyst. The life cycle 
is concluded as sporozoites are produced within the oocyst and, after the rupture of the 
oocysts, the sporozoites end up in the mosquito’s salivary glands (Tuteja, 2007; Soulard, 
2015; Cowman, 2016; CDC, 2018a). 
1.2.1.2 Clinical manifestations and malaria diagnosis 
Acute febrile illness is typically the initial clinical sign of malaria infection, accompanied by 
other symptoms, resembling an Influenza-like illness (ILI). These symptoms differ among 
infected individuals, albeit usually including headache, joint pain, nausea, fatigue, chills and 
vomiting. The incubation period, representing the time interval between infection and initial 
clinical manifestation, spans from a mean of 12 days for P. Knowlesi and P. falciparum, to 17 
days for P. ovale or P. vivax and to at least 18 days for P. malariae (Ashley, 2018). At this 
stage, malaria is characterized as uncomplicated and hence a timely, complete treatment 
can eliminate the infection. Any new, reoccurring sign of the symptoms could be due to 
unfinished treatment (P. falciparum) or resurgence of hypnozoites in the liver, which are 
products of P. vivax or P. ovale infection and inactively reside in the liver of the infected 
individual (Cowman, 2016). 
Uncontrolled malaria infection resulted from only partial or complete absence of treatment for 
uncomplicated malaria, leads to severe malaria, which is a serious and potential fatal form of 
disease. The majority of severe malaria cases are due to P. falciparum infection and are 
dominated by damage to the central nervous system, for instance coma (cerebral malaria), 
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development of severe anemia and failures of the pulmonary or renal systems (Bartoloni, 
2012). The aforementioned complications, with the addition of sudden bursting of an 
enlarged spleen, have been reported for the less frequent case of severe vivax malaria. 
Crucially, risk of severe malaria primarily concerns young children, as people living in 
endemic populations with stable transmission naturally acquire infection-immunity 
(premunition) to malaria, which means that an individual is protected against severe illness 
and high parasitaemia while still being blood infected. 
Diagnosis of malaria concerns the observation of any clinical manifestations, the 
confirmation of the existence of parasites and the examination of an individual’s health 
history. The gold standard for laboratory diagnosis for presence of parasites is the malaria 
(light) microscopy test. Specifically, the test utilizes blood films for identifying the presence of 
parasites, their density and their speciation. An alternative to microscopy testing is the Rapid 
Diagnostics Tests (RDTs) which use a patient’s blood specimen extracted from a finger-prick 
to identify presence of malaria antigens and thus confirm parasitaemia (WHO, 2015a; CDC, 
2018b). RDTs are currently extensively used in malaria-endemic countries, reaching an 
estimated high of 75% share among all malaria tests performed in SSA, against a 40% use 
in the year 2010 (WHO, 2019a).  The rise of RDTs is mainly due to their simplicity in use, 
easy access to areas lacking good quality microscopy capabilities, speedy provision of an 
outcome and rather small amount of training required for the person performing the test. 
1.2.1.3 Malaria determinants 
Environmental factors directly influence malaria transmission and thus constitute an 
important malaria determinant. Temperature influences the time Plasmodium needs to 
develop inside the mosquito and below a specific threshold, it can even terminate the 
parasite cycle. Specifically, 180 C and 150 C are the absolute lowest temperatures at which 
P. falciparum and P. vivax can sustain their life cycle, while between 250 C and 300 C, the 
parasites experience their fastest development within the mosquito (Patz, 2006). 
Additionally, temperature influences the population dynamics of the Anopheles mosquito 
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itself, as for instance low temperatures extend the developmental period of mosquitos from 
eggs to adults and thus result in low mosquito densities (Beck-Johnson, 2013). Increase of 
altitude by 1,000 meters leads to a mean 60 C decrease in temperature and hence altitude 
influences malaria transmission and mosquito abundance (Patz, 2006). Rainfall also 
decisively influences the density of the Anopheles mosquitos, as it provides their breeding 
sites. As dry conditions influence the survival of the mosquitos, presence of scrubland or 
other suitable forms of vegetation may provide shelter and sustain transmission (Ricotta, 
2014). 
Socio-economic and demographic factors are major malaria determinants. Poverty and rural 
residency, for instance, are associated with lower housing quality, which allows the infected 
mosquitos to easier enter a residence and spread the disease (Tusting, 2015). Conversely, 
malaria disease may block individuals from regular business activities or substantially 
increase the expenses of families for diagnosis and treatment, thus leading to poverty. 
Knowledge of malaria characteristics, prevention capabilities and treatment solutions may be 
hindered by illiteracy or limited education of individuals (Degarege, 2019). Improved water 
and sanitation facilities are also associated with reduced malaria transmission (Bartram, 
2005). Children under the age of five and pregnant woman constitute the most vulnerable 
groups becoming malaria infected. 
1.2.1.4 Malaria burden 
The global estimate for the number of malaria cases for the year 2017 is 219 million cases, 
reduced by 20 million cases from 2010 (WHO, 2018b). The Africa continent disproportionally 
shares 92% of all cases occurring worldwide, from which almost all (99.7%) are due to P. 
falciparum. Nigeria, Democratic Republic of the Congo and Mozambique account for the 
highest share of cases, followed by India and 12 more African countries. Globally, 435,000 
deaths are attributed to malaria, approximately 60% of which are in children below the age of 
five. Similarly to the total number of cases, the African regions account for more than 92% of 
the total number of deaths worldwide. The disability-adjusted life-years (DALYs) for the 
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malaria disease at global scale are 45 million, encouragingly an approximately 34% 
reduction since 2007 (GBD 2017 DALYs and HALE Collaborators, 2018). An important 
aspect of malaria disease is fever, as it is the most usual clinical manifestation of 
parasitaemia infection and therefore malaria is directly associated with the fever burden. 
1.2.2 Febrile response 
Since childhood diseases are the causal agents of under-five mortality, an important 
safeguard against premature death is the observation and understanding of the clinical 
manifestations that a child exhibits. Febrile response constitutes one of the most frequent 
manifestations of illness and thus cause for medical consultation. It is defined as the above 
normal raising of the human body temperature as a response to an infection or inflammatory 
disease and which subsequently leads to improved protection through the stimulation of the 
immune system (Evans, 2015). The importance of fever as a clinical outcome is particularly 
relevant for the children below the age of five as this particular age band, together with 
elderly people and pregnant woman, have the highest risk of contracting diseases among 
the general population (WHO, 2019e). In the African setting, fever is a major public health 
concern as this part of the world accounts for the highest number of deaths under the age of 
five and because fever is the clinical manifestation of the leading causes of pre-school 
mortality, i.e. acute respiratory infection (ARI) presented as pneumonia, diarrhoea and 
malaria (WHO. Regional office for Africa, 2019f). 
An important aspect of the manifestation of fever is to accurately identify which is the 
aetiology of a febrile response. In low and middle-income countries fever can be the 
outcome of a large set of potential diseases, for instance blood parasite diseases such as 
Malaria and Trypanosomiasis, viral infections such as Dengue fever or Influenza and 
bacterial zoonoses such as Q or Trench fever (Prasad, 2015). Additionally, the majority of 
low-income countries often lack the tools and health systems needed to identify the root 
cause of a febrile response in a patient, particularly in remote areas of a given country where 
access to diagnostic tools and health facilities is limited. Hence, febrile response is 
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sometimes wrongly attributed to a particular disease and subsequently falsely treated. In the 
African setting, children under the age of five presenting fever are often over-diagnosed and 
over-treated for malaria while, for instance, recent evidence has shown that only 37.7% of all 
malaria-positive under-fives experiencing fever had developed a febrile response due to 
Plasmodium falciparum infection (Dalrymple, 2019). These estimates are alarming, 
especially since recent studies have also suggested that health-seeking behaviour for fever 
among under-fives might be rather low, since less than half of pre-school children with febrile 
response would seek treatment, even if their home were less than a two-hours distance form 
a public health facility (Alegana, 2018). 
1.3 Socio-economic, demographic and environmental factors 
An analogous association of socioeconomic, demographic and environmental factors with 
malaria exists between these factors and under-five mortality (Yaya, 2018). The wealth index 
of the household in which a child resides has, for instance, a strong effect on U5MR, as 
children living in a poor environment may have only partial or even no access to crucial 
health interventions, such as malaria bednets, ACTs or antibiotics. Rural residence may also 
hinder child well-being due to limited access to health care facilities or logistical issues 
concerning the transportation and implementation of prophylactic or curative measures in 
remote areas. Maternal education is connected with greater knowledge of health-related 
issues and thus improved family responses to health challenges. Altitude, temperature and 
humidity are among the climatic factors associated with some of the leading causes of 
under-five mortality, such as respiratory infections, diarrhoea and malaria, and so contribute 
to mortality rate (Mirsaeidi, 2016; Liu, 2016; Azage, 2017). 
1.4 Health interventions 
Preventative or curative health interventions constitute the core tool against child mortality 
and consecutively their distribution and utilization play a major role for African countries in 
their efforts to achieve the 3.2 target of the SDGs. Such interventions can be broadly 
categorized into different groups, based on the means and against which diseases they aim 
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to provide prophylactic capabilities. Vaccination interventions are preventive health solutions 
that offer immunization against infectious diseases, among others, neonatal tetanus, 
poliomyelitis and measles. Malaria preventive interventions aim to minimize the vector-
human interaction and include the access and utilization of Insecticide-treated nets (ITNs) 
and Indoor Residual Spraying (IRS) of households. Another example is micronutrient 
supplementation against Vitamin A or iron deficiency, which ensures child growth and 
provides support against infections (WHO, 2019d). In terms of curative solutions, 
prescription of antibiotics for children with ARI symptoms, Artemisinin-based combination 
therapy (ACT) against malaria, oral rehydration solution against diarrhoea and deworming 
medication are some of the core tools for treating the leading causes of under-five mortality 
in SSA. 
The core interventions against malaria infection and malaria-related mortality can be 
classified into four different groups: vector control interventions, chemoprevention, as well as 
diagnosis and treatment (WHO, 2015b). Indoor Residual Spraying (IRS), Insecticide-Treated 
Nets (ITNs) and Long-Lasting Insecticide-Treated Nets (LLINs) are members of the vector 
control interventions group aiming to minimize the human-vector interaction. These 
interventions have played a crucial role in the prevention of an estimated 663 million cases 
of clinical malaria since 2000, 68% of which have been contributed to ITNs (Bhatt, 2015). 
Chemoprevention mainly refers to the use of intermittent preventive treatment (IPT) for 
pregnant women and infants in at least moderate malaria transmission areas of SSA and 
currently primarily focuses on falciparum malaria. Artemisinin-based combination therapy 
(ACT) is the current gold standard of falciparum and vivax malaria treatment, albeit for vivax 
malaria, treatment with chloroquine in non-chloroquine-resistant areas is possible (WHO, 
2018a). In addition to the prior core interventions and as of now, the first malaria vaccine 
RTS,S/AS01 (RTS,S) is currently under evaluation for potentially being added to the core 
tools against malaria (WHO, 2019b). The vaccine is currently undergoing a pilot 
implementation programme in Ghana, Malawi and Kenya. As a final note, an ongoing threat 
to the core interventions is the emergence of insecticide resistant mosquitos, which results in 
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reduced efficacy of vector control interventions (Hemingway, 2016; Hancock, 2018; 
Kleinschmidt, 2018). 
Following the Millennium commitment for improved child health and well-being, coupled with 
a renewed interest to fight leading causes of mortality such as malaria, most countries in 
Africa experienced a rapid scaling-up in the coverage of preventative or curative health 
interventions (Snow, 2015). As an example, ownership of ITNs increased from 50 to 80 
percent over the last five years of the MDGs period, while access to ITNs within a household 
doubled (WHO, 2017a). The impact of these interventions on the survival of under-fives has 
been immense. For instance, it has been estimated that malaria control tools, championed 
by the use of ITNs, have averted 663 million clinical malaria cases for the period 2000-2015 
(Bhatt, 2015). It has also been well-documented that vaccinations, improved hygiene 
facilities and oral rehydration solutions have assisted in the decline of pneumonia and 
diarrhoea-related deaths (UN IGME, 2019). Yet, despite the proven impact of such 
interventions, an important issue regarding their distribution is the significant discrepancies 
in the coverage of interventions within and between countries (Yourkavitch, 2018). This can 
be attributed to the existence of sub-national hotspots in many countries where coverage is 
notably lower compared to other areas. As differences in health intervention coverage may 
have a significant impact on the survival of children, it is of major public health importance to 
examine and prioritize potential sub-national health inequalities. The aforementioned issue is 
especially relevant for the SSA region, as this part of the world experiences the highest 
under-five mortality burden, coupled with generally low socio-economic status that further 
fuels inequality (UNICEF, 2014).  
1.4.1 Health equities 
The remarkable reductions in the total number of under-five deaths and the strong impact of 
health interventions on children’s survival are two quantities that have not been equally 
distributed across space on the African continent. As of 2016, 13 SSA countries had an 
U5MR below 50 deaths per 1000 live births, while simultaneously seven countries had a rate 
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of more than 100 deaths (GBD 2016 Mortality Collaborators, 2017). Other studies have 
estimated and mapped at high spatial resolution unequal declines of under-five mortality 
across various regions in Africa over the MDGs period (Golding, 2017). For instance, large 
areas in Mali, Burkina Faso, Sierra Leone and the north of Nigeria and Cameroon still have 
an unacceptably high U5MR, whereas Rwanda, Uganda, Tanzania, Zimbabwe and 
Botswana saw important declines in mortality between 2000 and 2015. These discrepancies 
in U5MR can be partially explained by the variation in the effectiveness of health 
interventions. For instance, modelling studies utilizing cross-sectional, national and 
subnational representative, household-based survey data from Burkina Faso and Uganda 
concluded on strong sub-national variation in the associations between under-five mortality 
and child, maternal and household health interventions (Millogo, 2019; Nambuusi, 2019). It 
follows that these spatial discrepancies in the association of health interventions with U5M 
create inequalities for populations residing in areas where health solutions are less effective, 
compared to other regions within a country or a national average effect. The definition of 
health inequities describes inequalities that lead to unfairness and since these spatial 
variations in the effectiveness of health interventions incite unfairness for the people 
experiencing them, inequities in health interventions constitute an imminent chief priority for 
public health. Currently, modelling studies associating health interventions and under-five 
mortality at sub-national level are rather scarce, while at the same there is a sparsity of 
studies identifying health inequities based on the effectiveness of health interventions on 
pre-school mortality. Therefore, there is a need for modelling studies to assess the variation 
of the effect of health interventions in space, in order to provide key information to decision 
makers that will help to improve health equity in SSA. 
1.5 Spatial variation of under-five mortality 
The child mortality outcome is correlated in space, because it is influenced by 
environmental, socio-economic and other factors that are spatially varying. Geostatistical 
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models provide a state-of-the-art, flexible framework, which can incorporate such 
correlations. 
1.5.1 Geostatistical modelling   
Statistical models constitute a subclass of mathematical models, which quantify associations 
between random variables via mathematical expressions. Typically, one of the random 
variables called dependent variable is assumed to be explained by all others, namely 
independent variables, and it is assigned a probability distribution that is hypothesized to 
generate its realizations. Subsequently, one of the parameters of the distribution, assigned 
to the dependent random variable, is re-parametrized in terms of a function that contains a 
linear equation of all independent variables, i.e. the linear predictor. Assuming that the linear 
predictor contains only non-random quantities, i.e. the independent random variables for 
which we have observed data values, the model is called fixed effects model. An addition of 
random terms in the linear predictor, for which there are no observed data but are rather 
generated by a probability distribution, render the model a mixed effects model. 
One of the most common assumptions of statistical modelling is the independence of 
observations. Yet this hypothesis is not appropriate for ecological studies and data derived 
from processes that inherit spatial and temporal correlations (Cressie, 2009; Hoeting, 2009). 
Instead, geostatistical models refer to a class of mixed-effect models that are employed 
under the assumption of a spatially correlated outcome. The term geostatistical refers to the 
type of geographical information we possess on the data. Specifically, the geographical 
information reflects fixed spatial points, for instance, coordinates, over a continuous study 
region, e.g. a country. Other kinds of spatial data than the geostatistical (point-level) include 
aggregated quantities over a spatial area (areal data) and observations for which their 
locations are derived from a random process (point pattern data). The spatial correlation in 
geostatistical models is usually incorporated in the linear predictor as a random term, which 
is assumed to follow a multivariate distribution that incorporates a functional form of some 
measure of the distance between unique data locations in its covariance matrix (Banerjee, 
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2014). Typically, a zero-mean multivariate Gaussian distribution with exponential correlation 
function is assumed. The introduction of geostatistical modelling was made by Diggle et al. 
in 1998 (Diggle, 1998) and since then these procedures have been extensively utilized for 
modelling associations, together with mapping efforts, of various diseases and their risk 
factors in the African setting. For instance, recent studies include the modelling of the 
malaria-mortality association in Kenya (Khagayi, 2019), the impact of changes in climate on 
malaria incident cases between 2013 and 2017 in Uganda (Ssempiira, 2018) and on spatial 
patterns of schistosomiasis in Zimbabwe (Pedersen, 2017). 
The powerhouse of geostatistical modelling is Bayesian inference, as it allows for a more 
flexible, computationally advantageous model formulation over the frequentist approaches 
and addresses better heavy parametrized models for which frequentist approaches, such as 
the maximum likelihood estimation, are impractical (Gelfand, 1990). Bayesian inference 
comes in different flavours but its cornerstone has been the well-established, sampling-
based Markov Chain Monte Carlo (MCMC) methods (McElreath, 2015). The MCMC 
procedures are based on repeated sampling from the posterior distribution of the model 
parameters, with the Gibbs sampling and its by-products being perhaps the most widely 
used MCMC techniques (Gelfand, 1990). More recently, efforts on Hamiltonian Monte Carlo 
have provided a faster and more effective procedure for MCMC (Gelman, 2013). Yet 
geostatistical modelling using MCMC can be computationally expensive or even infeasible, 
as the calculations involving the geostatistical intercept require matrix operations of 
dimensionality equal to the number locations in which the data were observed. A recent, 
reliable alternative to MCMC that particularly focuses on spatio-temporal data is a 
deterministic algorithm named Integrated Nested Laplace Approximation (INLA). The INLA 
procedure is based on Gaussian Markov random fields and the use of stochastic partial 
differential equations in order to accelerate all matrix operations concerning the geostatistical 




1.5.2 Geostatistical variable selection  
Given the correlations among the child mortality determinants and the spatial correlation in 
the under-five mortality outcome, geostatistical variable selection methods can assist on 
assessing the most suitable predictors for final model fitting between under-five mortality and 
a set of predictors. Variable selection methods are statistical procedures that evaluate the 
suitability of dependent variables for subsequent model-fit and prediction, based on some 
well-defined criteria that each method sets. When properly implemented, variable selection 
procedures can offer faster statistical analysis and improve overall prediction accuracy 
(Reunanen, 2003). For fixed effect models, Stochastic Search Variable Selection (SSVS) 
was the pioneering method for parameter selection in the Bayesian inference context, by 
enabling an inclusion indicator in the prior distribution (George, 1993). Following the work of 
George and McCulloch (1993), a series of different selection methods were proposed, for 
instance methods adapting the SSVS (Kuo, 1998; Dellaportas, 2002) or methods exploring 
simultaneously the whole of model space (Green, 1995), with O’Hara and Sillanpää making 
a recent review on such methods in the Bayesian context (O’Hara, 2009). Bayesian variable 
selection methods have been further extended to mixed effects model, for instance in logistic 
regression (Kinney, 2007; Yang, 2011). Recently, interest has been attracted to variable 
selection methods for spatially varying coefficient models, a specific branch of mixed-effects 
spatial models that, in addition to a geostatistical intercept explaining the correlation in the 
response, allow one or more coefficients to vary in space (Reich, 2010; Boehm Vock, 2015; 
Zhang, 2016; Choi, 2016).  
1.5.3 Data sources 
National civil registration and vital statistics systems (CRVS) constitute the data powerhouse 
that provides key information for the health status of a country and thus is the source for 
evidence-based policies concerning society and health. CRVS records events such as birth 
and death of an individual, causes of illness and mortality, as well as marriage-related 
measures (Ye, 2012). While prominent in developed nations, SSA countries completely lack, 
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or have only partially-developed CRVS systems, which renders the adoption of evidence-
based policies challenging. To tackle this issue, Health and Demographic surveillance 
systems (HDSS) were established in SSA, with the creation of the first surveillance site in 
South Africa dating back to 1940. HDSS operate in a pre-specified geographical area, 
following prospectively a cohort of the population with the aim of monitoring information on 
key vital events (Chandramohan, 2008). The growing global presence of HDSS sites 
resulted in the creation of the International Network for the Demographic Evaluation of 
Populations and Their Health in Developing Countries (INDEPTH) in 1998, with a mandate 
of improving evidence in health based on a collaborative approach (INDEPTH Network, 
2019). As of now, INDEPTH runs a network of 49 sites across 20 countries worldwide.  
Despite the great value of INDEPTH network, its current utilization is only complementary to 
the main source of key health indicators across all countries in Africa, i.e. the Demographic 
and Health Surveys (DHS) (Ye, 2012). Established in 1984, DHS are open-access, cross-
sectional, national-representative, household-based surveys which are typically conducted 
every five years (The DHS program, 2019a). The nature of the collected data, together with 
the questionnaires and tests conducted by the program, have been considerably changed 
over the years by the continuous addition of indicators collected and the adoption of 
biomarker tests since 1995 (Corsi, 2012; The DHS program, 2019b). National-agencies, of 
the countries within which the surveys are conducted, are an integral part of the DHS 
project, which is funded by the United States Agency for International Development (USAID) 
(USAID, 2018) and implemented by the Inner City Fund (ICF) (ICF, 2019). Key components, 
relevant to our work, are measured indicators concerning under-five mortality, health 
interventions, such as malaria bed-nets and vaccination, maternal and household 
characteristics, as well as results from malaria parasitaemia and anemia haemoglobin 
testing. Complementary to the above, remote sensing and other open access data sources 
provide key information on the environmental and climatic conditions across SSA and 
therefore these data can be integrated to the DHS in order to reflect on the environmental 
and climatic conditions that each surveyed household was exposed. Examples of such data 
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sources include the U.S. Geological Survey-Earth Resources Observation Systems 
(USGSS) Data Portal, the Shuttle Radar Topography Mission (SRTM) and the Moderate 
Resolution Imaging Spectroradiometer (MODIS). 
1.6 Rationale 
The Sustainable Development Goals and the urgent need for the African countries to 
accelerate efforts on reducing U5M have inspired our work. Specifically our efforts address 
open research questions in the literature and contribute to the existing knowledge of the 
dynamics and main drivers of U5M in SSA. In terms of malaria-mortality modelling, previous 
studies utilizing survey data faced challenges associating malaria parasitaemia with U5M. 
Crucially, most of the modelling studies estimating malaria-related deaths have overlooked 
indirect causes of malaria-mortality, such as anemia. Both previous points raised are of great 
importance, as they might have resulted on underestimation of the malaria burden in SSA. In 
terms of health interventions and U5M, strong local-scale variation of the health interventions 
coverage and of the U5MR have been reported. Therefore, sub-national health inequalities 
and inequities might be present across various regions in SSA. Yet, there is sparsity of 
modelling studies identifying health inequities based on the effectiveness of health 
interventions on U5M. Further, another key issue is the contribution of the leading childhood 
diseases on fever burden. A common limitation shared among most studies investigating the 
contribution of illnesses to febrile response burden is the utilization of hospital-related data 
across a well-defined geographical area, i.e. specific, small in number, sites within a given 
country. Another shortage in the existing literature is that, to our knowledge, there are only a 
few modelling studies having tried to associate the contribution of diseases to fever at 
national level, but also exploring the geographical variation of the association within 
countries. Crucially, understanding the contribution of diseases on fever can assist with 
another widely reported issue, i.e. the over-diagnosis and hence over-treatment of malaria 
among under-five children with fever in SSA, as under-five children presenting fever in a 
health facility are mostly treated with antimalarial drugs. Furthermore, despite the proven 
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association between health interventions and under-five mortality in the African setting, there 
is a scarcity of studies taking a holistic approach and associating a large set of well proven 
for their effectiveness health interventions with under-five mortality, in order to take into 
account the synergistic effect of the scaling-up of multiple interventions. In addition, to our 
knowledge, there are no studies yet that have explicitly modelled the impact of interventions 
on the changes in mortality risk in Africa. Finally, given the recent attention attracted to 
Bayesian variable selection methods for spatially correlated data, there is a need for further 
assessing the sensitivity of such methods. 
1.7 Thesis objectives and structure  
The overall goal of this PhD thesis is to estimate spatio-temporal changes of U5M and of 
their association with health interventions and leading childhood diseases. To achieve that, 
we compiled and modeled approximately one million, cross-sectional, individual level data 
on under-five mortality and associated them with the malaria-anemia comorbidity prevalence 
and preventive or curative health interventions in sub-Saharan Africa. The core tool of our 
analysis was the development, implementation and interpretation of Bayesian geostatistical 
models with spatially varying coefficients. The point-by-point aims of this thesis are as 
follows: 
1. To estimate the association of malaria parasitaemia, anemia, and malaria-anemia 
comorbidity with all-cause U5M and evaluate the potential of malaria-anemia 
comorbidity prevalence as a measure to quantify the malaria-related deaths in SSA 
(chapter 2); 
2. To identify health inequities within countries in SSA due to the geographical variation 
in the association between curative or preventive health interventions and under-five 
mortality (chapter 3); 
3. To assess the contribution of the leading causes of U5M, e.g. malaria parasitaemia, 




4. To estimate the association between health interventions and spatio-temporal 
changes of U5M in SSA. (chapter 5); 
5. To evaluate and further develop geostatistical variable selection methods for models 
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Different methods and data sources have been utilized to determine the relationship 
between malaria and mortality in endemic countries. Most of these efforts have focused on 
deaths directly attributed to malaria, while they overlooked causes of mortality that might be 
indirectly related to the disease, for instance anemia. We estimated the association of 
malaria parasitaemia, anemia, and malaria-anemia comorbidity with all-cause under-five 
mortality and evaluated the potential of malaria-anemia comorbidity prevalence to quantify 
malaria-related deaths in sub-Saharan Africa. We analysed data from Demographic and 
Health Surveys (DHS) and employed Bayesian geostatistical models. Mortality hazard 
obtained from malaria-anemia comorbidity prevalence was up to 3·5 times higher compared 
to the hazard related to Plasmodium parasitaemia only. Malaria parasite prevalence alone 
could not always capture a statistically important association with under-five mortality. 
Geographical variation of the malaria-anemia comorbidity effect was observed in most, but 
not all, countries. We concluded that the malaria burden in sub-Saharan Africa is 
considerably underestimated when anemia in not taken into account and that the malaria-













In 2016, malaria caused an estimated 216 million clinical episodes and 445,000 deaths 
(WHO, 2017a). Sub-Saharan Africa is the most afflicted region globally; indeed, 91% of all 
malaria deaths are concentrated in this part of the world. Children under the age of 5 years 
are at highest risk and might contribute up to 70% of all malaria-related deaths. Large-scale 
control efforts led to an 18% reduction in the incidence rate of malaria between 2000 and 
2016 and six countries were certified by the World Health Organization (WHO) as malaria-
free (WHO, 2017a). In 2016, the financial investment in malaria control and elimination was 
estimated at US$ 2·7 billion. Eliminating malaria by 2030 is part of the aspirations of the 
Sustainable Development Goals (SDGs) (UN, 2018). The 10 sub-Saharan African countries 
with the highest malaria burden experienced an increase in malaria incidence from 2015 to 
2016, therefore the WHO recently launched the 10+1 initiative (WHO, 2018d) which aims to 
renew the focus on achieving the objectives set up by the Global Technical Strategy and 
Sustainable Development Goals. 
Understanding the relation between malaria transmission and malaria-related mortality 
provides a useful insight in monitoring and evaluation of malaria control and elimination 
efforts. Furthermore, it helps in the planning of interventions since regions that are expected 
to have high malaria deaths could have interventions in place, such as availability of rapid 
diagnostic tests (RDTs) and Artemisinin-based combination therapy (ACT) in health facilities 
and information campaigns to prevent progression to severe malaria and therefore death. 
Several approaches and different data sources have been utilized to quantify malaria-related 
deaths. For example, the ‘Malaria Transmission Intensity and Mortality Burden across Africa’ 
(MTIMBA) project collected geo-referenced entomological data, which were linked with all-
cause and malaria-specific mortality data derived from health and demographic surveillance 
systems (HDSS). A geostatistical analysis (Rumisha, 2014) of the MTIMBA data from the 
Rufiji HDSS in Tanzania found no significant relation between neonate, infant, and 1- to 4-
year-old child survival with malaria transmission, the latter measured by the entomological 
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inoculation rate (EIR). In contrast, a 5-year collection of monthly data from the Kisumu HDSS 
in Kenya revealed a strong association between malaria-mortality and malaria transmission, 
the latter determined by the slide positivity rate (SPR) (Khagayi, 2017). Malaria survey and 
mortality data from the Demographic and Health Surveys (DHS) linked to malaria incidence 
from the Malaria Atlas Project (MAP) suggested a 57% decrease of malaria-related mortality 
during 1990 – 2015 (Gething, 2016). However, analyses of DHS mortality data from Mali and 
Malawi with historical malaria survey data were not able to capture a statistically significant 
malaria-mortality relation (Gemperli, 2006; Kazembe, 2007). A systematic analysis (Murray, 
2012) of malaria mortality data between 1980 and 2010 estimated 1.238 million malaria 
deaths globally in 2010. 
Most of the studies estimating malaria-related deaths overlooked indirect causes of malaria 
mortality (WHO, 2017b). Indeed, one of the main outcomes of Plasmodium infection is 
anemia caused by the rupture of red blood cells as part of the complex life cycle (Kai, 2008). 
P. falciparum leads to severe malarial anemia, which might be responsible for around one 
third of malaria deaths (Haldar, 2009). Righetti and colleagues (Righetti, 2013) reported a 
significant negative association between Plasmodium infections and haemoglobin 
concentrations. Another study reported stronger associations of anemia with malaria than 
iron deficiency or other nutritional, infectious, and genetic contributors (Foote, 2013). Despite 
the proven association between anemia, malaria, and mortality, modelling studies 
quantifying the association between malaria-anemia comorbidity and under-five mortality are 
rather few. 
We estimated the association of malaria parasitaemia, anemia, and malaria-anemia 
comorbidity with all-cause under-five mortality and evaluated the potential of malaria-anemia 
comorbidity prevalence to quantify malaria-related deaths in sub-Saharan Africa. We 
compiled available household-based data collected from DHS and Malaria Indicator Surveys 
(MIS) and employed a rigorous Bayesian geostatistical modeling framework. We estimated 
within-country variation of the association between comorbidity and under-5 mortality, using 
45 
 
spatially varying coefficient models. Our results are presented at high spatial resolution, 
including model-based risk maps of malaria, anemia, and malaria-anemia comorbidity.  
2.2 Methods 
Data sources 
We analysed household representative survey data from 16 sub-Saharan African countries 
that had available malaria, anemia, and mortality data at survey locations. The surveys were 
conducted between 2010 and 2017. A summary of the data extracted from the DHS is 
provided in Table 2.1. 
For each child, the mortality-related data consisted of the age and vital status (i.e. alive or 
dead) of the child. Furthermore, we considered in the analysis information on maternal, 
household and individual child characteristics. Maternal data included the educational 
attainment and literacy of the mother, age at pregnancy, delivery methods, other pregnancy 
terminations, and time intervals succeeding or preceding birth. Each child was classified into 
a socioeconomic category, using a household-based asset index which was already 
available in the data (Rutstein, 2004). We also obtained information on the living standards 
of each child (e. g. improved sanitation facilities, improved drinking water sources, and open 
defecation practises). Individual child covariates included the sex of a child, birth order, 
breastfeeding practises of the mothers, and vaccination status. 
Malaria and anemia data were extracted from readily available MIS. Some of the surveys 
used a combination of malaria microscopy and rapid diagnostic tests (RDTs) to diagnose 
malaria, while others used RDTs only. We classified the anemia level of a child based on 
guidelines put forward by the World Health Organization (WHO), as follows: (i) moderate or 
severe anemic if haemoglobin (Hb) levels were below 100 g/l and (ii) severe anemic if Hb 
levels were below 70 g/l. We also considered indicators of malaria intervention coverage at 
cluster level such as the proportion of households reporting indoor residual spraying (IRS), 
Artemisinin-based combination therapy coverage, the proportion of use or ownership of 
insecticide-treated nets (ITN), and the prevalence of iron supplementation in order to adjust 
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for interventions. We defined comorbidity as malaria parasitaemia with moderate or severe 
anemia and severe comorbidity as parasitaemia with severe anemia. The DHS Program 
maintains strict standards for protecting the privacy of respondents and household members 
in all DHS surveys. Before each interview or biomarker test is conducted, an informed 
consent statement is read to the respondent, who may accept or decline to participate. Also, 
verbal informed consent for each parasitaemia test is provided by the child’s 
parent/guardian/caregiver on behalf of children less than 5 years before the test is 
conducted. Verbal consent is conducted by the interviewer reading a prescribed statement to 
the respondent and recording in the questionnaire whether or not the respondent consented 
or assent is provided. The interviewer signs his or her name attesting to the fact that he/she 
read the consent statement to the respondent. Written consent is not included 
(https://dhsprogram.com/publications/publication-dhsm7-dhs-questionnaires-and-
manuals.cfm). 
We extracted environmental and climatic data from remote sensing and other open access 
data sources. We downloaded from Moderate Resolution Imaging Spectroradiometer 
(MODIS) the normalized difference vegetation index (NDVI) and the land surface 
temperature (LST) at 1x1 km2 spatial resolution. We also obtained from MODIS the land 
cover type (LC) and distance from nearest water bodies (DWATER) at 0·5x0·5 km2 spatial 
resolution. LC was recoded to the following categories: forests, grasslands, and croplands. 
Rainfall data were obtained from the U.S. Geological Survey-Earth Resources Observation 
Systems (USGSS) Data Portal, while altitude data were extracted from the Shuttle Radar 
Topography Mission (SRTM) at 0·5x0·5 km2 spatial resolution. Locations were classified to 
rural or urban residence according to the Global Rural and Urban Mapping Project. 
Statistical analysis 
We fitted separate Bayesian geostatistical Weibull survival models, for each one of the 
morbidity indicators considered in our study, i.e. malaria parasitaemia, moderate/severe 
anemia, severe anemia, moderate comorbidity and severe comorbidity, in order to assess 
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their effect on all-cause under-five mortality. The outcome of the survival model outcome the 
age of death or current age of a child (in months), together with the corresponding censoring 
status, i.e. alive children were considered as censored observations. The indicators 
measured cluster-level prevalence and thus each child was associated with the prevalence 
at the corresponding cluster. Therefore, the prevalence of malaria parasitaemia, anemia, 
and malaria-anemia comorbidity at a given location was treated as an exposure that children 
receive at that location. For each model, the association between the mortality outcome and 
the corresponding indicator was adjusted for confounders, which were selected based on 
rigorous variable selection procedures, carried out separately for each country. In particular, 
we fitted separate Weibull survival geostatistical models with the candidate covariates and 
included only the statistically important ones (i.e. Bayesian credible interval did not include 
zero). We used throughout the paper terminology consistent with the Bayesian inference and 
call statistically important effects regression coefficients that are known as statistically 
significant in frequentist inference. The variance inflation factor was used to exclude the 
highly correlated predictors (O’Brien, 2007). The final models included different sets of 
covariates for each country in order to estimate the malaria parasitaemia, anemia, and 
comorbidity effect from the most parsimonious model. We included spatially random effects 
at cluster level modelled by a Gaussian process with Matérn covariance matrix (Banerjee, 
2014). 
An additional analysis was carried out to assess the sensitivity of the results to the selected 
confounders. Specifically, we re-fitted the parasitaemia and comorbidity prevalence models 
using a common set of confounders across all countries based on the biggest set derived by 
combining all country-specific confounders. Furthermore, we re-fitted the models with the 
comorbidity prevalence adjusting for parasitaemia prevalence only (prevalence of children 
with positive parasite test which are not moderate or severe anemic) and moderate-to-
severe anemia prevalence only (prevalence of moderate or severe anemic children which 
are not positive for a malaria parasite test).   
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We identified the geographical distribution in the effects of moderate comorbidity on all-
cause under-five mortality, by fitting a spatially varying coefficient model for each country, 
assuming a spatially continuous Gaussian process on the comorbidity effect. Estimates were 
summarised by the posterior median, 2·5 and 97·5 quantiles. The models were adjusted for 
malaria or anemia interventions, climatic, maternal, individual child, and household 
characteristics.  
We used geostatistical models to estimate disease risk surfaces and created national maps 
based on pixel-based estimates. Environmental predictors and spatial random effects were 
modelled on the logit scale. Prediction was carried out into a grid formed by 2x2 km2 
resolution pixels. 
The analysis was conducted in R software (version 3.3.2). We used the integrated nested 
Laplace approximations (INLA) approach (Rue, 2009) to perform fast approximate Bayesian 
inference. Model details are provided in the Appendix. 
2.3 Results 
A total of 8,116 unique locations from 16 sub-Saharan Africa countries were included in this 
study. Of these, Angola, Benin, and Uganda have the highest number of locations. The 
earliest survey from which we extracted data is from Burkina Faso, conducted in 2010, while 
the latest is from Burundi, conducted in 2016-2017. Malaria prevalence among children 
under 5 years ranged from 2.2% in Rwanda to 76·1% in Burkina Faso. All countries of West 
Africa, except Senegal, had higher malaria prevalence compared to East African countries. 
The highest moderate/severe anemia prevalence was found in Burkina Faso (69.6%). 
Burkina Faso, Guinea, and Cameroon showed, in descending order, the highest under-five 
mortality rate. Despite relatively high malaria parasitaemia and anemia levels, Ghana 
revealed the second lowest under-five mortality rate among the 16 countries examined. 
Burkina Faso, Burundi, Mozambique, and Uganda were the four countries characterized by 
a higher malaria burden compared to the anemia burden. All countries except Burkina Faso 
(11.1%) had severe anemia levels below 10% with the lowest rate observed in Rwanda 
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(0·7%). Overall, the mean malaria prevalence was 31·1%, mean moderate/severe anemia 
was 39·7%, and mean severe anemia was 3·7%. 
Our estimates (Fig. 2.1) highlight a statistically important effect of comorbidity on under-five 
mortality across all countries, except Rwanda and Tanzania. We identified a statistically 
important effect of malaria-anemia comorbidity on under-five mortality in 14 out of 16 
countries (except Rwanda and Tanzania), while malaria prevalence alone was statistically 
important in half of the countries. In Benin, the hazard ratio (HR) of comorbidity was 3·5 
times the hazard ratio of parasitaemia alone. The HR of comorbidity was approximately 50% 
higher in Cameroon, Mozambique, and Togo and approximately 30% higher in Uganda and 
the Democratic Republic of the Congo compared to the HR of parasitaemia alone. We 
observed the lowest difference in hazard ratios in Angola and Mali, with 7% and 3% higher 
malaria-anemia comorbidity hazard, respectively.  Burkina Faso was the only country with an 
important comorbidity effect and no statistically important difference in the hazard ratios of 
comorbidity and parasitaemia. 
Using the same set of confounders across all countries, we found a statistically important 
association of malaria-anemia comorbidity prevalence with under-five mortality in 9 out of 16 
countries examined (Appendix, Table 2.4). Similarly to the results above, the comorbidity 
prevalence was associated with mortality in countries which did not have an important 
parasitaemia-mortality relation. In countries with a significant parasitaemia-mortality 
association, the coefficient of the comorbidity was greater than that of parasitaemia (except 
Burkina Faso, as observed with country-specific covariates). Estimates for the comorbidity 
prevalence, adjusted for parasitaemia only prevalence, anemia only prevalence and country-
specific confounders, were higher in 7 out of 11 countries compared to unadjusted models 
for parasitaemia and anemia only prevalences (Appendix, Table 2.5). However, in the 
adjusted analyses the comorbidity was not statistically important in Angola, Guinea and Mali.   
Severe disease expressed either as severe anemia or severe comorbidity has the highest 
burden on under-five mortality. As all countries have relatively low severe anemia 
prevalence, there is high uncertainty in our estimates, contributing to important associations 
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only in 4 out of the 16 countries investigated (Fig. 2.1). However, when the severe 
comorbidity-mortality relation is captured, the HR can be more than five times higher to that 
of comorbidity, as observed in Cameroon and Côte d'Ivoire. Similarly, when we identify an 
important severe anemia-mortality association, the HR estimates of severe anemia are 
greater than the ones of comorbidity, albeit lower than that of severe comorbidity. Hence it 
can be inferred that severe disease has the greatest impact on under-five survival. 
Figure 2.2 demonstrates the geographical distribution of the comorbidity association with all-
cause under-five mortality. All countries with a statistically important comorbidity effect at 
national level demonstrate subnational geographical variations. In some countries (i.e. 
Benin, Côte d'Ivoire, Democratic Republic of the Congo and Mozambique) there are large 
areas with a statistically important comorbidity effect. In others, (i.e. Angola, Burkina Faso, 
Burundi, Cameroon and Ghana) the effect is rather focal. 
Model-based risk surfaces of the comorbidity effect on under-five mortality are presented in 
Figure 2.3 and of malaria parasitaemia and anemia in the Appendix. In some countries, we 
observed strong spatial patterns of moderate-to-severe anemia risk surfaces while in others 
there are only a few high risk hotspots. Noteworthy are areas in which coincide high malaria 
parasitaemia risk coincides with densely populated surfaces, for example in northern 
Burundi, central-south Cameroon, central Guinea, and north-east Mozambique. Severe 
anemia-malaria maps refine all areas of high risk within a country and demonstrate regions 
of severe disease, i.e. areas between Lunda Sul and the Moxico border in Angola, Ngozi 
province in Burundi, Mopti province in Mali, the south-eastern part of Senegal, North 
Tanzania, and the south-western part of Côte d'Ivoire.  
2.4 Discussion  
This is the first study assessing the association of malaria-anemia comorbidity with child 
mortality using routinely collected household survey data from DHS and MIS. We employed 
Bayesian geostatistical modeling and rigorous variable selection procedures to assess the 
geographical variation of the comorbidity effect on under-five mortality. We included in the 
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analysis survey data with information on mortality, anemia and malaria at the same location 
to avoid potential bias from surveys misaligned in space and time. 
Our findings demonstrate a strong association between under-five mortality and comorbidity 
burden, suggesting that higher prevalence of the comorbidity are related to higher mortality 
rates. Low malaria parasite prevalence, low under-five mortality, and moderate-to-high 
malaria intervention coverage were observed in countries with no statistically important 
comorbidity effects (i.e. Rwanda and Tanzania). In countries with a statistically important 
malaria-mortality relation, with the exception of Burkina Faso, the mortality hazard of 
comorbidity was higher than the mortality hazard of parasitaemia. A cross-sectional study in 
Rwanda found that children with moderate/severe anemia had a four times higher risk of 
malaria infection (Kateera, 2015). A prospective observational study in Gabon (Bouyou-
Akotet, 2009) showed that moderate/severe malarial anemia was strongly associated with 
parasitaemia in children aged below four years. Other studies (Osterbauer, 2012; 
Magalhães, 2013; Ceesay, 2015; Moraleda, 2017; Menon, 2015) also suggested a strong 
relationship between malaria and anemia, irrespective of the malaria prevalence levels 
(McCuskee, 2014). Our work demonstrates that moderate anemic children with malaria 
parasites have higher mortality hazards compared to those children with only parasitaemia. 
When a common set of confounders was used across all models, we observed an important 
comorbidity-mortality association in fewer countries, albeit these countries did not have an 
important parasitaemia-mortality association. This modelling approach incorporates, in each 
model, unnecessary covariates and it does not take into account multicollinearity which can 
bias parameter estimation. The mortality-comorbidity association was not statistically 
important in Angola, Guinea and Mali when the model was adjusted for parasitaemia only 
and anemia only prevalences. In fact these countries have the highest anemia only 
prevalence (together with Senegal and Tanzania) which may explain the variation in 




Among the factors investigated in our study, severe comorbidity has the highest impact on 
all-cause under-five mortality. Due to the low severe comorbidity prevalence, we obtained 
higher uncertainty in our estimates and thus we were only able to find an important 
association with under-five mortality in Cameroon, Côte d'Ivoire, Democratic Republic of the 
Congo, and Uganda. In these countries, the magnitude of association of severe comorbidity 
is far greater compared to that of other conditions and types of diseases examined. A study 
from the University Teaching Hospital in Ebonyi state in Nigeria showed that malaria 
accounted for approximately 77% of all children with severe anemia admission in the 
hospital (Muoneke, 2012) and associated severe anemia with high under-five mortality rates. 
In western Kenya, an association of 85% between parasitaemia and severe anemia in 
hospital admissions is reported (Obonyo, 2007), with severe anemia contributing to 
approximately half of malaria-related deaths. Severe comorbidity accounts for more than 
30% in paediatric mortality (Perkins, 2011). Apart from profound results on children survival, 
severe malarial anemia could also be associated with long-term impairment in cognitive 
ability (Bangirana, 2014). 
Our findings revealed considerable geographical variation of the malaria-anemia comorbidity 
effect on all-cause under-five mortality in most countries. Several geographical areas with 
important comorbidity association coincide with known areas in which high mortality and low 
antimalarial treatment or ITN coverage exists (Gething, 2016), for instance areas in Lunda 
Norte, Huila and Malanje provinces in Angola, Orientale, Katanga and Kivu provinces in 
Democratic Republic of the Congo, parts in north Cameroon and central Côte d'Ivoire, 
Faranan and Kankan provinces in Guinea and most of the areas shown in Mali. Additionally, 
some of the areas reside in provinces that experienced severe malaria burden at the year 
that the DHS-MIS was conducted, for instance the Orientale province in Democratic 
Republic of the Congo (DOCTORS WITHOUT BORDERS, 2018).  
In countries lacking a clear malaria-mortality relation, we found an important anemia-
mortality association. Democratic Republic of the Congo, Mozambique, and Uganda are the 
only countries in this study showing that both malaria parasite and anemia prevalence are 
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related to mortality. Greenwell and Neuman (Greenwell, 2018) supported that anemia is an 
important indicator for monitoring malaria burden. Based on our findings, the malaria-anemia 
comorbidity indicator could be used to monitor severe disease.  
Our work assessed the potential of anemia and malaria parasitaemia comorbidity prevalence 
to estimate malaria-related under-five mortality. Our findings confirm earlier results showing 
that malaria parasite prevalence alone fails to fully capture a statistically important 
association with mortality. Presence of malaria parasites is not directly linked to severe 
malaria that leads to death and thus statistical models may fail to capture the known 
association between malaria and mortality. In contrast, the comorbidity indicator can identify 
cases that experience severe disease, and hence, it is better related to mortality. It follows 
that the effect of comorbidity prevalence on all-cause under-five mortality can be a better 
indicator of malaria-related deaths than malaria prevalence alone, in survey data. Studies 
should further evaluate the use of comorbidity indicator in estimating malaria deaths for 
under-five children using malaria-specific mortality data. 
Our work does not take into account changes in prevalence that might have been occurred 
over the last five years that mortality has been studied. This assumption may influence data 
stemming from the most recent surveys, when the scaling up of malaria interventions had 
already taken place. Yet, our analysis includes mostly surveys conducted before 2013, thus 
before the further scaling up of interventions. In our study the estimated effects are 
quantifying associations and by no means imply causal relations. Children with severe 
malaria anemia are less likely to participate in DHS or MIS, leading to underestimation of this 
effect.  
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Table 2.1: Descriptive analysis of malaria survey data in 16 sub-Sahara African countries, collected from the DHS programme. 

















Angola 10/2015 - 
3/2016 
625 13·1% (R) 34·0 2·2 10·1 1·5 31·0 68 
Benin 12/2011 - 
4/2012 
747 28·4% (M) 32·1 3·0 10·9 1·0 79·8 70 
Burkina Faso 1/2010 - 
12/2010 
542 76·1% (R) 69·6 11·1 53·2 8·5 56·9 129 
Burundi 10/2016 - 
3/2017 
552 37·9% (R) 36·3 3·6 21·0 2·9 46·1 78 
Cameroon 1/2011 - 
8/2011 
577 30·0% (R) 32·8 1·7 16·8 1·4 36·4 122 
Côte d'Ivoire 12/2011 - 
5/2012 
341 41·5% (R) 49·7 3·3 27·7 2·4 67·3 108 
DRC 8/2013 - 
2/2014 
492 22·6% (M) 27·1 2·3 11·9 1·4 70·0 104 
Ghana 9/2014 - 
12/2014 
423 36·4% (R) 39·1 2·2 25·0 2·1 68·3 60 
Guinea 6/2012 - 
10/2012 
300 43·9% (M) 52·4 7·6 27·0 4·9 47·0 123 
Mali 11/2012 - 
2/2013 
413 51·6% (R) 60·8 9·3 33·4 6·7 84·4 95 
Mozambique 5/2011 - 
12/2011 
610 38·3% (R) 26·6 1·4 21·7 2·7 51·4 97 
Rwanda 11/2014 - 
4/2015 
492 2·2% (M) 15·7 0·7 1·5 0·2 80·6 50 
Senegal 10/2010 - 
4/2011 
385 2·9% (M) 53·2 4·9 2·5 0·6 62·9 72 
Tanzania 8/2015 - 
2/2016 
608 5·6% (M) 31·2 1·6 2·4 0·2 65·6 67 
Togo 10/2013 - 
4/2014 
330 36·4% (M) 44·8 2·4 22·5 1·8 65·4 88 
Uganda 6/2016 - 
12/2016 
679 30·3% (R) 29·2 2·3 17·1 1·8 78·4 64 
* Representing prevalence; ** Insecticide-treated net ownership; *** Under-five mortality (per 1,000); **** M for microscopy rest; R for RDT. 
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Figure 2.1: Bayesian estimates (posterior median, 95% BCI) of malaria parasitaemia, moderate/severe anemia (<100 g/l), severe anemia (<70 g/l), comorbidity, and severe comorbidity prevalence on 
under-five mortality in 16 sub-Sahara African countries. Models were adjusted for climate, maternal and household characteristics, malaria- anemia interventions, and individual child covariates. 
 
ANG, Angola; BEN, Benin; BFA, Burkina Faso; BUR, Burundi; CAM, Cameroon; CIV, Côte d'Ivoire; DRC, Democratic Republic of the Congo; GHA, Ghana; GUI, Guinea; 
MAL, Mali; MOZ, Mozambique; RWA, Rwanda; SEN, Senegal; TAZ, Tanzania; TOG, Togo; UGA, Uganda
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Figure 2.2: Posterior median of the malaria-anemia comorbidity effect on all-cause under-five mortality. Effects which are not statistically 
important (pixel-level posterior distribution includes zero) are indicated in grey colour. 
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Figure 2.3: Posterior median of malaria parasitaemia and moderate or severe anemia comorbidity risk estimates at 2x2 km2 from 
Bayesian geostatistical models for 16 sub-Sahara African countries. 
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Bayesian geostatistical Weibull survival model 
We developed a geostatistical Weibull survival model to assess the association of malaria, 
anemia, and malaria-anemia comorbidity with under-five mortality in 16 sub-Saharan Africa 
countries. Let 𝑠𝑠 = {𝑠𝑠1, 𝑠𝑠2, … , 𝑠𝑠𝑛𝑛}, 𝑠𝑠𝑖𝑖 ⊂ 𝑅𝑅2 be the set of surveyed locations with observed 
malaria, anemia, and mortality data. We defined 𝛵𝛵𝑗𝑗𝑖𝑖 the age of death for the j-th child at 
location 𝑠𝑠𝑖𝑖 and 𝑋𝑋𝑗𝑗𝑖𝑖 the row-vector of the associated covariates. We assumed a Weibull 
lifetime distribution for time 𝛵𝛵𝑗𝑗𝑖𝑖 with shape parameter 𝛼𝛼 and scale parameter 𝜆𝜆 and probability 
density function 𝑓𝑓�𝑡𝑡𝑗𝑗𝑖𝑖� = 𝑎𝑎 𝑡𝑡𝑗𝑗𝑖𝑖𝑎𝑎−1 𝜆𝜆 exp�−𝜆𝜆 𝑡𝑡𝑗𝑗𝑖𝑖𝑎𝑎� ,𝛼𝛼 > 0, 𝜆𝜆 > 0. Under this specification, the 
corresponding hazard ℎ(𝑡𝑡) and survival 𝑆𝑆(𝑡𝑡) have the following form: ℎ�𝑡𝑡𝑗𝑗𝑖𝑖� = 𝑎𝑎 𝑡𝑡𝑗𝑗𝑖𝑖𝑎𝑎−1 𝜆𝜆 and 
𝑆𝑆�𝑡𝑡𝑗𝑗𝑖𝑖� = exp�−𝜆𝜆𝑡𝑡𝑗𝑗𝑖𝑖𝛼𝛼�. We introduced predictors on the scale parameter using a log link 
function, that is: 𝜆𝜆𝑗𝑗𝑖𝑖 = exp�𝜂𝜂𝑗𝑗𝑖𝑖�, where  𝜂𝜂𝑗𝑗𝑖𝑖 is the linear predictor defined by the equation,  




where 𝛽𝛽 = (𝛽𝛽0,𝛽𝛽1, … ,𝛽𝛽𝜅𝜅)𝑇𝑇  is the vector of 𝛫𝛫 regression coefficients, 𝑥𝑥𝑗𝑗𝑖𝑖𝜅𝜅 represents the 
value of the κ-th predictor and 𝜉𝜉(𝑠𝑠) = (𝜉𝜉1, 𝜉𝜉2, … , 𝜉𝜉𝑛𝑛)𝜏𝜏 are multivariate Normal distributed 
random variables that take into account for spatial correlation in the response among the s 
locations. The multivariate Normal distribution followed a zero-mean specification with 
covariance between locations 𝑠𝑠1 and 𝑠𝑠2 described by the Matérn function, i.e. 𝜉𝜉(𝑠𝑠) ∼ 𝑁𝑁(0,𝛴𝛴1) 




, with 𝜎𝜎12 being the spatial process variance, 
𝑑𝑑(𝑠𝑠1, 𝑠𝑠2) the distance between locations 𝑠𝑠1 and 𝑠𝑠2 and 𝜅𝜅1 the scaling parameter. 𝛫𝛫𝜈𝜈 is the 
modified Bessel function of second kind and order 𝜈𝜈. Spatial range (𝑟𝑟1) describes the 
distance at which the spatial correlation becomes negligible and under the Matérn 
specification is defined as 𝑟𝑟1 =
√8
𝜅𝜅1
. We selected normally distributed priors 𝑁𝑁(0,10) for 
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regression coefficients and the default priors of INLA for the spatial hyperparameters and the 
shape of the Weibull distribution.  
Spatially varying coefficient modelled via a spatially continuous 
Gaussian process 
The above model was extended to include a spatially varying comorbidity effect. In 
particular, the linear predictor was written as follows: 




where 𝑏𝑏𝑖𝑖 represents a spatially continuous Gaussian process, 𝒃𝒃 ∼ 𝑁𝑁(𝛽𝛽1,𝛴𝛴2) and 𝒃𝒃 =
(𝑏𝑏1, … , 𝑏𝑏𝑛𝑛)𝜏𝜏. The mean 𝛽𝛽1 represents the global comorbidity effect (i.e. at national scale). 𝛴𝛴2 
is a Matérn covariance function with spatial process variance 𝜎𝜎22 and scaling parameter 𝜅𝜅2 
(section 1.1.1). The geographical distribution of the comorbidity effect was estimated by 
predicting the Gaussian process over a gridded surface of 2x2 km2 spatial resolution. 
Bayesian geostatistical binomial model 
We developed Bayesian geostatistical binomial models to estimate disease risk surfaces, i.e. 
malaria parasitaemia, moderate/severe anemia, severe anemia, comorbidity, and severe 
comorbidity. We defined 𝑌𝑌𝑖𝑖 as the number of diseased under-five children at location 𝑠𝑠𝑖𝑖, 𝑠𝑠 =
(𝑠𝑠1, 𝑠𝑠2, … , 𝑠𝑠𝑛𝑛)𝜏𝜏, 𝑠𝑠𝑖𝑖 ⊂ 𝑅𝑅2 and 𝑁𝑁𝑖𝑖 the total number of children observed at that location. We 
assumed that for each location 𝑠𝑠𝑖𝑖 the number of positive to the disease children 𝑌𝑌𝑖𝑖 follows a 
binomial distribution, i.e., 𝑌𝑌𝑖𝑖  | 𝑁𝑁𝑖𝑖 ,𝜋𝜋𝑖𝑖  ∼ 𝐵𝐵𝐵𝐵𝐵𝐵(𝑁𝑁𝑖𝑖 ,𝜋𝜋𝑖𝑖), with 𝜋𝜋𝑖𝑖 being the disease risk at that 
location. The disease risk 𝜋𝜋𝑖𝑖 was reparameterised in terms of predictor variables and 
regression parameters by using the logit link function as follows: 
𝑙𝑙𝑙𝑙𝑙𝑙𝐵𝐵𝑡𝑡(𝜋𝜋𝑖𝑖) = 𝛽𝛽𝜏𝜏𝑋𝑋𝑖𝑖 + 𝜑𝜑𝑖𝑖 , 
where 𝑋𝑋𝑖𝑖 is a set of environmental predictors observed at location 𝑠𝑠𝑖𝑖 and 𝛽𝛽 = (𝛽𝛽0,𝛽𝛽1, … ,𝛽𝛽𝑘𝑘)𝑇𝑇 
the corresponding regression coefficients. The latent spatial process 𝜑𝜑(𝑠𝑠) = (𝜑𝜑1,𝜑𝜑2, … ,𝜑𝜑𝑛𝑛)𝜏𝜏 
follows the same specification as defined above. 
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Environmental and climatic data 
Table 2.2: Sources of environmental and climatic data. 
Data Source Spatial resolution 
Annual average Normalised Difference 
Vegetation Index (NDVI) 
MODIS 1x1 km2 
Annual average Day and Night Land 
Surface Temperature (LST) 
MODIS 1x1 km2 
Land Cover Type (LC) MODIS 0·5x0·5 km2 
Distance from water bodies (DWATER) MODIS 0·5x0·5 km2 
Annual average Rainfall USGSS 8x8 km2 
Altitude (Digital Elevation model) SRTM 0·5x0·5 km2 
Urban rural extent GRUMP 1x1 km2 
 
Additional Results 
Table 2.3: Bayesian estimates (posterior median, 95% BCI) of malaria, anemia, and malaria-anemia comorbidity 
prevalence on under-five mortality. Models were adjusted for country-specific confounders related to climate, mother, 






















































































































































































Table 2.4: Bayesian estimates (posterior median, 95% BCI) of malaria parasitaemia and malaria-anemia comorbidity 
prevalence on under-five mortality. Models were adjusted for a common set of confounders based on the biggest set 



















































































Table 2.5: Bayesian estimates (posterior median, 95% BCI) of malaria-anemia comorbidity on under-five mortality. 
Models were adjusted for parasitaemia only prevalence (children without moderate/severe anemia), anaemia only 





Malaria-moderate/ severe anemia 
Angola 0.31 
 (-0.16,0.78) 
Benin 1.78  
(0.19,3.31) 




































Figure 2.4: Bayesian geostatistical model based malaria parasitaemia risk estimates in 16 sub-Sahara African countries at 2x2 km2. 
Angola 2015-16 Benin 2011-12 Burkina Faso 2010 Burundi 2016-17 
 
 
Cameroon 2011 Côte d'Ivoire 2011-12 DRC 2013-14 Ghana 2014 
 
 
Guinea 2012 Mali 2012-13 Mozambique 2011 Rwanda 2014-15 
 
 





Figure 2.5: Bayesian geostatistical model based moderate/severe anemia risk estimates in 16 sub-Sahara African countries at 2x2 km2. 
Angola 2015-16 Benin 2011-12 Burkina Faso 2010 Burundi 2016-17 
 
 
Cameroon 2011 Côte d'Ivoire 2011-12 DRC 2013-14 Ghana 2014 
 
 
Guinea 2012 Mali 2012-13 Mozambique 2011 Rwanda 2014-15 
 
 





Figure 2.6: Bayesian geostatistical model based severe anemia risk estimates in 16 sub-Sahara African countries at 2x2 km2. 
Angola 2015-16 Benin 2011-12 Burkina Faso 2010 Burundi 2016-17 
 
 
Cameroon 2011 Côte d'Ivoire 2011-12 DRC 2013-14 Ghana 2014 
 
 
Guinea 2012 Mali 2012-13 Mozambique 2011 Rwanda 2014-15 
 
 




Figure 2.7: Bayesian geostatistical model based severe comorbidity risk estimates in 16 sub-Sahara African countries at 2x2 km2. 
Angola 2015-16 Benin 2011-12 Burkina Faso 2010 Burundi 2016-17 
 
 
Cameroon 2011 Côte d'Ivoire 2011-12 DRC 2013-14 Ghana 2014 
 
 
Guinea 2012 Mali 2012-13 Mozambique 2011 Rwanda 2014-15 
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Under-five mortality accounted for 5.4 million deaths in 2017. The African continent is the 
most afflicted region globally, albeit saw its under-five mortality rate being more than halved 
between 1990 and 2017. Most of these gains were due to scale-up of various preventive or 
curative health interventions. Yet, the scaling-up has been unevenly distributed across 
various regions of the continent, resulting on strong disparities in the health intervention 
coverages and in the effectiveness of the interventions at sub-national level. It follows that 
health inequities exist among different, geographically defined, populations. We compiled 
data coming from the Demographic and Health surveys and developed Bayesian, Weibull-
survival, spatially varying coefficient models in order to assess the sub-national associations 
between various health interventions and all-cause under-five mortality across 28 African 
countries. We then utilized these estimates to identify health inequities within countries. 
Uganda, Ghana, Guinea, Benin, Senegal and Togo were, in descending order, the countries 
with the highest number of negative associations between health interventions and all-cause 
under-five mortality. Vaccination, vitamin A supplementation and deworming medication for 
children, as well as skilled antenatal care for pregnant woman had an important association 
with all-cause under-five mortality in almost all countries. Benin, Côte d'Ivoire, Guinea and 
Mali are the most inequitable countries in Africa, followed by Cameroon, Ghana, Liberia, 
Senegal, Mozambique, Zambia and Uganda.  Egypt, Rwanda and Burundi were the most 
equitable ones. We concluded on strong health inequities across various regions of Africa 
and on an urgent need for further assessment of the geographical effectiveness of health 







An outstanding reduction of under-five mortality was achieved between 1990 and the end of 
the Millennium Development Goals (MDGs) era, as the number of global deaths was nearly 
halved (United Nations, 2015). In the African setting and as of 2017, the mortality of under-
five years (U5M) old children was estimated to 73.7 per thousand live births, compared to a 
177.5 in the year 1990 (UNICEF, WHO, World Bank, UN DESA/Population Division, 2018). 
Yet, an estimated 5.4 million deaths in children below the age of five occurred worldwide in 
2017, with the African region being the most afflicted (WHO, 2019c). A recent report (United 
Nations, 2017a) from the United Nations (UN) highlighted the need for accelerated progress 
towards U5M reduction, if the African continent is to achieve the 3.2 target of the Sustainable 
Development Goals (SDGs), which champions the reduction of U5M to a maximum of 25 per 
thousand live birth for all countries worldwide. In Africa, the main drivers of these deaths are 
malaria, pneumonia, diarrhoea, birth asphyxia and preterm birth complications. Nigeria, 
Democratic Republic of the Congo, Ethiopia, Angola and Tanzania are among the ten 
countries with the highest number of pre-school deaths (Liu, 2016). Additionally, other 
factors such as anemia (Papaioannou, 2019) and malnutrition (WHO, 2019f), are interacting 
with the above causes of mortality and thus indirectly contributing to the total number of 
under-five deaths. 
Health interventions constitute the cornerstone in reducing U5M. During the MDGs era, the 
coverage of health interventions has been increased across most regions in Africa, leading 
to unpresented mortality reduction during that time. For instance, in 2016 it was estimated 
that 54% of the population at risk of malaria slept under an insecticide-treated net (ITN), 
compared to an estimated 30% in 2010. Additionally, during the same period, household ITN 
ownership rose to 80% from 50% while access to an ITN within a household doubled to 61% 
in 2016 (WHO, 2017a). The World Health Organization (WHO) depicts the importance of 
health interventions by informing that access to uncomplicated, reasonable-priced health 
interventions in Africa could have averted approximately half of the under the age of five 
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deaths (WHO, 2019f). A statistical analysis of cross-sectional Demographic and Health 
Surveys (DHS) data from Kenya 2014 found an important association of neonatal mortality 
with unskilled ANC provision and absence of tetanus immunization (Arunda, 2017). A 
modelling study using DHS data from 149 countries found that under-five years old children 
living in an area with full vaccination coverage have reduced mortality risk compared to 
those receiving no vaccinations and argued that scaling-up of measles and maternal tetanus 
immunization could considerably decrease U5M in sub-Saharan Africa (SSA) (McGovern, 
2015). A meta-analysis of 21 studies showed that preventive vitamin A supplementation 
resulted to a 15% decline of all-cause U5M, albeit the sub-group meta-analysis from two 
African studies showed no statistical association between vitamin A supplementation and 
pre-school mortality (Imdad, 2011).  
The remarkable reduction in U5M and increase of health intervention’s coverage have been 
accompanied by strong geographical variations of both metrics at sub-national level. For 
instance, the Global Burden of Disease (GBD) 2016 study estimated that 13 countries in 
SSA had below 50 under-five deaths per thousand live births, while at the same time 7 
countries had above 100 under-five deaths per thousand live births (GBD 2016 Mortality 
Collaborators, 2017). A modelling study (Golding, 2017) estimated U5M at 5x5 km grid cells 
in SSA and showed substantial heterogeneity in the U5M rate between and within countries, 
as well as unequal declines of pre-school mortality in the period 2000-2015. In terms of 
health interventions, data coming from national surveys such as the Malaria Indicator Survey 
(MIS) can quantify such variations in coverage. For instance, within Ghana, the household 
ownership of long-lasting insecticide-treated nets (LLIN) varies from 61% in Greater Accra 
region to 94% in the Upper East region (Ghana Statistical Service (GSS), Ghana Health 
Service (GHS), and ICF, 2017). In an effort to assess the implications of such variability, 
Bayesian geostatistical analyses of the Burkina Faso 2010 DHS and the Uganda 2011 DHS 
showed considerate sub-national variation of the associations between U5M and child, 
maternal and household health interventions (Millogo, 2019; Nambuusi, 2019). Yet, in the 
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African setting, modelling studies associating health interventions and pre-school mortality at 
sub-national level are rather scarce. 
Strong sub-national spatial variation of the health interventions coverage and of the 
association of interventions with U5M drives health inequities among the populations that 
experience these differences. The WHO describes health inequity as unfair or avoidable 
health differences, which are present among, for instance geographically defined, population 
groups (Solar, 2010). Importantly, health inequity is not to be confused with health inequality, 
as the latter does not necessarily leads to unfairness, which is included in the definition of 
health inequity (Dhaliwal, 2019). A review of DHS data from 54 countries examined 
inequities of health interventions by comparing intervention coverages, stratified by wealth 
index, and reported that, in the African setting, the most inequitable countries were Chad, 
Nigeria, Somalia, Ethiopia, Niger and Madagascar (Barros, 2012). A qualitative study 
examined the equity impact of Participatory Learning and Action (PLA) health intervention in 
women in south Asia and Africa, through 42 focus group discussions (FGDs) and reported 
that accessibility, relevance and the engaging format of the PLA intervention resulted in 
equitable effects (Morrison, 2019). A scoping review examined the health equity in the 
context of Health Impact Assessment (HIA) in SSA argued the need for a more systematic 
stratification of community subgroups (Leuenberger, 2019). To our knowledge, there is a 
sparsity of studies identifying health inequities based on the effectiveness of health 
interventions on U5M. 
Our study aims to model the geographical variation in the association between health 
interventions and U5M in order to identify health inequities experienced by populations within 
countries. To achieve that, we compiled geolocated, cross-sectional, household-based 
survey data coming from the DHS and MIS and developed Bayesian geostatistical models, 
which associate health interventions with all-cause U5M at national and sub-national level. 
Our approach allowed us to calculate the number of statistically important associations 
between interventions and mortality at regional level and hence to assess if health equity of 





To enable our study, we downloaded, compiled, and managed data from two different 
sources, i.e. the DHS program and remote sensing sources. 
Mortality and health interventions data 
We processed all-cause under-five mortality, health interventions, demographic and socio-
economic data coming from the cross-sectional, household based DHS. These are national, 
regional (states and departments) and residence representative surveys collecting key 
information on population, health and nutrition, with an overall goal to assist countries with 
monitoring and evaluation queries. The DHS program uses a stratified two-stage cluster 
design to extract the survey samples and a variety of survey instruments to obtain the data, 
i.e. questionnaires, biomarkers and geographical information. Protection of the privacy of 
respondents and household members is achieved by the strict standards employed by the 
DHS program. Specifically, an informed consent statement is read to the respondent, before 
each interview or biomarker test, and who may accept or decline to participate. A child’s 
parent/guardian/caregiver is responsible for providing verbal informed consent on behalf of 
children less than 5 years before any test is conducted. A prescribed statement to the 
respondent is read as a query for verbal consent and the reply for consent or assent is 
recorded in the questionnaire by the interviewer. The interviewer signs his or her name 
attesting having read the consent statement to the respondent. Written consent is not 
included (https://dhsprogram.com/publications/publication-dhsm7-dhs-questionnaires-and-
manuals.cfm). We utilized surveys conducted between 2010 and 2017, containing 
information on 336,735 under-five children.  
For each country and survey, we extracted a number of individual level mortality and health-
related data, as well as a number of maternal, demographic and socio-economic 
characteristics, spanning from 5,046 individual level data for Namibia to 31,225 for Nigeria. 
Specifically, we had available information on the current or death age of each child, its sex, 
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birth order, the geographical coordinates of its residence and mode of delivery. Additionally, 
we had data on the educational level of each child’s mother, age at birth and residence. 
Each child observation was linked with a wealth index, based on the wealth quantile that its 
household belonged to. For our work, we considered and extracted data on the following 
intervention categories: malaria bednets, Water, Sanitation and Hygiene (WASH) practises, 
reproductive health, breastfeeding, vaccinations, micronutrients supplementation and 
treatment of diseases. We provide a complete list and description of all health interventions 
in Table 4.1. We aggregated the health interventions at cluster level and linked them with 
each child based on the geographical coordinates of the cluster that each child was declared 
to reside. The aggregation method was preferred as various interventions are not reported 
by the DHS for the dead children and thus individual level inputs for the health interventions, 
in the statistical models employed by our study, would have resulted on biased estimates. 
Environmental and climatic data 
To adjust our models for potential confounding from infectious diseases, we used climatic 
and environmental data to approximate them. We compiled open-access data from the 
Moderate Resolution Imaging Spectroradiometer (MODIS), the U.S. Geological Survey-
Earth Resources Observation Systems (USGSS) Data portal, the Shuttle Radar Topography 
Mission (SRTM) and the Global Rural and Urban Mapping Project (GRUMP). Specifically, 
we had available information on the altitude (SRTM), normalized difference vegetation index 
(NDVI) (MODIS), land surface temperature at night (LSTN) (MODIS), land surface 
temperature at day (LSTN) (MODIS), rainfall (USGSS) and the distance to the nearest water 
bodies (DWATER) (MODIS) for each under-five child based on its geolocations. We also 
had data on the land cover type (LC) (MODIS), which we recoded to correspond to one of 
the following categories: croplands, grasslands and forests. Based on GRUMP, we classified 
the residence of each child to either urban or rural. A list of environmental and climatic data 




Statistical analysis  
We developed geostatistical Weibull survival models in order to associate health 
interventions with U5M and to identify health inequities across 28 SSA countries. 
Specifically, for each child there was available information on its survival status, i.e. zero 
(death) or one (alive), together with its death or current age. The geostatistical component of 
the model corresponds to a random intercept that accounts for the spatial correlation of the 
outcome, i.e. under-five mortality, across the different unique geolocations for which we had 
available data. This spatial random intercept was modelled via a cluster level Gaussian 
process with Matérn covariance matrix (Banerjee, 2014). The Bayesian inference summaries 
regression coefficients by their posterior distribution and thus implies that a coefficient is 
considered as statistically significant if its posterior Bayesian Credible Interval does not 
include the value zero. Throughout the paper, we call (statistically) important effects or 
associations the regression coefficients that would have been considered as statistically 
significant by frequentist inference.  
We conducted a bivariate geostatistical variable selection procedure for each country and 
health intervention, separately, in order to consider interventions for the final model fit 
(Appendix). Then, a spatially varying coefficient extension of the Bayesian geostatistical 
Weibull survival model was employed and fitted for each country and intervention, 
separately, to estimate the effect of each intervention at sub-national (province) level. The 
spatially varying coefficient formulation was achieved by incorporating an additional random 
slope with exchangeable structure (for the coefficient of the health intervention) to the 
random part of the linear predictor. The posterior mean of the regression coefficient of the 
health intervention was interpreted as the national effect in the intervention-U5M association. 
A posterior sample of size 1,000 was obtained from the province-specific effects and was 
added up to national estimate in order to obtain the province-level association between the 
health intervention and U5M. When the 95% of the posterior sample was important (did not 
include zero), we concluded an important association. All spatially varying coefficient models 
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were adjusted for maternal, individual-child, socio-economic, environmental and climatic 
factors. We also used, prior to model fitting, the Variance Inflation Factor (VIF) to exclude 
highly correlated predictors from the model and thus to avoid collinearity (O’Brien, 2007). All 
national estimates are presented in Table 4.2 and the total number of province-level 
important association for each country is illustrated in Figure 4.1. In Figure 4.2, we extracted 
all province-level U5M rates from the DHS reports and illustrated them in a continental Africa 
map.  
We used the R software (version 3.6.1) (R Core Team (2019), 2019) and its associated 
integrated development environment, the RStudio (RStudio Team (2018), 2018), for the data 
management, statistical analysis and mapping efforts. Bayesian inference was performed 
using the Integrated Nested Laplace Approximation (INLA) (Rue, 2009; Lindgren, 2011). 
Appendix contains further information concerning our model specification.  
3.3 Results 
Our study included 16,693 unique locations across 28 countries in Africa, ranging from 214 
locations in Senegal to 1,741 locations in Egypt. The earliest survey incorporated in our 
analysis was from the Burkina Faso 2010 DHS while the latest from the Benin 2017 DHS, 
with the average survey year being between 2013 and 2014. Nigeria had the richest dataset, 
including 31,225 under-five children, while the Namibian dataset had the lowest number of 
observations, accounting for 5,046 children. Egypt had by far the lowest U5M rate among 
the countries considered in the study, with Rwanda, Senegal, Kenya and Namibia having an 
U5M rate of approximately 52 deaths per 1,000 live births. Contrarily, Sierra Leone, Chad, 
Burkina Faso, Guinea and Cameroon had, in descending order, the highest U5M. 
Considerable variation in coverage was observed between countries and across different 
health interventions. Specifically, across all countries, the highest mean coverage, 
accounting for more than 85%, was observed in Bacillus Calmette–Guérin (BCG) 
vaccination, presence of iodized salt in a household and the reception of antenatal care 
(ANC) from a skilled provider for pregnant woman. The lowest mean coverages, accounting 
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for less than 30%, were reported for iron supplementation, intake of Artemisinin-combination 
therapy (ACT) for children with fever and the percentage of new-borns receiving first 
postnatal check-up from a skilled provider within hours after delivery. When focusing on a 
single health intervention, strong between-countries differences in coverage were also 
noted. For instance, ownership of at least one Insecticide-Treated net (ITN) varied from 
below 35% in Angola and Namibia to above 90% in Benin. Additionally, prevalence of 
vitamin A supplementation for children was measured at 6% for Angola and at 86.4% for 
Rwanda, while exclusive breastfeeding practises ranged from 0.3% in chad to 87.3% in 
Rwanda. Overall, Benin championed all malaria bed-net coverages, primarily because the 
Benin survey was the most recent we included in our study, and Rwanda was the country 
with the highest coverages across most health interventions. A description of health 
interventions can be found in Table 4.1, while a summary of the data in the Appendix. 
Results from the bivariate geostatistical variable selection and the national estimates of the 
association between health interventions and U5M (using the spatially varying coefficient 
models) demonstrated substantial differences across health interventions and countries. 
Diphtheria, Tetanus, and Pertussis (DPT), Measles and BCG vaccinations were negatively 
statistically associated with all-cause U5M in all 28 countries included in our analysis. 
Additionally, vaccination interventions had, in most occasions, the highest magnitude of 
association with U5M. Vitamin A supplementation for children, skilled ANC for pregnant 
woman, deworming medication in the past 6 months and immunization against polio and 
neonatal Tetanus were associated with decreased mortality risk in more than 20 countries. 
Contrarily, ACT and exclusive breastfeeding had the lowest number of bivariate statistical 
associations. Bed-net interventions against malaria were considered in our study through 
five distinct coverage indicators. We observed that cumulatively in nine countries at least 
one bed-net indicator was associated with U5M. Uganda, Ghana, Guinea, Benin, Senegal 
and Togo were, in descending order, the countries with the highest number of health 
interventions associated with all-cause U5M. On the other hand, Tanzania had the fewest 
associations. On average, 12 health interventions were associated with mortality for each 
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country. All results from the bivariate geostatistical variable selection are presented in the 
Appendix. 
Our multivariate geostatistical models with spatially varying coefficients for the effects of 
intervention coverage suggest strong sub-national health inequities, based on the number of 
within-country associations between health interventions and U5M. Benin, Côte d'Ivoire, 
Guinea and Mali are the most inequitable countries, as they contain simultaneously at least 
one province with very few (0 to 3) important interventions and at least one province with 
many effective interventions (at least 10). Cameroon, Ghana, Liberia, Senegal, 
Mozambique, Zambia and Uganda demonstrate also important disparities within their 
borders. Contrarily, Egypt, Rwanda and Burundi are the most equitable countries, as all 
theirs provinces share approximately the same number of health interventions with 
statistically important effects on U5M. Generally, poor performance of health interventions, 
by means of the number of statistically important associations, is observed in most parts of 
Angola, Chad and Nigeria, some regions of Tanzania and Ethiopia, the Savanes region of 
Côte d'Ivoire, the Donga department of Benin, the Mopti region in Mali and the north-west 
areas of Guinea (Figure 4.1).  
3.4 Discussion 
To our knowledge, this is the first study to link health inequity with the geographical variation 
of the effects of health interventions on mortality across most countries in Africa. We 
employed rigorous geostatistical models and used data of highest quality generated from 
DHS and MIS. Our results indicate health inequities based on large differences of the total 
number of effective interventions at subnational level, across different regions of Africa. 
We defined inequalities according to the differences in the number of interventions that are 
statistically associated to U5M between regions. Hence, the provinces of countries like 
Angola are not considered to experience inequalities as they were identified having almost 
the same number of important associations, albeit unacceptably low. Our model-based 
health equity map (Figure 4.1) coincides with a recent map presenting the estimated equity 
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index for deworming, based on DHS data for household wealth index and the corresponding 
coverage, in low and middle-income countries (Lo, 2019). Another study (Wariri, 2019) 
utilized data from the World Health Organization (WHO) and the United Nations International 
Children’s Emergency Fund (UNICEF) to evaluate equality gaps in Bacille Calmette Guerin 
(BCG) and diphtheria-tetanus-pertussis dose 3 (DPT3) and reported health inequities for 
Guinea, Mali, Nigeria (BCG and DPT3) and Cote d’Ivoire (BCG), which we also reported 
among the most inequitable countries. A recent trend and multi-country pooled analysis 
(Taylor, 2017) studied equity tendencies in ITN ownership using DHS data for 19 SSA 
countries and concluded that Mali and Mozambique had not experience better equity from 
2006-2007 to 2011-2013 (years in which the DHS surveys were conducted), with Senegal 
showing worsened equity trends among the two periods. These results from the trend 
analysis coincide with our conclusions, albeit they also reported a decrease in equity for 
Angola.  
Our statistical analysis models associations between the outcome and the predictors and it 
does not imply causal relations, for which a causal modelling approach should have been 
used. Lack of association between health interventions and U5M, as obtained from our 
variable selection approach, does not imply that the corresponding intervention is not 
effective against U5M, but instead it means that geographical changes in the coverage of a 
specific intervention are not associated with changes in all-cause under-five mortality. Our 
analysis does not consider changes in the coverage of health interventions during the 5 
years period that mortality has been estimated from a given survey. This may have led to an 
underestimation of the association of some of the interventions with all-cause pre-school 
mortality. 
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Table 3.1: Description of health interventions. 
Intervention Description of Intervention 
Malaria bednets   
%H_1ITN Percentage of households with at least one Insecticide-Treated net (ITN) 
%H_1ITN2 Percentage of households with at least one ITN for every two people 
%P_ITNA Percentage of population with access to an ITN within their household 
%P_ITNS Percentage of population in a household that slept under an ITN the previous night before the survey 
%P_ITN5 Percentage of under-five children in a household who slept under an ITN the night before the survey 
%P_ITNU Percentage of existing ITNs used by the population in a household the previous night of the survey 
WASH  
Improved Water Percentage of households with improved source of drinking water 
Improved Sanitation Percentage of households with improved sanitation facilities 
Reproductive health  
ANC provider Percentage of pregnant mothers receiving antenatal care (ANC) from a skilled provider 
4+ ANC visits Percentage of pregnant woman making at least four ANC visits during their pregnancy 
Fansidar Percentage of pregnant woman which received Fansidar during pregnancy 
Postnatal Care Percentage of new-borns receiving first postnatal check-up from a skilled provider within hours after delivery 
Breastfeeding   
Immediate  Percentage of infants which breastfed within one hour after birth 
Exclusive Percentage of infants which exclusively breastfed during the first six months after delivery 
Vaccinations  
Tetanus Percentage of last-born children protected against neonatal Tetanus 
BCG Percentage of children vaccinated against Bacillus Calmette–Guérin (BCG) 
DPT Percentage of children with complete  Diphtheria, Tetanus, and Pertussis (DPT) vaccination 
Polio Percentage of children with complete Polio vaccination 
Measles Percentage of children vaccinated against Measles 
Micronutrients  
Vitamin A Percentage of children which received vitamin A supplements in the past 6 months 
Iron Percentage of children which received iron supplements in the past 7 days 
Iodized salt Percentage of children which lived in a household with positive test for iodized salt 
Treatments  
ORS Percentage of children with diarrhoea given fluid from oral rehydration solution (ORS) 
ACT Percentage of children with fever during the two weeks prior to the survey which took Artemisinin-combination therapy (ACT) 





Table 3.2: Posterior estimates of health interventions on U5M, at national scale, obtained from a spatially varying coefficient model and adjusted for demographic, socio-economic and climatic 
confounders. Estimates are presented for the health interventions, which were estimated to be statistically associated with U5M, based on a bivariate geostatistical variable selection procedure. 
 Angola Benin Burkina Faso Burundi Cameroon Chad DRC 
H_1ITN        
H_1ITN2        
P_ITNA        
P_ITNS        
P_ITN5       -0.43 (-0.85,-0.01) 
P_ITNU       -0.68 (-1.23,-0.14) 
Improved 
Water 
  -0.33 (-0.60,-0.06)     
Improved 
Sanitation 
 -0.59 (-1.29,0.10) -0.33 (-0.90,0.24) -0.59 (-0.99,-0.19)  -0.88 (-1.47,-0.28) -0.54 (-0.92,-0.16) 
ANC 
provider 
-0.63 (-1.30,0.03) -0.80 (-1.33,-0.26) -0.46 (-0.86,-0.07) -2.27 (-3.38,-1.15) -0.61 (-1.25,0.02) -0.52 (-0.94,-0.10)  
4+ ANC 
visits 
-0.28 (-0.96,0.40) -0.81 (-1.38,-0.25) -0.23 (-0.79,0.21)  -1.01 (-1.58,-0.43)   
Fansidar -0.27 (-0.96,0.43) -1.03 (-1.54,-0.51)    -0.59 (-1.12,-0.05)  
Post. Care   -0.44 (-1.01,0.13)     
Immediate     -0.25 (-0.65,0.16)   
Exclusive        
Tetanus -0.68 (-1.36,0) -1.07 (-1.59,-0.55) -1.54 (-2.16,-0.92)  -0.86 (-1.50,-0.23) -0.50 (-0.92,-0.07)  
BCG -0.73 (-1.37,-0.08) -1.82 (-2.45,-1.19) -3.12 (-3.61,-2.62) -4.02 (-4.92,-3.13) -3.21 (-3.77,-2.64) -0.65 (-0.94,-0.36) -1.43 (-1.76,-1.10) 
DPT -1.16 (-2.02,-0.30) -1.54 (-2.13,-0.95) -1.82 (-2.24,-1.41) -3.54 (-4.42,-2.67) -1.62 (-2.04,-1.21) -0.52 (-0.90,-0.14) -1.09 (-1.42,-0.76) 
Polio -0.77 (-1.68,0.14) -1.37 (-1.98,-0.76) -1.56 (-1.97,-1.16) -2.47 (-3.23,-1.71) -1.18 (-1.60,-0.75) -0.59 (-1.06,-0.13) -0.80 (-1.27,-0.34) 
Measles -0.69 (-1.50,0.12) -1.37 (-2.03,-0.71) -2.16 (-2.60,-1.71) -2.92 (-3.77,-2.08) -2.06 (-2.53,-1.58) -0.69 (-1.01,-0.37) -1.51 (-1.90,-1.13) 
Vitamin A  -0.75 (-1.13,-0.37) -0.84 (-1.18,-0.51) -1.50 (-1.99,-1.02) -0.83 (-1.28,-0.37) -0.48 (-0.86,-0.10) -0.94 (-1.28,-0.59) 
Iron  -0.40 (-0.92,0.11)   -1.03 (-2.06,-0.01)  -1.06 (-1.62,-0.50) 
Iodized Salt  -0.82 (-1.47,-0.17)      
ORS     -1.76 (-3.49,-0.03)   
ACT      -0.88 (-1.75,-0.01)  












 Egypt Ethiopia Gabon Ghana Guinea Ivory Coast Kenya 
H_1ITN     -0.62 (-1.18,-0.06)   
H_1ITN2        
P_ITNA     -0.70 (-1.52,0.11)   
P_ITNS        
P_ITN5    -0.93 (-1.77,-0.10)    
P_ITNU        
Improved 
Water 
       
Improved 
Sanitation 
-0.34 (-0.87,0.20) -0.55 (-1.43,0.33)   -0.50 (-1.11,0.12) -0.29 (-0.85,0.27)  
ANC provider -0.46 (-1.19,0.27) -0.41 (-0.94,0.11) -1.98 (-3.03,-0.92) -2.80 (-4.05,-1.56) -0.85 (-1.40,-0.30) -1.58 (-2.26,-0.90) -1.36 (-1.98,-0.74) 
4+ ANC visits  -0.56 (-1.22,0.09)  -1.51 (-2.44,-0.57) -0.80 (-1.45,-0.15) -0.83 (-1.50,-0.16)  
Fansidar    -1.93 (-2.92,-0.94) -0.26 (-0.91,0.39)   
Post. Care    -1.29 (-2.43,-0.15)    
Immediate  -0.47 (-0.96,0.02) -0.87 (-1.52,-0.22) -0.76 (-1.41,-0.11)  -0.34 (-0.82,0.14) -0.67 (-0.27,0.03) 
Exclusive        
Tetanus -1.12 (-1.70,-0.55) -0.74 (-1.29,-0.19) -1.95 (-3.04,-0.85) -1.91 (-3.02,-0.81) -1.10 (-1.74,-0.45) -1.37 (-2.03,-0.71)  
BCG -6.14 (-6.57,-5.71) -0.99 (-1.61,-0.36) -2.84 (-3.70,-1.97) -4.78 (-5.84,-3.73) -1.65 (-2.18,-1.13) -1.85 (-2.34,-1.37) -5.58 (-6.22,-4.94) 
DPT -4.61 (-5.13,-4.10) -0.61 (-1.29,0.07) -1.62 (-2.60,-0.64) -2.38 (-3.24,-1.52) -0.62 (-1.12,-0.13) -1.28 (-1.75,-0.81) -2.90 (-3.38,-2.42) 
Polio -3.86 (-4.41,-3.31) -1.20 (-2.17,-0.23)  -1.49 (-2.25,-0.74) -0.84 (-1.40,-0.28) -1.06 (-1.56,-0.57) -0.88 (-1.25,-0.51) 
Measles -1.90 (-2.47,-1.33) -1.05 (-1.77,-0.32) -1.55 (-2.42,-0.68) -3.53 (-4.55,-2.50) -1.11 (-1.62,-0.60) -1.40 (-1.96,-0.84) -2.74 (-3.27,-2.22) 
Vitamin A -1.25 (-2.05,-0.46) -1.01 (-1.50,-0.52) -1.75 (-2.61,-0.89) -1.26 (-2.01,-0.50) -0.72 (-1.27,-0.16) -0.47 (-0.92,-0.02) -1.59 (-2.01,-1.17) 
Iron -1.39 (-2.59,-0.20)       
Iodized Salt        
ORS     -1.88 (-3.58,-0.18)   
ACT    -0.61 (-1.05,-0.16)    










 Liberia Malawi Mali Mozambique Namibia Nigeria Rwanda 
H_1ITN       -1.00 (-1.93,-0.07) 
H_1ITN2        
P_ITNA       -0.81 (-1.68,0.06) 
P_ITNS  -0.58 (-1.11,-0.04) -1.00 (-1.76,-0.24)     
P_ITN5  -0.76 (-1.20,-0.33) -0.82 (-1.44,-0.20)     
P_ITNU  -0.44 (-0.92,0.03)      
Improved 
Water 
     -0.12 (-0.28,0.04)  
Improved 
Sanitation 
     -0.17 (-0.40,0.05)  
ANC provider -1.71 (-2.66,-0.77) -1.91 (-2.67,-1.14) -0.96 (-1.60,-0.32) -1.04 (-1.76,-0.32) -1.31 (-2.46,-0.16) -0.19 (-0.53,0.14) -1.99 (-3.36,-0.63) 
4+ ANC visits -1.20 (-1.91,-0.49) -0.83 (-1.43,-0.23) -1.22 (-1.96,-0.49) -0.91 (-1.54,-0.27) -0.84 (-1.74,0.06) -0.08 (-0.44,0.28) -1.57 (-2.48,-0.65) 
Fansidar  -1.87 (-2.59,-1.15)  -1.02 (-1.70,-0.35)  -0.19 (-0.67,0.29)  
Post. Care      -0.74 (-1.46,-0.03)  
Immediate  -0.85 (-1.35,-0.34)  -0.63 (-1.15,-0.11) -1.16 (-1.95,-0.36) -0.46 (-0.75,-0.17) -1.66 (-2.58,-0.73) 
Exclusive        
Tetanus -1.63 (-2.44,-0.83) -1.42 (-2.09,-0.75) -0.91 (-1.54,-0.27) -0.92 (-1.55,-0.30)  -0.24 (-0.60,0.11)  
BCG -2.31 (-2.89,-1.73) -2.94 (-3.70,-2.19) -1.50 (-1.96,-1.04) -3.25 (-3.81,-2.67) -5.62 (-6.79,-4.45) -0.93 (-1.22,-0.63) -8.12 (-9.47,-6.78) 
DPT -1.44 (-1.97,-0.90) -2.24 (-2.98,-1.51) -0.90 (-1.36,-0.45) -1.96 (-2.44,-1.47) -2.36 (-3.21,-1.51) -1.00 (-1.33,-0.68) -5.38 (-6.41,-4.35) 
Polio -1.03 (-1.63,-0.43) -0.91 (-1.53,-0.28) -0.69 (-1.28,-0.10) -1.59 (-2.05,-1.12) -1.39 (-2.22,-0.56) -0.94 (-1.32,-0.55) -2.81 (-3.55,-2.07) 
Measles -2.06 (-2.67,-1.45) -1.37 (-2.12,-0.63) -1.12 (-1.61,-0.64) -2.72 (-3.25,-2.18) -2.64 (-3.56,-1.72) -0.97 (-1.31,-0.64) -0.77 (-1.38,-0.16) 
Vitamin A -0.87 (-1.36,-0.37) -1.50 (-1.98,-1.03) -1.01 (-1.45,-0.57) -2.27 (-2.80,-1.75) -2.83 (-3.64,-2.02) -0.91 (-1.24,-0.58) -3.31 (-4.18,-2.44) 
Iron -0.68 (-1.47,0.11)  -1.24 (-1.84,-0.64) -0.67 (-1.36,0.01)    
Iodized Salt  -0.33 (-0.64,-0.01)      
ORS    -1.49 (-2.87,-0.11)    
ACT        










 Senegal Sierra Leone Tanzania Togo Uganda Zambia Zimbabwe 
H_1ITN     -1.02 (-1.54,-0.50)   
H_1ITN2     -0.75 (-1.25,-0.25)   
P_ITNA     -0.95 (-1.46,-0.44)   
P_ITNS     -0.72 (-1.23,-0.22) -0.75 (-1.31,-0.19)  
P_ITN5     -0.66 (-1.10,-0.22) -0.59 (-1.04,-0.15)  
P_ITNU -0.71 (-1.29,-0.13)       
Improved 
Water 
   -0.28 (-0.64,0.07)    
Improved 
Sanitation 
-0.33 (-1.03,0.36)   -1.08 (-2.44,0.28)    
ANC provider -0.79 (-2.07,0.48) -1.18 (-2.19,-0.18)  -0.70 (-1.39,-0.02) -1.55 (-2.43,-0.68) -1.54 (-2.38,-0.72) -2.39 (-3.22,-1.55) 
4+ ANC visits -1.73 (-2.84,-0.62) -0.83 (-1.40,-0.26)  -0.62 (-1.36,0.13) -0.88 (-1.53,-0.24)  -1.76 (-2.60,-0.91) 
Fansidar -1.22 (-2.39,-0.05)   -1.18 (-1.92,-0.44) -1.06 (-1.73,-0.39) -1.29 (-2.01,-0.56)  
Post. Care -1.39 (-2.28,-0.50)       
Immediate    -0.54 (-1.03,-0.05)  -0.57 (-1.02,-0.12) -0.61 (-1.37,0.15) 
Exclusive      -1.62 (-2.90,-0.35) -1.19 (-2.11,-0.26) 
Tetanus -0.79 (-1.96,-0.38) -1.42 (-2.37,-0.48)  -0.91 (-1.75,-0.08) -1.18 (-1.90,-0.46)  -2.21 (-3.08,-1.35) 
BCG -1.86 (-2.80,-0.93) -3.63 (-4.27,-3.00) -2.04 (-2.89,-1.19) -3.71 (-4.57,-2.85) -2.81 (-3.60,-2.01) -4.57 (-5.21,-3.92) -1.79 (-2.79,-0.79) 
DPT -1.74 (-2.51,-0.96) -1.57 (-2.03,-1.11) -1.28 (-2.05,-0.52) -1.76 (-2.40,-1.13) -2.23 (-2.91,-1.56) -2.34 (-2.86,-1.82) -1.07 (-2.06,-0.08) 
Polio -1.01 (-1.76,-0.26) -1.54 (-1.99,-1.08)  -1.37 (-2.08,-0.67) -1.90 (-2.57,-1.22) -1.04 (-1.59,-0.49)  
Measles -2.03 (-2.86,-1.20) -2.29 (-2.88,-1.70) -1.28 (-2.14,-0.43) -1.96 (-2.67,-1.26) -1.86 (-2.60,-1.11) -3.34 (-3.95,-2.74) -1.81 (-2.88,-0.73) 
Vitamin A -1.78 (-2.74,-0.83) -1.92 (-2.43,-1.42) -1.03 (-1.64,-0.42) -2.30 (-2.91,-1.69) -1.08 (-1.54,-0.62) -2.10 (-2.62,-1.59) -2.10 (-2.62,-1.59) 
Iron  -1.00 (-1.52,-0.49)      
Iodized Salt  -0.36 (-0.70,-0.01)   -0.65 (-1.54,0.24)   
ORS   -2.63 (-4.32,-0.94)     
ACT        




Figure 3.1: Number of statistically important associations between health interventions and U5M, presented at 






Figure 3.2: Under-five mortality rate, presented at administrative level 1, for all countries included in the study. Data 
were extracted from the DHS program.  
Egypt: All areas have an U5M rate of less than 40 per thousand live births, except the rural regions of Upper Egypt, which have 
an U5M rate of 42 deaths per thousand live births. 
Senegal: U5M rates for the Senegal continuous DHS 2016 were reported by major regions, instead of provinces. We used data 
from the continuous DHS 2017, which reported U5M at province-level. 






Let the age of a child being represented by 𝛵𝛵𝑗𝑗𝑖𝑖, with 𝑗𝑗 corresponding to each child and 
𝐵𝐵 corresponding to one of the 𝐵𝐵 surveyed locations, i.e. 𝑠𝑠 = {𝑠𝑠1, 𝑠𝑠2, … , 𝑠𝑠𝑛𝑛}, 𝑠𝑠𝑖𝑖 ⊂ 𝑅𝑅2 is the set of 
surveyed locations. 𝛵𝛵𝑗𝑗𝑖𝑖 was assigned a Weibull lifetime distribution which assumes a fixed 
shape parameter 𝛼𝛼 and a scale parameter 𝜆𝜆 that is reparametrized in terms of model 
parameters. Specifically: 
𝜆𝜆𝑗𝑗𝑖𝑖 = exp�𝜂𝜂𝑗𝑗𝑖𝑖�, 




where 𝜂𝜂𝑗𝑗𝑖𝑖 is the linear predictor (linked with the scale parameter using the log link function), 
𝛽𝛽 = (𝛽𝛽0,𝛽𝛽1, … ,𝛽𝛽𝜅𝜅)𝑇𝑇  is the vector of 𝛫𝛫 regression coefficients (corresponding to the health 
intervention and its confounders) and 𝑥𝑥𝑗𝑗𝑖𝑖𝜅𝜅 represents the value of the κ-th predictor for the 𝑗𝑗-
th child at the 𝐵𝐵-th location. A zero-mean, multivariate Gaussian distributed random vector 
with Matérn covariance matrix 𝜉𝜉(𝑠𝑠) = (𝜉𝜉1, 𝜉𝜉2, … , 𝜉𝜉𝑛𝑛)𝜏𝜏 corresponds to a location-specific 
(cluster) random effect that accounts for the spatial correlation in the outcome, i.e. under-five 
mortality. As the name suggests, the Matérn function governs the covariance between 





with 𝜎𝜎12 being the spatial process variance, 𝑑𝑑(𝑠𝑠1, 𝑠𝑠2) the distance between locations 𝑠𝑠1 and 𝑠𝑠2 
and 𝜅𝜅1 the scaling parameter. The modified Bessel function of second kind and order 𝜈𝜈 is 
represented by 𝛫𝛫𝜈𝜈 in the Matérn’s function formula. The Matérn specification defines the 
spatial range 𝑟𝑟1 as 𝑟𝑟1 =
√8
𝜅𝜅1
  that particularly determines the distance at which the spatial 
correlation becomes negligible. The above model specification describes the bivariate 
geostatistical Weibull survival model, which we used to select the subset of statistically 
important health interventions from all 25 health interventions considered in our study. The 
selected interventions were fitted separately for each country using an extension of the 
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above model, specifically a spatially varying coefficient model. Assuming that from the set of 
regression coefficients 𝛽𝛽 = (𝛽𝛽0,𝛽𝛽1, … ,𝛽𝛽𝜅𝜅)𝑇𝑇, the 𝛽𝛽1 corresponds to the effect of a health 
interventions on under-five mortality and hence the set (𝛽𝛽2, , … ,𝛽𝛽𝜅𝜅)𝑇𝑇 corresponds to the 
confounders. The spatially varying specification is achieved by the addition of a random 
slope, which makes the model flexible to allow for estimation of sub-national (province) level 
effects:  
𝜆𝜆𝑗𝑗𝑖𝑖 = exp�𝜂𝜂𝑗𝑗𝑖𝑖�, 
𝜂𝜂𝑗𝑗𝑖𝑖 = 𝛽𝛽0 + �𝛽𝛽1 + 𝜀𝜀1 𝑚𝑚(𝑖𝑖)� 𝑥𝑥𝑗𝑗𝑖𝑖1 + �𝛽𝛽𝜅𝜅𝑥𝑥𝑗𝑗𝑖𝑖𝜅𝜅
𝛫𝛫
𝜅𝜅=2
+ 𝜉𝜉𝑖𝑖 , 
where now, we 𝛽𝛽1 represents the national effect of the health intervention on under-five 
mortality, 𝜀𝜀1 = (𝜀𝜀11, … , 𝜀𝜀1𝑀𝑀)𝑇𝑇 are the spatially varying effects of 𝛽𝛽1 at the different 𝑀𝑀 
provinces of each country and 𝑚𝑚(𝐵𝐵) acting as a filter on which of the 𝑀𝑀 provinces the 𝑗𝑗-th 
child at the 𝐵𝐵-th location belongs. 𝜀𝜀1 is a vector of independent and Gaussian distributed 
random variables for which their exchangeable structure implies that region identifiers are 
weighted by the values of the health intervention coverage and follow an exchangeable 




 √𝜏𝜏 exp (−
1
2




Environmental and climatic data 
Table 3.3: Sources of environmental and climatic data. 
Data Source Spatial resolution 
Annual average Normalised Difference 
Vegetation Index (NDVI) 
MODIS 1x1 km2  
Annual average Day and Night Land 
Surface Temperature (LST) 
MODIS 1x1 km2  
Land Cover Type (LC) MODIS 0·5x0·5 km2 
Distance from water bodies (DWATER) MODIS 0·5x0·5 km2 
Annual average Rainfall USGSS 8x8 km2 
Altitude (Digital Elevation model) SRTM 0·5x0·5 km2 




















Angola 2015 625 14322 68 30.9 11.3 19.7 17.6 21.7 71.0 52.3 32.2 81.6 61.4 
Benin 2017 540 13262 96 91.5 60.5 77.2 71.1 76.3 73.4 71.2 13.3 83.2 52.1 
Burkina Faso 2010 541 14159 129 56.9 18.5 36.1 31.5 47.4 79.6 77.0 15.2 94.9 33.7 
Burundi 2016 552 13135 78 46.2 17.1 32.3 34.7 39.9 86.9 82.9 39.4 99.2 49.3 
Cameroon 2011 577 11723 122 36.4 9.0 20.9 14.8 21.0 61.9 70.8 35.9 84.7 62.2 
Chad 2014 624 18623 133 77.3 42.4 61.2 33.3 36.4 48.6 55.3 6.6 63.7 31.0 
DRC 2013 492 17152 104 70.0 25.4 46.5 50.2 55.8 82.8 48.7 18.4 88.4 48.0 
Egypt 2014 1741 15744 27 * * * * * * 97.8 76.6 90.3 82.8 
Ethiopia 2016 622 10221 88 * * * * * * 64.8 6.3 62.4 31.8 
Gabon 2012 330 6019 65 36.1 14.5 26.9 26.7 38.8 86.6 93.0 33.7 94.7 77.6 
Ghana 2014 423 5801 60 68.3 45.2 59.0 35.7 46.6 48.6 89.8 13.6 97.3 87.3 
Guinea 2012 300 7039 123 47.4 9.7 25.3 18.9 26.0 68.7 74.9 19.0 85.2 56.6 
Ivory Coast 2011 641 7555 108 67.3 31.7 49.0 33.2 37.2 58.8 78.3 18.0 90.6 44.2 
Kenya 2014 1584 20851 52 58.9 34.5 48.2 42.6 54.3 77.3 71.3 22.7 95.5 57.6 
Liberia 2013 322 7606 94 54.6 22.1 37.0 31.7 38.1 67.4 72.6 14.2 95.9 78.1 
Malawi 2015 850 17286 64 56.9 23.5 38.8 33.9 42.7 73.3 87.2 51.8 94.8 50.6 
Mali 2012 413 10326 95 84.4 41.8 65.1 60.5 69.0 88.7 66.0 22.0 74.2 41.2 
Mozambique 2011 609 11089 97 51.4 22.6 37.0 29.5 35.7 68.3 51.0 16.7 90.6 50.6 
Namibia 2013 537 5046 54 24.4 12.0 18.1 3.9 5.6 21.1 86.9 33.5 96.6 62.5 
Nigeria 2013 889 31225 128 49.5 22.1 36.1 12.9 16.6 34.7 60.6 30.1 60.6 51.1 
Rwanda 2014 492 7856 50 80.6 42.6 63.8 61.4 67.7 77.4 72.9 54.1 99.0 43.9 
Senegal 2016 214 6725 51 82.4 56.4 75.7 63.1 68.2 66.6 81.8 44.7 95.9 53.8 
Sierra Leone 2013 435 11938 156 64.4 14.9 37.7 41.8 49.0 91.9 60.6 9.6 97.1 76.0 
Tanzania 2015 208 10233 67 65.6 38.8 55.9 49.0 54.4 69.4 61.4 19.1 98.0 50.7 
Togo 2013 329 6979 88 65.4 32.9 48.8 33.6 42.8 61.2 64.1 12.2 50.0 57.2 
Uganda 2016 685 15276 64 78.4 51.1 64.6 55.0 62.0 74.0 78.3 18.7 97.3 59.9 
Zambia 2013 719 13412 75 67.7 27.4 46.6 34.9 40.6 63.6 64.5 25.4 95.7 55.5 
Zimbabwe 2015 399 6132 69 47.9 26.4 37.2 8.5 9.0 18.8 78.1 37.0 93.3 75.7 
Mean 2013-14 625 14322 85.9 60.0 29.0 44.8 35.8 42.4 66.1 71.9 26.4 87.5 56.5 
 
1. Under-five mortality; 2. Represents percentages; 3. Improved Sanitation 





Table 3.5: Summary of the DHS data extracted from the DHS STATcompiler (part II). 
 Fans.1 Post. 
Care2 
Immed.3 Exclus.4 Tetanus BCG Measles Vitamin A Iron Iodized 
Salt 
ORS ACT Dew.5 
Angola 55.9 16.3 48.3 37.5 66.2 71.9 56.1 6.0 * 88.5 42.6 76.7 * 
Benin 50.3 60.4 54.1 41.5 70.7 88.2 67.9 52.2 23.9 91.4 22.2 6.5 38.3 
Burkina Faso 73.8 * 42.1 24.8 85.5 96.5 87.3 63.0 7.4 95.4 21.2 8.7 12.8 
Burundi 29.6 4.2 85.0 82.8 84.3 97.7 93.8 68.7 7.9 99.0 35.6 5.3 67.6 
Cameroon 44.0 * 39.8 20.2 73.3 87.1 70.6 55.3 9.2 90.4 17.2 6.1 51.1 
Chad 24.2 3.4 23.0 0.3 55.7 59.6 56.9 44.1 15.7 82.8 20.4 2.7 26.6 
DRC 34.8 5.9 51.9 47.6 65.5 83.4 71.6 70.4 15.6 92.1 39.1 5.0 60.6 
Egypt * 14.2 27.1 39.7 74.4 99.1 95.8 16.7 7.6 90.1 28.4 * 10.8 
Ethiopia * 11.7 73.3 57.5 49.0 69.2 54.3 44.7 9.2 87.9 29.5 0.7 12.7 
Gabon 19.5 12.1 32.3 6.0 78.3 91.5 74.3 53.8 20.5 97.4 26.1 8.8 72.3 
Ghana 82.9 18.6 55.6 52.3 78.0 96.8 89.3 65.2 24.4 61.9 48.6 37.9 38.3 
Guinea 31.7 16.3 16.6 20.5 75.6 82.4 61.8 40.8 11.5 65.8 34.3 4.8 28.5 
Ivory Coast 29.0 26.7 30.8 12.1 67.2 83.4 64.5 60.8 13.4 90.9 17.2 3.0 36.7 
Kenya 30.4 33.1 62.2 61.4 75.6 96.7 87.1 71.7 2.7 99.5 53.8 85.8 22.2 
Liberia 68.1 28.8 61.2 55.2 87.8 93.9 74.2 60.2 26.7 98.7 60.4 23.9 56.1 
Malawi 90.5 58.1 76.3 61.0 90.2 97.6 91.3 64.2 12.4 89.3 64.7 34.5 44.8 
Mali 56.2 9.8 57.8 32.4 47.3 83.6 71.7 60.8 25.4 95.4 36.8 4.3 31.4 
Mozambique 37.2 * 76.7 38.1 66.9 91.1 81.5 74.6 24.4 45.6 55.0 17.9 46.3 
Namibia 9.1 19.3 71.2 48.5 65.9 94.2 89.5 83.6 * 75.7 71.6 3.8 43.0 
Nigeria 27.3 11.2 33.2 17.4 52.8 51.2 42.1 41.3 5.7 * 33.7 6.0 19.9 
Rwanda * * 80.5 87.3 82.4 98.9 95.2 86.4 * 99.7 27.5 11.2 80.1 
Senegal 91.6 27.4 29.4 36.4 81.6 94.1 80.6 77.5 1.8 62.9 20.5 1.5 65.3 
Sierra Leone 64.8 22.4 53.8 32.0 90.0 95.6 78.6 83.2 36.1 79.6 85.1 37.2 57.6 
Tanzania 69.4 39.0 51.2 59.2 88.0 96.0 86.0 41.3 2.0 78.9 44.8 43.4 37.6 
Togo 76.8 3.9 60.6 57.5 77.0 95.3 74.3 81.7 25.6 82.4 18.5 9.1 47.9 
Uganda 78.5 53.2 66.1 65.5 80.6 96.3 80.0 61.6 6.5 99.6. 46.7 62.8 60.7 
Zambia 92.1 1.0 65.8 72.5 81.9 94.9 84.9 76.5 7.4 95.3 64.1 36.0 59.8 
Zimbabwe * 55.0 57.6 47.7 54.3 89.9 81.9 67.4 * 94.6 40.5 * 18.0 
Mean 52.8 23.0 52.9 43.3 73.1 88.4 76.5 59.8 14.2 85.8 39.5 20.9 42.4 
 




Table 3.6: Posterior estimates obtained from the bivariate geostatistical variable selection. Results are presented only for the statistically important associations between health interventions and U5M. 
 # count Angola Benin Burkina Faso Burundi Cameroon Chad DRC 
H_1ITN 3        
H_1ITN2 1        
P_ITNA 3        
P_ITNS 4        
P_ITN5 6       -0.36 (-0.74,-0.01) 
P_ITNU 3       -0.61 (-1.13,-0.09) 
Improved 
Water 
3   -0.47 (-0.74,-0.20)     
Improved 
Sanitation 
12  -1.00 (-1.57,-0.42) -0.74 (-1.19,-0.29) -0.70 (-1.07,-0.34)  -0.69 (-1.14,-0.24) -0.53 (-0.85,-0.20) 
ANC 
provider 
26 -0.78 (-1.33,-0.22) -0.90 (-1.39,-0.42) -0.68 (-1.01,-0.34) -2.22 (-3.25,-1.19) -1.12 (-1.63,-0.61) -0.43 (-0.78,-0.08)  
4+ ANC 
visits 
19 -0.66 (-1.22,-0.11) -0.96 (-1.47,-0.46) -0.53 (-1.05,-0.01)  -1.30 (-1.78,-0.82)   
Fansidar 12 -0.61 (-1.18,-0.04) -1.10 (-1.58,-0.62)    -0.59 (-1.05,-0.14)  
Post. Care 4   -0.65 (-1.21,-0.09)     
Immediate 14     -0.38 (-0.77,0)   
Exclusive 2        
Tetanus 21 -0.78 (-1.35,-0.21) -1.13 (-1.62,-0.64) -1.80 (-2.39,-1.21)  -1.30 (-1.86,-0.75) -0.42 (-0.79,-0.06)  
BCG 28 -0.82 (-1.38,-0.26) -1.94 (-2.51,-1.38) -3.09 (-3.52,-2.66) -3.91 (-4.77,-3.04) -2.85 (-3.29,-2.42) -0.58 (-0.83,-0.33) -1.24 (-1.54,-0.93) 
DPT 28 -1.36 (-2.12,-0.60) -1.61 (-2.15,-1.08) -2.02 (-2.40,-1.63) -3.56 (-4.40,-2.72) -1.64 (-2.00,-1.30) -0.61 (-0.93,-0.28) -0.97 (-1.27,-0.67) 
Polio 25 -1.07 (-1.88,-0.27) -1.43 (-2.00,-0.87) -1.77 (-2.13,-1.41) -2.47 (-3.20,-1.74) -1.30 (-1.67,-0.93) -0.60 (-1.00,-0.21) -0.66 (-1.07,-0.25) 
Measles 28 -0.94 (-1.66,-0.22) -1.52 (-2.15,-0.89) -2.39 (-2.81,-1.96) -2.87 (-3.67,-2.08) -2.19 (-2.61,-1.76) -0.71 (-1.01,-0.42) -1.40 (-1.77,-1.04) 
Vitamin A 27  -0.74 (-1.09,-0.39) -1.00 (-1.31,-0.70) -1.55 (-2.02,-1.08) -0.88 (-1.32,-0.45) -0.56 (-0.89,-0.22) -0.86 (-1.18,-0.54) 
Iron 8  -0.48 (-0.93,-0.02)   -1.40 (-2.38,-0.42)  -1.07 (-1.60,-0.55) 
Iodized 
Salt 
4  -0.68 (-1.32,-0.05)      
ORS 4     -1.80 (-3.48,-0.12)   
ACT 2      -0.90 (-1.66,-0.15)  
Deworming 26  -0.83 (-1.27,-0.39) -0.50 (-1.00,-0.01) -1.59 (-2.11,-1.08) -1.72 (-2.17,-1.28) -0.37 (-0.73,-0.01) -0.89 (-1.25,-0.54) 











 Egypt Ethiopia Gabon Ghana Guinea Ivory Coast Kenya 
H_1ITN     -0.66 (-1.20,-0.13)   
H_1ITN2        
P_ITNA     -0.80 (-1.58,-0.02)   
P_ITNS        
P_ITN5    -0.73 (-1.42,-0.03)    
P_ITNU        
Improved 
Water 
       
Improved 
Sanitation 
-0.59 (-1.10,-0.08) -1.11 (-1.84,-0.37)   -0.89 (-1.40,-0.39) -0.43 (-0.85,-0.01)  
ANC provider -0.81 (-1.48,-0.13) -0.97 (-1.38,-0.56) -1.62 (-2.47,-0.76) -2.42 (-3.57,-1.27) -0.99 (-1.43,-0.54) -1.50 (-2.11,-0.89) -1.11 (-1.67,-0.56) 
4+ ANC visits  -1.29 (-1.79,-0.79)  -1.27 (-2.11,-0.42) -1.08 (-1.61,-0.55) -0.88 (-1.39,-0.36)  
Fansidar    -1.87 (-2.81,-0.94) -0.61 (-1.20,-0.03)   
Post. Care    -1.00 (-1.96,-0.04)    
Immediate  -0.58 (-1.03,-0.13) -0.81 (-1.39,-0.23) -0.65 (-1.28,-0.03)  -0.46 (-0.92,-0.01) -0.58 (-1.04,-0.11) 
Exclusive        
Tetanus -0.96 (-1.51,-0.41) -1.15 (-1.62,-0.68) -1.69 (-2.60,-0.78) -1.72 (-2.74,-0.69) -1.30 (-1.84,-0.76) -1.39 (-1.96,-0.83)  
BCG -5.90 (-6.29,-5.52) -1.49 (-2.02,-0.96) -2.32 (-3.02,-1.61) -4.80 (-5.85,-3.76) -1.75 (-2.19,-1.30) -1.78 (-2.23,-1.33) -5.60 (-6.23,-4.98) 
DPT -4.55 (-5.05,-4.06) -1.36 (-1.91,-0.82) -1.11 (-1.98,-0.24) -2.43 (-3.29,-1.58) -0.93 (-1.36,-0.49) -1.37 (-1.77,-0.97) -2.86 (-3.32,-2.39) 
Polio -3.77 (-4.29,-3.24) -2.13 (-2.93,-1.33)  -1.33 (-2.04,-0.64) -1.13 (-1.61,-0.66) -1.17 (-1.58,-0.76) -0.81 (-1.15,-0.48) 
Measles -1.99 (-2.54,-1.44) -1.57 (-2.21,-0.92) -1.48 (-2.34,-0.63) -3.61 (-4.62,-2.60) -1.33 (-1.80,-0.87) -1.51 (-2.04,-0.97) -2.61 (-3.12,-2.10) 
Vitamin A -1.33 (-2.10,-0.56) -1.20 (-1.66,-0.75) -1.23 (-2.04,-0.41) -1.13 (-1.83,-0.44) -0.79 (-1.25,-0.32) -0.68 (-1.12,-0.24) -1.28 (-1.68,-0.88) 
Iron -1.60 (-2.77,-0.44)       
Iodized Salt        
ORS     -1.78 (-3.42,-0.14)   
ACT    -0.61 (-1.02,-0.19)    










 Liberia Malawi Mali Mozambique Namibia Nigeria Rwanda 
H_1ITN       -0.77 (-1.53,-0.02) 
H_1ITN2        
P_ITNA       -0.72 (-1.45,0) 
P_ITNS  -0.59 (-1.06,-0.13) -0.96 (-1.68,-0.25)     
P_ITN5  -0.72 (-1.12,-0.33) -0.93 (-1.53,-0.33)     
P_ITNU  -0.56 (-1.01,-0.12)      
Improved 
Water 
     -0.34 (-0.48,-0.20)  
Improved 
Sanitation 
     -0.41 (-0.61,-0.22)  
ANC provider -1.26 (-2.07,-0.45) -1.99 (-2.71,-1.27) -1.23 (-1.72,-0.74) -0.94 (-1.59,-0.28) -1.45 (-2.52,-0.38) -0.83 (-1.10,-0.56) -1.99 (-3.36,-0.63) 
4+ ANC visits -0.78 (-1.38,-0.18) -0.90 (-1.45,-0.35) -1.51 (-2.13,-0.88) -0.78 (-1.35,-0.21) -1.01 (-1.85,-0.16) -0.80 (-1.09,-0.50) -1.50 (-2.38,-0.62) 
Fansidar  -1.94 (-2.63,-1.25)  -0.98 (-1.54,-0.42)  -0.93 (-1.35,-0.51)  
Post. Care      -1.72 (-2.34,-1.09)  
Immediate  -0.75 (-1.23,-0.27)  -0.62 (-1.09,-0.14) -0.90 (-1.66,-0.13) -0.71 (-0.98,-0.43) -1.45 (-2.33,-0.56) 
Exclusive        
Tetanus -1.15 (-1.82,-0.48) -1.56 (-2.19,-0.93) -1.08 (-1.64,-0.52) -0.81 (-1.38,-0.24)  -0.88 (-1.16,-0.59)  
BCG -1.94 (-2.46,-1.42) -2.79 (-3.52,-2.06) -1.40 (-1.82,-0.98) -3.08 (-3.61,-2.55) -5.89 (-7.01,-4.77) -1.11 (-1.33,-0.89) -8.26 (-9.56,-6.96) 
DPT -1.14 (-1.63,-0.65) -2.18 (-2.89,-1.47) -1.16 (-1.59,-0.73) -1.83 (-2.28,-1.40) -2.48 (-3.30,-1.66) -1.30 (-1.56,-1.05) -5.44 (-6.43,-4.44) 
Polio -0.79 (-1.32,-0.26) -0.99 (-1.59,-0.39) -0.96 (-1.52,-0.41) -1.44 (-1.85,-1.02) -1.59 (-2.36,-0.81) -1.40 (-1.73,-1.07) -2.81 (-3.53,-2.09) 
Measles -1.83 (-2.40,-1.26) -1.30 (-2.02,-0.58) -1.30 (-1.77,-0.83) -2.59 (-3.09,-2.09) -2.69 (-3.54,-1.83) -1.25 (-1.51,-0.99) -0.74 (-1.34,-0.14) 
Vitamin A -0.75 (-1.20,-0.30) -1.53 (-2.00,-1.06) -1.21 (-1.63,-0.79) -2.00 (-2.48,-1.53) -2.83 (-3.58,-2.08) -1.11 (-1.38,-0.84) -3.28 (-4.14,-2.42) 
Iron -0.70 (-1.39,-0.01)  -1.46 (-2.06,-0.86) -0.72 (-1.27,-0.17)    
Iodized Salt  -0.40 (-0.71,-0.09)      
ORS    -1.44 (-2.72,-0.15)    
ACT        










 Senegal Sierra Leone Tanzania Togo Uganda Zambia Zimbabwe 
H_1ITN     -0.95 (-1.45,-0.46)   
H_1ITN2     -0.70 (-1.15,-0.25)   
P_ITNA     -0.89 (-1.37,-0.42)   
P_ITNS     -0.69 (-1.15,-0.22) -0.60 (-1.13,-0.06)  
P_ITN5     -0.59 (-1.01,-0.18) -0.51 (-0.94,-0.08)  
P_ITNU -0.69 (-1.28,-0.10)       
Improved 
Water 
   -0.42 (-0.74,-0.09)    
Improved 
Sanitation 
-0.83 (-1.32,-0.34)   -1.66 (-2.69,-0.64)    
ANC provider -1.84 (-2.96,-0.72) -1.02 (-1.91,-0.12)  -0.83 (-1.30,-0.37) -1.40 (-2.19,-0.60) -1.05 (-1.78,-0.33) -2.38 (-3.10,-1.66) 
4+ ANC visits -2.35 (-3.26,-1.45) -0.76 (-1.29,-0.22)  -1.09 (-1.76,-0.42) -0.78 (-1.38,-0.18)  -1.81 (-2.60,-1.03) 
Fansidar -1.91 (-2.93,-0.89)   -1.60 (-2.22,-0.97) -1.04 (-1.68,-0.40) -0.92 (-1.57,-0.28)  
Post. Care -1.91 (-2.65,-1.18)       
Immediate    -0.64 (-1.08,-0.20)  -0.48 (-0.91,-0.05) -0.77 (-1.49,-0.06) 
Exclusive      -1.76 (-3.03,-0.49) -1.56 (-2.41,-0.70) 
Tetanus -1.69 (-2.76,-0.61) -1.20 (-2.05,-0.35)  -1.47 (-2.23,-0.71) -1.12 (-1.79,-0.46)  -2.23 (-3.02,-1.45) 
BCG -2.33 (-3.20,-1.46) -3.46 (-4.05,-2.86) -1.93 (-2.77,-1.08) -3.80 (-4.54,-3.07) -2.76 (-3.54,-1.98) -4.58 (-5.25,-3.91) -1.68 (-2.61,-0.75) 
DPT -2.13 (-2.86,-1.40) -1.46 (-1.90,-1.03) -1.13 (-1.88,-0.38) -1.97 (-2.52,-1.43) -2.16 (-2.82,-1.50) -2.32 (-2.84,-1.80) -1.06 (-2.01,-0.10) 
Polio -1.38 (-2.03,-0.73) -1.41 (-1.84,-0.98)  -1.60 (-2.21,-0.99) -1.81 (-2.46,-1.16) -0.66 (-1.12,-0.20)  
Measles -2.13 (-2.90,-1.37) -2.22 (-2.79,-1.66) -1.15 (-1.99,-0.31) -2.18 (-2.85,-1.51) -1.78 (-2.51,-1.06) -3.42 (-4.02,-2.81) -1.82 (-2.87,-0.78) 
Vitamin A -2.23 (-3.14,-1.33) -1.77 (-2.25,-1.30) -0.85 (-1.42,-0.29) -2.63 (-3.22,-2.03) -0.96 (-1.39,-0.52) -2.05 (-2.55,-1.54) -1.37 (-2.05,-0.69) 
Iron  -0.90 (-1.39,-0.41)      
Iodized Salt  -0.40 (-0.72,-0.08)   -0.90 (-1.70,-0.11)   
ORS   -1.92 (-3.57,-0.28)     
ACT        






Figure 3.3: Spatially varying effects of percentage of households with at least one ITN on under-five mortality at administrative 
level 1 estimated by a Bayesian geostatistical Weibull survival model. 
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Figure 3.4: Spatially varying effects of percentage of households with at least one ITN for every two people on under-five 




Figure 3.5: Spatially varying effects of percentage of population with access to an ITN within their household on under-five 
mortality at administrative level 1 estimated by a Bayesian geostatistical Weibull survival model. 
 






Figure 3.6: Spatially varying effects of percentage of population in a household that slept under an ITN the previous night 
before the survey on under-five mortality at administrative level 1 estimated by a Bayesian geostatistical Weibull survival 
model. 
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Figure 3.7: Spatially varying effects of percentage of existing ITNs used by the population in a household the previous night of 
the survey on under-five mortality at administrative level 1 estimated by a Bayesian geostatistical Weibull survival model. 
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Figure 3.8: Spatially varying effects of percentage of households with improved source of drinking water on under-five mortality 
at administrative level 1 estimated by a Bayesian geostatistical Weibull survival model. 
 







Figure 3.9: Spatially varying effects of percentage of percentage of new-borns receiving first postnatal check-up from a skilled 
provider within hours after delivery on under-five mortality at administrative level 1 estimated by a Bayesian geostatistical 
Weibull survival model. 
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Figure 3.10: Spatially varying effects of percentage of infants which exclusively breastfed during the first six months after 





Figure 3.11: Spatially varying effects of percentage of children which lived in a household with positive test for iodized salt on 
under-five mortality at administrative level 1 estimated by a Bayesian geostatistical Weibull survival model. 
 








Figure 3.12: Spatially varying effects of percentage of children with diarrhoea given fluid from oral rehydration solution (ORS) 
on under-five mortality at administrative level 1 estimated by a Bayesian geostatistical Weibull survival model. 
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Figure 3.13: Spatially varying effects of percentage of children with fever during the two weeks prior to the survey which took 
artemisinin-combination therapy (ACT) on under-five mortality at administrative level 1 estimated by a Bayesian geostatistical 



















Figure 3.14: Spatially varying effects of percentage of under-five children in a household who slept under an ITN the night 







Figure 3.15: Spatially varying effects of percentage of households with improved sanitation facilities on under-five mortality at 






Figure 3.16: Spatially varying effects of percentage of pregnant mothers receiving ANC from a skilled provider on under-five 






Figure 3.17: Spatially varying effects of percentage of pregnant woman making at least four ANC visits during their pregnancy 






Figure 3.18: Spatially varying effects of percentage of percentage of pregnant woman which received Fansidar during 






Figure 3.19: Spatially varying effects of percentage of infants which breastfed within one hour after birth on under-five mortality 






Figure 3.20: Spatially varying effects of percentage of last-born children protected against neonatal tetanus on under-five 







Figure 3.21: Spatially varying effects of percentage of children vaccinated against BCG on under-five mortality at administrative 






Figure 3.22: Spatially varying effects of percentage of children with complete DPT vaccination on under-five mortality at 






Figure 3.23: Spatially varying effects of percentage of children with complete Polio vaccination on under-five mortality at 






Figure 3.24: Spatially varying effects of percentage of children vaccinated against measles on under-five mortality at 






Figure 3.25: Spatially varying effects of percentage of children which received vitamin A supplements in the past 6 months on 






Figure 3.26: Spatially varying effects of percentage of children which received iron supplements in the past 7 days on under-






Figure 3.27: Spatially varying effects of percentage of children which took deworming medication in the past 6 months on 
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Febrile response is the clinical manifestation of various diseases and has traditionally being 
a frequent cause for medical consultation. In the sub-Saharan Africa (SSA) setting, 
development of fever is associated with all leading causes of mortality for children under the 
age of five, i.e. malaria, diarrhoea and acute respiratory infection (ARI). Crucially, presence 
of fever has been identified with malaria infection and so the clinical manifestation of fever 
leads to diagnosis and treatment of malaria without rigorous investigation of its aetiology. We 
utilized data coming from the Demographic and Health surveys, across 16 sub-Saharan 
Africa countries, in order to associate malaria parasitaemia, diarrhoea and ARI with the 
probability of developing fever. We employed a Bayesian geostatistical logistic regression 
model with spatially varying coefficients and quantified the associations at national and sub-
national level. We developed province-level maps of the African continent in which we 
illustrated our estimates and calculated the Potential Attributable Fraction (PAF) in order to 
quantify the contribution of childhood diseases on fever. In Angola, Benin, Burkina Faso, 
Cameroon, Côte d'Ivoire, Ghana, Mozambique, Rwanda, Tanzania and Uganda, most fever 
cases were attributed to diarrhoea, as estimated by PAF, compared to malaria parasitaemia 
or ARI. For the rest six countries, i.e. Burundi, DRC, Guinea, Mali, Senegal and Togo, ARI 
was the main contributor. On average, the fever cases attributed to diarrhoea were 61.68%, 
to ARI 56.03% and to malaria parasitaemia 19.31%. We observed strong province-level 
disparities of the malaria-fever association, albeit almost everywhere, a homogeneous 
association between ARI and diarrhoea with fever. We concluded on the strong association 
of ARI and diarrhoea with fever and on the need for a rigorous investigation of the aetiology 






Febrile response is an outcome of inflammatory disease or infection, which involves the 
above-normal raising of the human body temperature and leads to improved protective 
processes for the immune system (Evans, 2015). Due to its presence as clinical 
manifestation of illness sine antiquity, fever constitutes one of the most frequent causes for 
medical consultation (Ogoina, 2011). The aetiology of fever can be attributed to an immense 
set of potential diseases as, for instance, in low and middle-income countries fever could be 
the outcome of blood parasites, e.g. malaria and trypanosomiasis,  viral infections, e.g. 
dengue fever and Influenza, or bacterial zoonoses, e.g. q or trench fever (Prasad, 2015). 
Clinical manifestation of febrile response is particularly relevant for the age group of children 
less than five years, as pre-school children, elderly people and pregnant woman are the 
most vulnerable groups to contract diseases (WHO, 2019e). Geographically, the sub-Sahara 
African (SSA) countries are home to most under-five deaths globally and hence childhood 
fever is an important public health priority (WHO, 2019c). Specifically, febrile response is an 
outcome of the leading causes of under-five mortality in Africa, i.e. acute respiratory infection 
(ARI) manifested as pneumonia, diarrhoea and malaria, as well as of other infectious 
diseases (WHO. Regional office for Africa, 2019f). 
Different data sources and methods have been considered to assess the aetiology of fever 
among under-five children in SSA. In Tanzania, a study recruited 1005 children with fever, 
below the age of 10, from two different outpatient clinics and after a systematic and thorough 
examination, it reported that 62.2% of the children had ARI, 13.3% had a non-malaria and 
non-typhoid infection and that only 10.5% of all children had malaria (D'Acremont, 2014). 
Additionally in Tanzania, a prospective cohort study monitored 870 hospitalizations due to 
fever across two sites in northern Tanzania and reported Chikungunya (10.2%) and 
Leptospirosis (7.7%) as the leading causes of fever among children less than 13 years old, 
compared to only 1.3% attributed to malaria (Crump, 2013). Yet, the prior study did not 
reported a cause for fever for the majority of the children, i.e. 64% and did not take into 
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account respiratory viruses. In Kenya, a case-control study for children under-five 
experiencing fever concluded that, among cases, 41.5% had a respiratory virus, 5.2% had 
malaria and 2.3% had group A streptococcal (GAS) pharyngitis, while for 37.1% an aetiology 
for febrile illness was not established (O’Meara, 2015). A recent narrative review focusing on 
the causes of febrile illness in SSA concluded that viral upper respiratory and self-limiting 
arboviral infections account for the majority, i.e. 60%, of children seeking treatment in health 
centres (Maze, 2018).  
A common limitation shared among most studies investigating the contribution of illnesses to 
febrile response burden is the utilization of hospital-related data across a well-defined 
geographical area, i.e. specific, small in number, sites within a given country. Firstly, the 
selection of a very small number of sites, based on a non-systematic procedure, may not be 
representative of the dynamics of diseases at national level. Secondly, under-five children 
experiencing fever may not even attend a health facility for seeking diagnosis and treatment 
of fever. As depicted by a recent probabilistic modelling study, which analysed household 
survey data across 29 SSA countries, health-seeking behaviour for fever might be so low 
that, in an estimated 16 SSA countries, less than 50% of the under-five children with fever, 
which reside no further than two hours from a public health facility, would seek treatment 
(Alegana, 2018). Another shortage in the existing literature is that, to our knowledge, there is 
a scarcity of modelling studies trying to associate the contribution of diseases to fever at 
national level, but also exploring the geographical variation of the association within 
countries. An example of such a study for Uganda modelled the association of the leading 
causes of under-five mortality to fever, attributed the most cases to ARI and identified 
important regional variation of the effects (Nambuusi, 2019). Another issue which needs 
further investigation and that was also discussed in the aforementioned studies, is the over-
diagnosis and hence over-treatment of malaria among under-five children with fever in SSA, 
which stresses the need for further investigation of the relation between childhood diseases 
and fever in malaria-endemic countries (Bisoffi, 2013). For instance, a recent modelling 
study considering 41 surveys across 21 SSA countries concluded that only 37.7% of all 
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malaria-positive, under-five children experiencing fever had developed a febrile response 
due to Plasmodium falciparum infection (Dalrymple, 2019). 
Our work aims to assess the contribution of childhood diseases on febrile response among 
under-five children in SSA, by associating the prevalence of malaria parasitaemia, diarrhoea 
and ARI with fever. We utilized data coming from the cross-sectional, national-
representative, household-based Demographic and Health surveys (DHS) for 16 SSA 
countries and employed a Bayesian hierarchical modelling approach. Our models 
incorporated spatial random effects to account for correlations in the fever outcome and a 
spatially varying coefficient component imposed to the disease exposure that aims to assess 
the geographical variation of the disease exposure on fever. Additionally, models were 
adjusted for maternal, socio-economic, demographic and individual-child characteristics. 
Finding of this study will provide further insights in the contribution of diseases to fever, 
depict geographical variations of these associations and contribute to the understanding of 
over-diagnosis and over-treatment of malaria in SSA. 
4.2 Methods 
Data sources 
Our study is based on open-access surveys made available by the DHS program and 
remote sensing data. The DHS are cross-sectional surveys, typically conducted every five 
years, with a mandate to collect key health, demographic and nutrition related information. 
The surveys are represented on national and sub-national level, i.e. states, departments and 
residence, and are household-based. The goal of the DHS is to assist countries lacking 
strong vital registration systems to collect crucial information for evaluation and monitoring 
purposes. Questionnaires, biomarker tests and geographical information are some of the 
instruments used by the DHS to collect its data. DHS surveys are taking place in conjunction 
with the national agencies of each country. In order to protect the privacy of household 
members and respondents, the DHS program demands that before each interview or 
biomarker test, an informed consent statement is read to the respondent. It is therefore in 
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the respondent’s judgment to accept or decline the invitation for participation in the interview 
or test. For children less than five years of age, the parent, guardian or caregiver is 
responsible for providing verbal informed consent. Verbal consent consists of a prescribed 
statement and the interviewer records the reply from the respondent. Additionally, the 
interviewer signs by name to having read the consent statement to the respondent. Written 
consent is not included (https://dhsprogram.com/publications/publication-dhsm7-dhs-
questionnaires-and-manuals.cfm). 
Across all 16 surveys, corresponding to the countries included in this study, we had available 
information on under-five children, which consisted of indicators on childhood diseases, 
maternal, socio-economic, demographic and individual child characteristics, health 
interventions, as well as the geographical coordinates of the spatial cluster within which each 
child was residing. Specifically, we had data on the presence of fever for a child during the 
two weeks preceding the survey, severe cough in the form of short, rapid breathing, 
diarrhoea over the two weeks preceding the survey and presence of malaria parasites that 
was confirmed from rapid diagnostic tests (RDTs). As the information on diseases was only 
available for the alive children, we aggregated the severe cough, diarrhoea and malaria 
parasitaemia at cluster level and considered that this corresponds to the cluster-level 
exposure that all children, within that cluster, experience. Presence of fever was retained at 
individual level. We assumed that the severe cough, expressed as cough accompanied with 
short, rapid breathing, corresponds to acute respiratory infection. Further, we had data on 
the sex of each child, the mode of delivery and its birth order, as well as the educational 
level of its mother and the age at which the mother gave birth. Based on the wealth quantile 
assigned to the household in which a child was residing, we associated each child with a 
wealth index. For similar reasons as with the childhood diseases, we aggregated curative or 
preventive health interventions at cluster level and assigned them to each child based on 
geographical information. The interventions considered were: improved source of drinking 
water and sanitation facilities; Tetanus, Bacillus Calmette–Guérin (BCG), Diphtheria, 
Tetanus, and Pertussis (DPT), polio and measles immunization; vitamin A and iron 
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supplementation; deworming medication; antenatal care (ANC) from a skilled provider during 
pregnancy; malaria bednets.  
We downloaded remote sensing data from open access sources in order to adjust our 
models for other-than-malaria infectious diseases. We compiled information on land surface 
temperature at day, land surface temperature during night, distance to the nearest water 
bodies and the normalized difference vegetation index from the Moderate Resolution 
Imaging Spectroradiometer (MODIS) imaging sensor and the altitude of a location from the 
Shuttle Radar Topography Mission (SRTM). Also from MODIS, we extracted data on the 
land cover type, which we further transformed to three categories, i.e. forest, grassland and 
cropland, which we assigned to each child based on its geographical coordinates. From the 
U.S. Geological Survey-Earth Resources Observation Systems (USGSS) Data portal, we 
downloaded information on rainfall and from the Global Rural and Urban Mapping Project 
(GRUMP) we identified an either urban or rural residential status for each child. 
Statistical analysis 
We utilised Bayesian inference and developed a geostatistical logistic regression model, with 
a spatially varying coefficient component, in order to associate malaria parasitaemia, 
diarrhoea and ARI with fever across 16 SSA countries. The outcome of the model was a 
binary indicator that specified if an under-five child experienced fever or not and hence, we 
assumed that the outcome followed a Bernoulli distribution. The default logit-link function 
associated the probability of developing fever with the linear predictor, which incorporated an 
intercept, the exposure to a particular disease, confounders, a geostatistical intercept, which 
accounted for the spatial correlation in the fever outcome and a spatially varying part 
imposed to the disease exposure. Specifically, a Gaussian process with Matérn covariance 
matrix modelled the geostatistical intercept (Banerjee, 2014). The spatially varying 
coefficient accounted for the province-specific associations and was modelled via a 
multivariate Gaussian distribution with exchangeable structure. Before fitting the model, the 
Variance Inflation Factor was used to exclude from the linear predictor highly correlated 
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covariates and so to avoid collinearity (O’Brien, 2007). The posterior median from the 
regression coefficient of the disease exposure was interpreted as the national estimate of 
the disease-fever association. For the province-specific associations, we obtained a 
posterior sample of size 1,000 from the exchangeable structured effects, added them up with 
the national effect and summarized the estimates in terms of median and 95% credible 
interval. We applied the exponential function to all estimates in order to obtain the 
corresponding odds ratio. We summarized the national estimates in Table 5.2 and mapped 
the province-level associations in Figures 5.1–5.3. Throughout our work, we used 
terminology compatible with the Bayesian inference and called important coefficient what is 
called statistically significant from a frequentist perspective. Important coefficient means that 
the posterior distribution (95% Bayesian Credible Interval) does not include zero. We 
concluded our analysis by utilizing the Population Attributable Function (PAF) in order 
estimate the contribution of each childhood disease to fever (Leviton, 1973). PAF calculation 
for each of the provinces was based on the posterior sample of the spatially varying effects 
and so we summarized all PAF values in terms of posterior median and 95% Bayesian 
credible interval. 
We used the RStudio (RStudio Team (2018), 2018), an integrated development environment 
of R software (R Core Team (2019), 2019), for our analysis, i.e. data management, statistical 
analysis, mapping efforts and PAF calculation. We used the Integrated Nested Laplace 
Approximation (Rue, 2009; Lindgren, 2011) (INLA) to conduct Bayesian inference. The 
Appendix contains further details concerning our analysis and model specification. 
4.3 Results 
The Burkina Faso DHS was the earliest survey included in our study, conducted in 2010 and 
accounted  for the highest malaria parasitaemia prevalence (76.1%) and highest under-five 
morality rate (129 deaths per thousand live births) across all 16 DHS surveys included in our 
study. The Benin survey was the most recent, as it took place in 2017 and accounted for 540 
unique survey locations, out of the total 7,741 sites incorporated in our study. Angola and 
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Uganda contributed the most to the total number of unique survey sites, while Senegal had 
the lowest number of locations, i.e. 214. Guinea, Mali and Côte d'Ivoire followed Burkina 
Faso as the countries with the highest malaria parasitaemia prevalence, ranging between 
41% and 48%, while Rwanda and Senegal had the lowest. Burundi and Cameroon had the 
highest percentages of diarrhoea among their under-five children, accounting for more than 
20%, while Uganda and Burundi the highest percentages for ARI. Mali was among the 
countries with the lowest diarrhoea, ARI and fever prevalence. Based on the raw data, 
Burundi, Uganda, Democratic Republic of the Congo (DRC) and Guinea were the countries 
that simultaneously had the highest ARI and fever prevalence. A descriptive analysis of all 
DHS surveys is presented in Table 5.1. 
Across all countries the three main under-five diseases, i.e. malaria parasitaemia, diarrhoea 
and ARI, were increasing, in almost all occasions, the odds of a child developing fever. Only 
in Burkina Faso, Côte d'Ivoire, Mali, Senegal and Togo we did not find an important 
association between malaria parasitaemia and the probability of a febrile response. In 
Angola, Burkina Faso, Burundi, DRC, Ghana, Guinea, Mali, Senegal, Tanzania and Togo, 
the ARI had the highest odds ratio among all childhood diseases, with diarrhoea having the 
highest value for the rest of the countries. Across all cases, the highest odds ratio values 
were observed from the ARI-fever association, for instance in Senegal, Mali and Angola, 
while the odds ratio of malaria parasitaemia on fever were consistently the lowest from all 
childhood diseases for all countries. Results from the estimated odds ratios are presented in 
Table 5.2. 
Our model-based maps, depicting the geographical distribution of the contribution of 
childhood diseases on fever, showed strong disparities for the malaria parasitaemia-fever 
association, albeit a homogeneous association of fever with diarrhoea and ARI. The regions 
of Kindia and Labé in Guinea, Sikasso in Mali, Comoé and Woroba in Côte d'Ivoire, Hauts-
Bassins and Centre-Ouest in Burkina Faso, Upper-West in Ghana, Savanes and Plateaux in 
Togo and the Zou, Mono, Atlantique and Ouémé in Benin were the only provinces in West 
Africa with an important malaria parasitaemia-fever association. We observed more areas of 
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important association in Central and East Africa, i.e. several north and west departments of 
Cameroon, the Bas-Congo, Kivu and Bandundu provinces of DRC, northern Angola, several 
parts of Mozambique, most of Uganda, Rwanda and Burundi and all regions of Tanzania. 
Contrarily, we found almost everywhere an important association between diarrhoea or ARI 
prevalence with fever. Results from the estimated odds ratio for the childhood diseases on 
fever prevalence are presented at province-level in Figures 5.1–5.3. 
In Angola, Benin, Burkina Faso, Cameroon, Côte d'Ivoire, Ghana, Mozambique, Rwanda, 
Tanzania and Uganda, most fever cases could be attributed to diarrhoea, as estimated by 
PAF, compared to malaria parasitaemia or ARI. For the rest six countries, i.e. Burundi, DRC, 
Guinea, Mali, Senegal and Togo, ARI was the main contributor, albeit in half of the countries 
the posterior estimates (median) were relatively close. On average, the fever cases 
attributed to diarrhoea were 61.68%, to ARI 56.03% and to malaria parasitaemia 19.31%. 
Across all countries, malaria parasitaemia had the lowest median PAF estimate. Strong 
variation on the contribution of childhood diseases to fever was observed at sub-national 
level as, for instance, in the Nord-Ouest province of Cameroon, approximately 25% of all 
fever cases can be attributed to diarrhoea, compared to a national average of 51.02% and 
an estimated contribution of 75.86% for the Nord province. PAF estimates are summarized 
in the Appendix. 
4.4 Discussion 
To our knowledge, this is the first modelling study associating the leading causes of under-
five mortality with febrile response, using routinely collected, household-based survey data 
coming from the DHS for 16 SSA countries. We developed a Bayesian geostatistical logistic 
regression model, with spatially varying coefficients, in order to estimate the geographical 
variation of the association of malaria parasitaemia, diarrhoea and ARI with fever. We 
calculated the potential attributable fraction for each disease and country, separately, in 
order to estimate the percentage of potential fever cases attributed to a particular disease. 
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Development of acute respiratory infection led to the most increased odds of developing 
fever, among the childhood diseases examined, albeit diarrhoea was on average the main 
contributor of under-five fever across all 16 SSA countries. This dissimilarity was due to the 
very low prevalence of ARI compared to that of diarrhoea across all countries, which 
influenced the calculation of PAF. For instance in Senegal, the odds ratio of ARI was 
significantly higher than that of diarrhoea and yet we only estimated an approximately 7% 
difference in PAF between the two diseases, as the prevalence of diarrhoea was 4.5 times 
higher than that of ARI. Contrarily, exposure to malaria parasitaemia for under-five children 
was almost double to that of diarrhoea, but the corresponding odds ratio was so low, 
compared to the other two diseases, that the overall contribution of parasitaemia was 
estimated to be lower than diarrhoea and ARI. Our results supported findings of previous 
studies discussing the importance of ARI to fever cases (D'Acremont, 2014; Crump, 2013; 
Maze, 2018).  
Malaria parasitaemia is not the main contributor of fever cases among under-five children in 
SSA. The clinical manifestation of malaria infection is individual-specific and does not 
necessary lead to a febrile response (Ashley, 2018). Our results were consistent with the 
literature as, for instance, a systematic review of the association between fever and 
Plasmodium falciparum parasitaemia in Africa found that only 22% of all fever cases were 
attributed to Plasmodium infection (D'Acremont, 2010). These finding have important 
implications from a public health perspective. That is, our results highlight the need for 
laboratory diagnosis of malaria, among children under-five with fever, and the subsequent 
treatment upon confirmation of the cause, which is different from the common practise of 
assuming malaria, when fever is present, and prescribing anti-malaria treatment.  
Estimates for the contribution of the childhood disease on under-five fever based on PAF did 
not add up or even exceeded 100%, as in many occasions children could simultaneously 
experience more than one disease. For instance in Senegal, most of the under-five children 
experiencing ARI had also diarrhoea and thus, since only scarce cases were attributed to 
malaria, it was shown that most of the fever cases were both attributable to ARI and to 
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diarrhoea. This outcome is aligned with a recent modelling study from 21 SSA countries, 
which found that among under-five children with fever and a positive test for P. falciparum 
infection, only 37.7% of the fever cases were due to the malaria infection (Dalrymple, 2019). 
This stresses the need for further investigation of the aetiology of fever, even when it is 
proven that a child experiences a certain disease. 
The Bayesian hierarchical models used in our study are statistical models that establish 
associations and do not imply causal relations, for which a causal modelling approach 
should have been employed. The childhood diseases data from the DHS are only available 
for the alive children and since the outcome of our statistical models is fever we 
acknowledge that this may have affected our inference. 
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Diarrhoea ARI** Fever U5M*** 
Angola 2015 625 13.5 15.6 3.3 14.6 68 
Benin 2017 540 36.3 10.4 2.8 19.4 96 
Burkina Faso 2010 541 76.1 14.7 1.9 20.6 129 
Burundi 2016 552 37.9 22.5 7.1 39.5 78 
Cameroon 2011 577 30.0 20.9 5.4 25.9 122 
Côte d'Ivoire 2011 341 41.5 17.9 3.6 23.5 108 
DRC 2013 492 30.8 16.8 6.7 29.5 104 
Ghana 2014 423 36.4 11.7 3.6 13.8 60 
Guinea 2012 300 46.9 16.4 6.0 29.4 123 
Mali 2012 413 47.2 8.6 1.6 8.6 95 
Mozambique 2011 609 38.3 11.1 1.5 13.4 97 
Rwanda 2014 492 7.8 12.1 5.6 18.7 50 
Senegal 2016 214 0.9 15.3 3.3 12.7 51 
Tanzania 2015 608 14.4 11.8 3.7 17.9 67 
Togo 2013 329 37.8 15.0 3.4 21.6 88 
Uganda 2016 685 30.4 19.5 9.3 33.3 64 






Table 4.2: Posterior estimates (Odds Ratio, 95% Bayesian Credible Interval) of the association between childhood 
diseases and fever prevalence, adjusted for maternal, socio-economic, demographic and individual-child 
characteristics, as well as for health interventions. Estimates were obtained from a Bayesian geostatistical logistic 
regression model with spatially varying coefficients.  
 Malaria parasitaemia Diarrhoea Acute Respiratory Infection 
Angola 2.25 (1.64, 3.08) 19.32 (10.32, 36.14) 33.35 (14.43, 76.99) 
Benin 1.52 (1.13, 2.03) 9.53 (4.47, 20.29) 7.14 (3.37, 15.12) 
Burkina Faso 0.96 (0.71, 1.28) 15.57 (8.47, 28.57) 31.42 (13.60, 72.52) 
Burundi 3.02 (2.36, 3.87) 4.51 (2.62, 7.78) 12.56 (7.24, 21.79) 
Cameroon 1.99 (1.51, 2.62) 6.75 (3.57, 12.76) 3.84 (2.10, 6.99) 
Côte d'Ivoire 1.01 (0.70, 1.43) 27.48 (14.33, 52.69) 14.33 (6.42, 31.98) 
DRC 1.91 (1.53, 2.40) 14.80 (8.06, 27.15) 20.37 (11.44, 36.26) 
Ghana 1.69 (1.11, 2.56) 6.28 (2.69, 14.66) 7.73 (2.76,21.59) 
Guinea 1.54 (1.01, 2.39) 14.29 (5.25, 38.47) 21.11 (9.02, 49.40) 
Mali 1.55 (0.93, 2.60) 26.57 (9.20, 76.65) 68.15 (12.61, 367.78) 
Mozambique 1.55 (1.16, 2.10) 4.17 (1.24, 13.98) 2.66 (7.72, 22.38) 
Rwanda 3.48 (1.64, 7.34) 28.75 (13.83, 59.72) 15.87 (8.24, 30.53) 
Senegal 4.54 (0.36, 56.68) 43.44 (13.60, 138.54) 638.87 (123.16, 3309.65) 
Tanzania 4.88 (3.10, 7.68) 7.84 (3.09, 19.84) 9.08 (3.87, 21.29) 
Togo 1.48 (0.90, 2.42) 18.37 (9.59, 35.17) 21.56 (9.99, 46.53) 
Uganda 2.61 (2.01, 3.39) 13.44 (7.77, 23.23) 7.59 (4.45, 12.95) 
 
Table 4.3: Country estimates (Posterior Median, 95% Bayesian Credible Interval) of the Population Attributable 
Fraction (PAF) measuring the contribution of malaria, diarrhoea and acute respiratory infection on fever. Estimates 
were obtained from a Bayesian geostatistical logistic regression model with spatially varying coefficients. 
 Malaria parasitaemia Diarrhoea Acute Respiratory Infection 
Angola 17.56 (10.02, 26.04) 71.99 (56.79, 82.65) 65.05 (44.61, 81.86) 
Benin 16.44 (4.81, 29.04) 46.99 (26.22, 64.59) 32.57 (15.50, 52.78) 
Burkina Faso -3.33 (-26.42, 16.78) 67.11 (50.56, 79.02) 63.95 (41.96, 80.87) 
Burundi 41.27 (32.38, 50.28) 41.95 (25.86, 57.22) 63.33 (48.57, 75.46) 
Cameroon 24.47 (13.68, 34.77) 51.02 (33.03, 67.81) 28.75 (14.61, 46.83) 
Côte d'Ivoire 0.25 (-15.94, 16.13) 81.30 (70.05, 89.81) 52.38 (32.13, 73.46) 
DRC 24.36 (15.89, 32.73) 67.33 (50.83, 79.53) 68.61 (53.07, 80.05) 
Ghana 22.88 (3.54, 39.27) 40.72 (18.52, 63.99) 33.46 (10.56, 57.90) 
Guinea 21.09 (0.27, 38.93) 67.26 (39.95, 85.68) 70.92 (48.88, 85.08) 
Mali 20.19 (-1.85, 42.14) 71.79 (45.19, 87.99) 72.40 (32.97, 94.41) 
Mozambique 17.00 (6.02,29.48) 24.99 (2.26, 58.79) 24.61 (7.00, 51.83) 
Rwanda 17.29 (5.35, 35.34) 77.72 (61.94, 87.56) 64.35 (47.50, 77.49) 
Senegal 6.88 (-1.44, 54.93) 88.99 (71.79, 96.04) 97.16 (85.76, 99.42) 
Tanzania 33.33 (21.71, 46.51) 43.97 (19.54, 68.06) 32.42 (14.16, 54.56) 
Togo 15.92 (-4.18, 37.50) 72.79 (58.21, 83.97) 73.49 (56.58, 86.52) 
Uganda 34.73 (25.45, 44.06) 70.90 (57.03, 81.28) 52.75 (36.68, 66.71) 
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Figure 4.1: Geographical distribution of the association between malaria parasitaemia and fever prevalence, among 
under-five children, in 16 sub-Saharan African countries. Estimates were obtained from a Bayesian geostatistical 








Figure 4.2: Geographical distribution of the association between diarrhoea and fever prevalence, among under-five 
children, in 16 sub-Saharan African countries. Estimates were obtained from a Bayesian geostatistical logistic 








Figure 4.3: Geographical distribution of the association between acute respiratory infection and fever prevalence, 
among under-five children, in 16 sub-Saharan African countries. Estimates were obtained from a Bayesian 










The outcome of the Bayesian geostatistical logistic regression model is a binary indicator, 
which takes the values 0 (no fever over the last 2 weeks preceding the survey) and 1 
(presence of fever). Specifically, it is represented as 𝑌𝑌𝑗𝑗𝑖𝑖, with 𝑗𝑗 corresponding to each under-
five child  for a given country and 𝐵𝐵 corresponding to one of the 𝐵𝐵 surveyed locations of a 
given country, i.e. 𝑠𝑠 = {𝑠𝑠1, 𝑠𝑠2, … , 𝑠𝑠𝑛𝑛}, 𝑠𝑠𝑖𝑖 ⊂ 𝑅𝑅2. 𝑌𝑌𝑗𝑗𝑖𝑖 follows a Bernoulli distribution with 
probability of success 𝑝𝑝𝑗𝑗𝑖𝑖, i.e. the probability of developing febrile response. 𝑝𝑝𝑗𝑗𝑖𝑖 is linked to 








where 𝛽𝛽 = (𝛽𝛽0,𝛽𝛽1, … ,𝛽𝛽𝜅𝜅)𝑇𝑇  is the vector of 𝛫𝛫 regression coefficients, 𝑥𝑥𝑗𝑗𝑖𝑖𝜅𝜅 represents the 
value of the κ-th predictor for the 𝑗𝑗-th child at the 𝐵𝐵-th location and 𝜉𝜉(𝑠𝑠) = (𝜉𝜉1, 𝜉𝜉2, … , 𝜉𝜉𝑛𝑛)𝜏𝜏 is a 
zero-mean, multivariate Gaussian distributed random vector with Matérn covariance matrix 
that accounts for the spatial correlation in the response. The effect of the geostatistical 
intercept is cluster-specific and so each effect corresponds to each of the unique surveyed 
locations, i.e. 𝑠𝑠 = {𝑠𝑠1, 𝑠𝑠2, … , 𝑠𝑠𝑛𝑛}, 𝑠𝑠𝑖𝑖 ⊂ 𝑅𝑅2. The Matérn specification is achieved with the use of 
Matérn function as a measure that governs the covariance between any two locations 𝑠𝑠1 and 




, with 𝜎𝜎12 being the 
spatial process variance, 𝑑𝑑(𝑠𝑠1, 𝑠𝑠2) the distance between locations 𝑠𝑠1 and 𝑠𝑠2 and 𝜅𝜅1 the 
scaling parameter. The modified Bessel function of second kind and order 𝜈𝜈 is represented 




  that particularly determines the distance at which the spatial correlation becomes 
negligible. In our work, we utilized an extension of the above model so that the predictor 
representing the disease exposure 𝑥𝑥𝑗𝑗𝑖𝑖1 is also assigned a spatially varying component, in 
addition to the regression coefficient 𝛽𝛽1, which represents the national estimate of the 
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disease exposure-fever association. Assuming that, for a given country, there are 𝑀𝑀 different 
provinces at which the effect of exposure would be estimated by the spatially varying effect, 




� = 𝛽𝛽0 + �𝛽𝛽1 + 𝜀𝜀1 𝑚𝑚(𝑖𝑖)� 𝑥𝑥𝑗𝑗𝑖𝑖1 + �𝛽𝛽𝜅𝜅𝑥𝑥𝑗𝑗𝑖𝑖𝜅𝜅
𝛫𝛫
𝜅𝜅=2
+ 𝜉𝜉𝑖𝑖 , 
where now 𝛽𝛽1 represents the national effect of the disease exposure on fever, 𝜀𝜀1 =
(𝜀𝜀11, … , 𝜀𝜀1𝑀𝑀)𝑇𝑇 are the spatially varying effects of 𝛽𝛽1 at the different 𝑀𝑀 provinces of each 
country and 𝑚𝑚(𝐵𝐵) is a filter of which of the 𝑀𝑀 provinces the 𝑗𝑗-th child at the 𝐵𝐵-th location 
belongs. The vector of spatially varying effects 𝜀𝜀1 follows a zero-mean, multivariate 
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The exchangeable structure implies that region identifiers are weighted by the values of the 
disease exposure and follow an exchangeable format. Under the logistic regression, the 
exponential function imposed on the regression coefficients provides the odds ratio. After 
model-fitting, a posterior sample of size 1,000 for each of the 𝑀𝑀 province-specific effects was 
obtained. We added up the posterior sample to the national effect and summarized all 
estimates in terms of posterior median and 95% Bayesian credible interval. Based on these 
estimates we derived Figures 4.1–4.3. We also utilized the posterior sample and the 
province-specific effects in order to calculate the Population Attributable Function (PAF), 
based on the formula: 
𝑃𝑃𝑃𝑃𝑃𝑃 =
𝑝𝑝 (𝑂𝑂𝑅𝑅 − 1)
(1 + 𝑝𝑝 (𝑂𝑂𝑅𝑅 − 1))
, 
where p represents the prevalence of a disease and OR represents the estimated odds ratio 
for a specific province. PAF can be interpreted as the percentage of all fever cases that can 






Table 4.4: Country and regional-specific estimates (Posterior Median, 95% Bayesian Credible Interval) of the 
Population Attributable Fraction (PAF) measuring the contribution of malaria, diarrhoea and acute respiratory 




 Malaria Diarrhoea ARI 
National 17.56 (10.02, 26.04) 71.99 (56.79, 82.65) 65.05 (44.61, 81.86) 
Regions    
Bengo 8.88 (-2.84, 31.00) 57.60 (19.39, 84.71) 51.43 (8.60, 91.10) 
Benguela 24.03 (10.13, 42.82) 80.64 (58.15, 92.06) 87.12 (50.82, 97.30) 
Bié 11.89 (-7.09, 32.44) 66.48 (32.23, 88.08) 40.71 (7.71, 81.68) 
Cabinda 12.95 (-2.29, 34.21) 66.95 (34.25, 88.25) 67.76 (22.81, 92.27) 
Cuando Cubango 15.12 (-7.89, 41.90) 74.71 (41.12, 91.84) 27.84 (3.47, 78.85) 
Cuanza Norte 22.00 (3.79, 40.60) 70.13 (39.30, 87.79) 37.88 (6.08, 74.30) 
Cuanza Sul 41.95 (20.97, 61.44) 76.50 (48.08, 90.61) 52.88 (12.65, 89.61) 
Cucene 0.62 (-0.12, 2.91) 64.80 (27.51, 87.84) 53.47 (10.18, 89.98) 
Huíla 3.96 (-0.76, 16.51) 77.56 (44.08, 91.99) 70.69 (25.40, 93.72) 
Huambo 2.59 (-0.01, 8.75) 75.77 (47.01, 92.05) 74.64 (36.05, 94.16) 
Luanda 13.12 (2.11, 32.48) 67.70 (41.31, 84.08) 66.92 (31.04, 90.22) 
Lunda Norte 22.87 (3.99, 45.79) 77.27 (50.58, 92.66) 74.11 (37.27, 93.29) 
Lunda Sul 5.24 (-2.47, 22.00) 64.31 (31.53, 87.89) 51.60 (9.98, 91.00) 
Malanje 29.94 (15.16, 46.53) 88.60 (72.60, 95.69) 84.86 (48.54, 97.04) 
Moxico 15.59 (-13.39, 43.84) 51.86 (15.97, 83.52) 55.44 (10.19, 91.62) 
Namibe 0.88 (-0.37, 4.85) 73.26 (40.83, 89.36) 80.08 (39.13, 95.91) 
Uíge 33.99 (14.44, 54.05) 65.13 (32.63, 86.41) 71.89 (26.89, 94.13) 
Zaire 13.22 (-0.98, 34.23) 57.62 (22.88, 83.37) 44.71 (6.39, 88.78) 
 
Benin 
 Malaria Diarrhoea ARI 
National 16.44 (4.81, 29.04) 46.99 (26.22, 64.59) 32.57 (15.50, 52.78) 
Regions    
Alibori 12.89 (-8.73, 36.50) 81.86 (44.93, 95.13) 82.57 (44.75, 96.16) 
Atakora 10.10 (-23.15, 37.93) 65.51 (27.05, 88.76) 21.85 (-0.93, 70.32) 
Atlantique 13.12 (0.75, 28.78) 10.57 (-3.64, 42.04) 23.48 (3.04, 54.88) 
Borgou 20.66 (-5.70, 44.72) 37.17 (2.86, 79.15) 17.18 (-0.88, 57.16) 
Collines 5.58 (-19.07, 31.61) 21.14 (-1.82, 66.84) 17.08 (-2.82, 53.47) 
Donga 14.58 (-9.00, 37.85) 53.84 (11.39, 86.59) 8.29 (-2.19, 41.70) 
Kouffo 8.95 (-20.13, 37.71) 31.82 (1.80, 73.02) 23.38 (-0.42, 65.16) 
Littoral 1.77 (-1.82, 9.91) 59.60 (18.15, 91.72) 32.96 (1.44, 78.57) 
Mono 24.93 (3.43, 48.78) 39.21 (0.98, 80.85) 38.93 (4.30, 76.44) 
Ouémé 13.01 (0.24, 29.30) 39.24 (8.16, 72.86) 23.67 (0.75, 69.96) 
Plateau 13.54 (-4.27, 33.24) 55.82 (17.19, 85.06) 50.48 (8.11, 87.54) 
Zou 27.04 (2.88, 48.97) 43.58 (10.63, 77.19) 52.71 (17.34, 81.58) 
 
Burkina Faso 
 Malaria Diarrhoea ARI 
National -3.33 (-26.42, 16.78) 67.11 (50.56, 79.02) 63.95 (41.96, 80.87) 
Regions    
Boucle du Mouhoun -14.41 (-58.49, 19.75) 76.05 (46.10, 90.95) 48.82 (6.62, 89.07) 
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Cascades 5.67 (-22.34, 32.28) 53.14 (17.67, 82.90) 86.22 (49.12, 97.23) 
Centre-Est -33.04 (-72.57, 6.25) 52.63 (21.17, 79.34) 38.55 (6.61, 80.38) 
Centre-Nord -30.83 (-75.41, 6.26) 69.92 (37.34, 89.35) 65.73 (16.91, 92.15) 
Centre-Ouest 3.46 (-35.60, 33.40) 57.54 (23.38, 81.27) 27.79 (3.24, 77.68) 
Centre-Sud 35.21 (4.38, 56.82) 78.90 (55.74, 91.11) 40.37 (6.87, 79.31) 
Centre -4.71 (-27.28, 20.57) 75.07 (46.93, 91.27) 57.04 (13.20, 88.62) 
Est -25.52 (-86.59, 21.07) 45.89 (13.20, 80.37) 53.26 (8.59, 89.28) 
Haut-Bassins 36.81 (14.74, 56.33) 73.44 (45.69, 89.53) 69.02 (22.56, 92.87) 
Nord 12.73 (-26.07, 38.87) 85.46 (63.03, 95.25) 72.56 (36.21, 93.37) 
Plateau-Central 2.44 (-34.63, 32.20) 68.03 (31.54, 88.46) 64.82 (26.02, 89.93) 
Sahel -27.23 (-60.91, 10.03) 51.83 (13.89, 83.86) 70.33 (32.04, 91.44) 
Sud-Ouest 23.43 (-15.45, 51.28) 61.95 (21.18, 86.93) 51.34 (8.99, 89.23) 
 
Burundi 
 Malaria Diarrhoea ARI 
National 41.27 (32.38, 50.28) 41.95 (25.86, 57.22) 63.33 (48.57, 75.46) 
Regions    
Bubanza 35.18 (13.19, 55.85) 50.04 (13.51, 78.38) 57.41 (22.35, 84.39) 
Bujumbura Mairie 5.84 (0.64, 16.57) 45.48 (10.98, 77.22) 43.22 (11.84, 74.99) 
Bujumbura Rural 12.20 (2.87, 26.67) 14.97 (-7.76, 47.84) 43.51 (10.64, 75.14) 
Bururi 22.08 (8.53, 40.78) 61.71 (33.27, 80.42) 84.13 (65.60, 94.13) 
Cankuzo 44.87 (22.93, 62.44) 27.13 (0.38, 63.30) 46.97 (13.27, 75.68) 
Cibitoke 42.40 (21.74, 61.90) 63.28 (26.89, 86.28) 64.50 (32.18, 87.19) 
Gitega 43.29 (26.79, 59.81) 47.61 (18.12, 72.20) 72.42 (47.75, 88.16) 
Karuzi 47.52 (29.54, 63.03) 34.37 (3.04, 68.95) 48.70 (15.90, 80.95) 
Kayanza 35.93 (15.63, 55.98) 48.12 (16.06, 75.46) 71.30 (44.65, 86.57) 
Kirundo 67.73 (55.20, 76.84) 72.53 (43.87, 88.37) 82.82 (60.93, 93.40) 
Makamba 33.37 (14.12, 53.35) 27.40 (-1.89, 62.47) 47.40 (12.98, 81.57) 
Muramvya 34.91 (16.98, 52.72) 43.01 (7.73, 74.83) 74.18 (43.16, 90.10) 
Muyinga 65.02 (51.27, 76.95) 61.32 (30.24, 83.09) 74.54 (42.27, 90.38) 
Mwaro 21.60 (5.32, 41.85) 6.89 (-12.90, 42.04) 49.80 (14.15, 79.44) 
Ngozi 60.27 (42.90, 72.85) 58.07 (27.15, 80.59) 66.90 (38.90, 87.24) 
Rutana 41.48 (21.85, 59.09) 44.10 (8.77, 75.37) 63.34 (27.86, 86.32) 
Ruyigi 10.70 (-13.75, 32.72) 5.09 (-10.50, 39.65) 28.99 (6.07, 67.13) 
 
Cameroon 
 Malaria Diarrhoea ARI 
National 24.47 (13.68, 34.77) 51.02 (33.03, 67.81) 28.75 (14.61, 46.83) 
Regions    
Adamaoua 23.32 (-0.61, 43.94) 39.70 (12.36, 69.60) 14.42 (-2.35, 53.15) 
Centre 27.84 (11.29, 44.68) 53.96 (29.20, 75.83) 33.40 (10.94, 57.93) 
Est 6.57 (-20.81, 32.28) 35.62 (5.30, 69.31) 8.66 (-6.57, 40.49) 
Extrême-Nord 29.81 (7.89, 51.46) 71.80 (45.90, 87.57) 44.06 (15.55, 70.78) 
Littoral 14.43 (2.22, 31.10) 42.68 (18.21, 70.29) 17.85 (-0.28, 48.74) 
Nord-Ouest 18.24 (2.17, 39.07) 25.89 (4.40, 56.86) 23.48 (0.66, 56.75) 
Nord 22.61 (3.64, 41.10) 75.86 (55.04, 87.89) 52.18 (21.98, 75.85) 
Ouest 26.57 (7.40, 45.98) 35.02 (6.58, 66.87) 7.80 (-9.50, 40.89) 
Sud-Ouest 54.28 (32.50, 70.22) 42.49 (14.72, 72.97) 43.65 (11.97, 77.45) 






 Malaria Diarrhoea ARI 
National 0.25 (-15.94, 16.13) 81.30 (70.05, 89.81) 52.38 (32.13, 73.46) 
Regions    
Abidjan 2.60 (-7.23, 19.63) 78.24 (55.42, 90.41) 69.39 (34.52, 88.39) 
Bas-Sassandra 4.09 (-28.79, 37.62) 69.83 (38.51, 89.04) 44.70 (7.14, 82.18) 
Comoé 43.69 (16.44, 62.92) 87.52 (74.41, 94.52) 74.22 (43.38, 92.24) 
Denguélé 14.88 (-12.13, 48.26) 78.10 (47.92, 92.76) 37.01 (5.33, 82.27) 
Gôh-Djiboua -31.48 (-58.29, 6.54) 66.98 (30.25, 87.24) 12.13 (0.32, 53.11) 
Lacs -5.21 (-33.41, 25.31) 79.38 (53.70, 92.15) 42.51 (6.06, 86.72) 
Lagunes -13.13 (-41.51, 20.76) 78.96 (51.03, 92.84) 61.22 (16.68, 90.53) 
Montagnes 16.05 (-11.98, 43.20) 80.53 (56.53, 91.57) 43.07 (11.95, 75.59) 
Sassandra-Marahoué -2.71 (-26.87, 26.73) 88.77 (73.95, 95.51) 68.41 (33.89, 88.03) 
Savanes 11.69 (-14.91, 39.44) 82.89 (61.35, 93.41) 43.28 (7.22, 84.16) 
Vallée du Bandama -14.07 (-28.04, 7.48) 77.36 (47.96, 92.08) 21.53 (0.63, 68.23) 
Woroba 36.56 (6.60, 60.02) 88.75 (73.41, 95.52) 78.50 (43.16, 94.49) 
Yamoussoukro -11.98 (-31.67, 25.27) 76.21 (42.48, 92.83) 27.76 (2.06, 80.27) 
Zanzan -3.37 (-34.17, 26.24) 78.00 (53.04, 92.63) 16.74 (-2.46, 60.96) 
 
Democratic Republic of the Congo 
 Malaria Diarrhoea ARI 
National 24.36 (15.89, 32.73) 67.33 (50.83, 79.53) 68.61 (53.07, 80.05) 
Regions    
Équateur 8.64 (-6.66, 25.46) 58.25 (20.21, 84.76) 63.99 (34.21, 83.32) 
Bandundu 10.03 (-2.12, 24.79) 58.59 (23.28, 84.51) 54.42 (24.37, 79.89) 
Bas-Congo 31.67 (9.54, 50.04) 26.01 (-1.84, 62.62) 48.15 (15.84, 79.05) 
Kasaï-Occidental 39.38 (16.09, 57.49) 76.18 (45.79, 91.85) 60.64 (29.79, 82.93) 
Kasaï-Oriental 20.56 (-2.23, 40.56) 88.33 (73.20, 95.13) 79.59 (59.36, 90.82) 
Katanga 36.01 (15.04, 52.76) 76.16 (47.99, 92.17) 62.05 (33.78, 83.07) 
Kinshasa City 30.90 (13.40, 49.13) 67.78 (24.00, 89.47) 45.96 (16.24, 77.47) 
Kivu 23.48 (8.59, 39.72) 78.61 (53.69, 90.73) 83.12 (66.83, 91.60) 
Orientale 11.84 (-9.34, 31.52) 56.75 (22.09, 82.86) 66.67 (39.04, 85.55) 
 
Ghana 
 Malaria Diarrhoea ARI 
National 22.88 (3.54, 39.27) 40.72 (18.52, 63.99) 33.46 (10.56, 57.90) 
Regions    
Ashanti 18.53 (-2.59, 44.10) 40.67 (6.38, 74.58) 34.34 (3.49, 75.56) 
Brong Ahafo 24.27 (-5.80, 52.27) 44.42 (7.43, 76.79) 35.58 (5.55, 76.66) 
Central 26.74 (-9.93, 53.37) 34.42 (3.61, 71.68) 20.75 (-1.53, 62.79 ) 
Eastern 9.23 (-20.69, 39.72) 26.79 (-0.02, 62.88) 35.06 (4.32, 70.77) 
Greater Accra 11.40 (-1.61, 31.94) 35.36 (2.69, 74.60) 31.66 (0.8, 74.89) 
Northern 1.00 (-37.33, 36.33) 63.02 (23.11, 88.31) 35.01 (4.14, 75.76) 
Upper East 15.76 (-3.84, 39.52) 29.71 (-0.01, 71.41) 29.32 (0.46, 72.17) 
Upper West 45.29 (9.44, 69.12) 51.71 (12.38, 82.83) 20.72 (1.07, 66.67) 
Volta 24.61 (-4.08,51.25) 43.11 (8.98, 82.14) 44.63 (5.30, 84.67) 







 Malaria Diarrhoea ARI 
National 21.09 (0.27, 38.93) 67.26 (39.95, 85.68) 70.92 (48.88, 85.08) 
Regions    
Boké 22.23 (-7.37, 49.29) 55.08 (9.56, 87.87) 66.94 (25.88, 89.03) 
Conakry 1.42 (-1.86, 11.33) 72.74 (35.82, 92.15) 33.20 (2.22, 75.51) 
Faranah -15.25 (-55.20, 26.16) 61.16 (20.59, 87.41) 56.75 (13.46, 87.11) 
Kankan 26.49 (-4.85, 51.29) 81.21 (43.34, 95.33) 87.85 (57.60, 97.35) 
Kindia 28.31 (1.32, 53.49) 82.17 (47.72, 95.84) 85.74 (59.71, 95.49) 
Labé 28.71 (1.70, 54.82) 82.14 (41.89, 94.85) 85.33 (62.50, 94.99) 
Mamou 23.82 (-5.44, 54.15) 40.90 (0.66, 78.96) 50.17 (9.10, 83.36) 
Nzérékoré 11.41 (26.43, 44.57) 45.22 (4.66, 83.43) 71.26 (22.80, 94.57) 
 
Mali 
 Malaria Diarrhoea ARI 
National 20.19 (-1.85, 42.14) 71.79 (45.19, 87.99) 72.40 (32.97, 94.41) 
Regions    
Bamako 3.10 (-2.62, 17.65) 43.26 (1.00, 84.13) 74.45 (20.87, 96.24) 
Kayes 19.19 (-6.81, 48.23) 70.69 (18.16, 96.05) 70.42 (16.76, 96.20) 
Koulikoro -5.34 (-34.73, 25.68) 30.71 (-0.01, 72.87) 59.90 (11.10, 93.67) 
Mopti 30.93 (-12.20, 59.01) 84.27 (48.19, 96.65) 76.65 (24.71, 96.33) 
Ségou 21.89 (-13.16, 51.92) 80.24 (41.91, 95.32) 73.38 (22.07, 96.26) 
Sikasso 40.34 (7.28, 63.29) 90.37 (60.52, 98.45) 76.36 (25.38, 96.39) 
Kidal – – – 
Tombouctou – – – 
Gao – – – 
 
Mozambique 
 Malaria Diarrhoea ARI 
National 17.00 (6.02,29.48) 24.99 (2.26, 58.79) 24.61 (7.00, 51.83) 
Regions    
Cabo Delgado 28.15 (4.67, 48.08) 11.18 (-2.39, 54.37) 18.24 (0.56, 66.05) 
Gaza 20.37 (1.76, 40.43) 33.37 (-0.23, 78.31) 32.43 (1.49, 78.06) 
Inhambane 4.96 (-15.94, 27.05) 5.81 (2.38, 44.28) 12.35 (-0.91, 55.42) 
Manica 15.06 (-4.82, 37.03) 11.72 (-5.46, 61.86) 25.18 (1.58, 68.76) 
Maputo City 0.78 (-0.55, 3.83) 6.67 (-7.53, 48.26) 30.80 (4.87, 68.41) 
Maputo 3.50 (-2.96, 16.13) 20.27 (-5.41, 69.62) 36.56 (0, 76.38) 
Nampula 4.32 (-18.50, 27.88) 23.03 (-3.54, 69.75) 28.16 (1.31, 77.50) 
Nassa 15.52 (-8.36, 38.42) 24.03 (-4.26, 72.65) 12.30 (-1.16, 53.26) 
Sofala 32.20 (15.48, 49.75) 59.43 (17.03, 86.64) 35.44 (6.46, 76.21) 
Tete 21.08 (0.68, 42.01) 26.41 (-3.34, 69.50) 18.18 (1.05, 60.49) 









 Malaria Diarrhoea ARI 
National 17.29 (5.35, 35.34) 77.72 (61.94, 87.56) 64.35 (47.50, 77.49) 
Regions    
Amajyaruguru 2.35 (0, 15.44) 74.81 (46.96, 91.09) 70.62 (36.77, 89.74) 
Amajyepfo 20.03 (7.49, 36.24) 76.26 (54.79, 89.45) 52.37 (30.47, 72.47) 
Iburasirazuba 32.47 (14.32, 52.27) 84.51 (66.71, 93.25) 72.29 (42.94, 88.88) 
Iburengerazuba 8.04 (0.69, 25.18) 78.77 (56.83, 90.42) 76.65 (53.62, 90.15) 
Umujyi wa Kigali 2.68 (-0.55, 16.01) 66.89 (29.96, 88.54) 43.41 (12.57, 71.48) 
 
Senegal 
 Malaria Diarrhoea ARI 
National 6.88 (-1.44, 54.93) 88.99 (71.79, 96.04) 97.16 (85.76, 99.42) 
Regions    
Dakar 3.33 (-0.83, 53.84) 89.53 (61.64, 97.77) 98.84 (90.01, 99.78) 
Diourbel 0.57 (-0.14, 15.56) 80.19 (36.11, 96.22) 92.13 (53.94, 99.09) 
Fatick 0.68 (-0.18, 16.50) 80.33 (39.55, 95.33) 96.66 (72.98, 99.60) 
Kédougou 27.30 (-9.39, 85.19) 83.04 (46.37, 96.94) 96.76 (75.97, 99.59) 
Kaffrine 2.24 (-0.80, 44.55) 95.13 (80.84, 98.87) 98.69 (89.93, 99.81) 
Kaolack 4.28 (-1.00, 58.11) 96.26 (84.38, 99.17) 98.87 (88.76, 99.81) 
Kolda 29.35 (-3.87, 88.32) 87.99 (62.00, 96.82) 97.91 (84.30, 99.76) 
Louga 3.35 (-0.83, 51.68) 88.92 (46.68, 98.51) 96.90 (74.25, 99.64) 
Matam 4.01 (-1.15, 58.33) 83.56 (41.50, 96.81) 94.60 (59.27, 99.38) 
Sédhiou 0.83 (-0.02, 19.49) 88.49 (57.17, 97.52) 97.12 (79.19, 99.60) 
Saint–Louis 3.24 (-0.84, 52.79) 83.97 (39.11, 97.62) 97.20 (81.30, 99.72) 
Tambacounda 9.61 (-2.46, 73.63) 88.47 (57.34, 97.96) 96.15 (75.55, 99.57) 
Thiès 1.24 (-0.25, 27.02) 74.98 (24.14, 95.82) 96.85 (76.29, 99.62) 
Ziguinchor 1.82 (-0.55, 38.22) 92.02 (65.90, 98.62) 98.23 (86.11, 99.80) 
 
Tanzania 
 Malaria Diarrhoea ARI 
National 33.33 (21.71, 46.51) 43.97 (19.54, 68.06) 32.42 (14.16, 54.56) 
Regions    
Arusha 3.81 (0.53, 11.87) 38.01 (5.41, 78.15) 30.27 (3.18, 69.67) 
Dar es Salaam 4.81 (0.72, 15.58) 44.90 (5.02, 79.35) 52.40 (15.24, 83.45) 
Dodoma 3.59 (0.50, 13.09) 45.27 (4.80, 81.30) 23.25 (2.27, 65.75) 
Geita 50.26 (27.65, 69.75) 28.80 (1.95, 71.50) 19.98 (1.20, 57.16) 
Iringa 3.84 (0.58, 13.12) 30.50 (1.67, 74.90) 40.79 (7.06, 78.98) 
Kagera 49.17 (23.40, 68.58) 23.87 (-1.84, 63.70) 34.35 (6.68, 70.33) 
Katavi 32.88 (10.26, 58.48) 42.24 (5.33, 79.21) 15.18 (1.70, 49.97) 
Kigoma 56.91 (34.95, 74.04) 59.58 (17.39, 86.97) 48.02 (10.37, 82.02) 
Kilimanjaro 3.60 (0.65, 12.76) 47.42 (10.32, 83.92) 53.59 (15.68, 84.87) 
Lindi 44.90 (16.70, 71.39) 49.38 (10.06, 82.03) 24.49 (2.50, 62.21) 
Manyara 3.49 (0.56, 12.49) 35.14 (1.10, 75.75) 11.10 (1.10, 44.53) 
Mara 51.44 (26.44, 72.32) 63.52 (20.98, 89.11) 31.34 (3.26, 71.29) 
Mbeya 3.16 (0.45, 11.43) 46.32 (4.82, 83.46) 34.71 (4.64, 75.91) 
Morogoro 46.54 (17.89, 70.90) 39.67 (4.40, 80.01) 38.55 (6.53, 78.60) 
Mtwara 54.53 (24.83, 75.90) 49.54 (4.85, 83.18) 46.18 (10.10, 82.58) 
Mwanza 36.57 (12.87, 62.31) 44.36 (12.09, 79.24) 34.74 (5.71, 69.60) 
Njombe 2.48 (0.36, 9.30) 38.85 (4.00, 79.56) 41.90 (8.00, 80.41) 
Pemba North 3.73 (0.58, 11.89) 47.14 (7.94, 83.32) 39.84 (6.29, 79.33) 
Pemba South 3.70 (0.46, 12.99) 56.28 (14.50, 87.07) 33.57 (5.77, 74.96) 
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Pwani 20.89 (0.34, 48.00) 42.08 (6.35, 80.45) 29.85 (2.55, 71.94) 
Rukwa 9.88 (1.73, 28.30) 62.40 (19.81, 88.40) 35.54 (6.50, 75.04) 
Ruvuma 46.95 (19.46, 70.74) 55.05 (14.71, 86.26) 4.02 (0.39, 22.29) 
Shinyanga 48.19 (23.17, 71.48) 43.74 (8.38, 79.78) 30.80 (5.74, 72.90) 
Simiyu 40.89 (15.28, 65.91) 52.69 (13.62, 83.76) 34.80 (7.87, 74.64) 
Singida 27.99 (8.68, 55.50) 37.84 (2.95, 79.66) 31.01 (4.30, 70.75) 
Tabora 39.49 (12.74, 65.21) 26.82 (3.14, 67.72) 15.18 (1.49, 48.14) 
Tanga 13.76 (2.58, 37.29) 29.14 (2.55, 70.88) 26.59 (3.67, 67.40) 
Zanzibar North 3.76 (0.60, 12.40) 31.64 (1.58, 74.68) 31.07 (2.81, 72.28) 
Zanzibar South and 
Central 
1.94 (0.28, 6.56) 25.53 (-0.18, 67.84) 14.72 (0.71, 53.78) 
Zanzibar West 3.69 (0.57, 11.27) 43.12 (5.88, 80.41) 31.99 (5.11, 72.03) 
 
Togo 
 Malaria Diarrhoea ARI 
National 15.92 (-4.18, 37.50) 72.79 (58.21, 83.97) 73.49 (56.58, 86.52) 
Regions    
Centre 16.29 (-19.85, 47.97) 73.69 (38.90, 92.50) 69.14 (27.38, 92.85) 
Kara -8.02 (-44.65, 32.84) 65.05 (32.24, 85.84) 25.16 (-0.32, 73.51) 
Maritime 7.99 (-6.65, 27.62) 28.39 (5.38, 58.77) 66.12 (39.45, 84.79) 
Plateaux 30.87 (1.07, 55.52) 58.31 (25.48, 80.62) 67.66 (37.08, 87.42) 
Savanes 33.18 (2.78, 60.18) 97.48 (93.95, 98.92) 96.67 (90.97, 98.88) 
 
Uganda 
 Malaria Diarrhoea ARI 
National 34.73 (25.45, 44.06) 70.90 (57.03, 81.28) 52.75 (36.68, 66.71) 
Regions    
Adjumani 7.12 (-2.50, 31.98) 47.42 (5.73, 89.71) 19.15 (-0.56, 66.89) 
Iganga 53.90 (22.72, 72.78) 89.78 (64.81, 97.40) 74.40 (36.87, 91.27) 
Jinja 1.60 (-7.83, 20.93) 35.26 (-0.60, 76.74) 26.73 (-2.50, 69.65) 
Kabale 56.50 (21.73, 80.61) 84.04 (47.13, 96.02) 46.68 (5.68, 82.89) 
Kabarole 53.09 (14.91, 77.92) 85.60 (50.75, 96.80) 36.50 (-11.68, 80.81) 
Kaberamaido 12.70 (-2.24, 38.48) 84.96 (46.07, 97.00) 41.44 (1.00, 82.16) 
Kalangala 17.70 (-30.05, 53.75) 38.00 (-0.54, 84.58) 27.91 (-2.04, 74.04) 
Kampala 63.40 (39.79, 78.29) 83.15 (50.75, 96.36) 47.29 (6.76, 86.37) 
Kamuli 18.54 (-7.09, 51.32) 55.45 (7.49, 90.96) 26.99 (-1.08, 79.02) 
Kamwenge 50.29 (21.77, 73.39) 74.75 (32.14, 93.58) 72.56 (28.62, 93.48) 
Kanungu 30.20 (-5.93, 60.82) 59.67 (10.51, 89.09) 20.02 (-8.53, 70.94) 
Apac 1.59 (-0.28, 7.95) 49.81 (4.88, 84.07) 72.25 (28.81, 94.17) 
Kapchorwa 22.03 (3.09, 51.09) 90.65 (63.84, 98.43) 73.88 (29.72, 93.54) 
Kasese 10.53 (-5.97, 40.23) 49.92 (-2.43, 88.38) 34.05 (-10.88, 79.90) 
Katakwi 4.28 (-0.98, 20.54) 54.89 (4.18, 91.42) 23.74 (-1.99, 74.65) 
Kayunga 1.00 (-0.13, 4.91) 45.44 (9.27, 78.66) 27.79 (-0.58, 69.09) 
Kibale 78.20 (58.42, 88.82) 92.99 (72.24, 98.61) 86.62 (50.43, 97.14) 
Kiboga 21.06 (0.19, 52.90) 72.75 (26.07, 93.73) 39.75 (-8.67, 82.29) 
Kisoro 19.76 (-5.10, 57.33) 48.61 (-1.04, 90.13) 30.49 (-5.11, 80.41) 
Kitgum 8.71 (-3.49, 35.92) 58.01 (3.29, 91.45) 49.17 (-2.16, 88.22) 
Kotido 35.14 (10.40, 62.35) 67.33 (20.04, 90.83) 39.74 (-1.09, 79.49) 
Kumi 70.24 (43.22, 84.98) 88.67 (58.58, 97.47) 82.73 (37.39, 96.33) 
Arua 52.24 (0.07, 79.40) 73.54 (14.97, 94.60) 49.40 (1.70, 88.55) 
Kyenjojo 14.28 (-13.22, 45.93) 38.09 (-0.84, 83.41) 6.16 (-0.17, 38.00) 
Lira 14.62 (-4.94, 48.17) 42.47 (-0.78, 88.76) 39.82 (-2.87, 83.91) 
Luwero 1.67 (-0.27, 8.09) 36.31 (-3.05, 82.75) 24.49 (-1.76, 75.29) 
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Masaka 56.94 (19.40, 77.43) 71.58 (23.97, 93.39) 71.67 (24.60, 92.27) 
Masindi 43.56 (2.56, 69.04) 73.51 (29.08, 93.75) 71.85 (25.67, 93.13) 
Mayuge 52.08 (25.02, 71.88) 94.81 (83.84, 98.61) 88.18 (62.65, 96.79) 
Mbale 48.59 (21.04, 71.33) 64.35 (16.46, 91.14) 56.40 (15.49, 86.40) 
Mbarara – – – 
Bugiri – – – 
Moroto 37.15 (8.69, 62.02) 80.04 (44.97, 94.46) 51.10 (14.28, 80.92) 
Moyo 15.75 (-8.66, 49.27) 64.45 (15.18, 93.46) 32.25 (-1.88, 82.50) 
Mpigi 54.29 (28.22, 77.05) 90.32 (64.30, 97.95) 83.55 (55.39, 95.40) 
Mubende -20.33 (-47.57, 17.11) 26.82 (-4.40, 77.19) 12.18 (-0.53, 60.36) 
Mukono 57.83 (38.81, 73.35) 85.86 (63.18, 95.62) 84.89 (55.95, 96.22) 
Nakapiripirit 15.35 (-2.44, 41.46) 59.70 (19.36, 89.48) 35.40 (3.04, 79.05) 
Nakasongola 15.14 (0.45, 41.06) 48.91 (12.93, 82.31) 43.12 (6.68, 81.71) 
Nebbi 32.89 (-7.47, 62.79) 54.57 (7.90, 88.55) 58.23 (11.30, 87.24) 
Ntungamo 13.33 (-2.13, 45.24) 77.89 (35.15, 95.91) 22.52 (0.50, 76.38) 
Pader 12.21 (-1.34, 39.86) 59.25 (13.41, 92.58) 46.67 (1.65, 86.86) 
Bundibugyo 21.76 (0.15, 52.12) 77.61 (35.71, 95.98) 65.22 (21.89, 91.97) 
Pallisa 34.31 (12.39, 58.29) 66.30 (30.42, 88.71) 31.27 (0.51, 70.49) 
Rakai 62.81 (31.63, 83.28) 81.57 (43.60, 96.49) 67.94 (26.27, 90.98) 
Rukungiri 10.73 (-1.14, 39.39) 71.39 (18.93, 94.65) 43.10 (2.69, 88.04) 
Sembabule 47.01 (14.87, 73.04)) 84.97 (46.86, 96.99) 75.71 (36.72, 93.76) 
Sironko 9.66 (-0.76, 36.40) 80.20 (47.95, 95.23) 77.63 (45.31, 93.65) 
Soroti 21.99 (-12.93, 54.93) 60.75 (15.27, 90.86) 43.39 (7.21, 83.84) 
Tororo 31.64 (11.38, 56.39) 76.70 (43.52, 94.47) 48.06 (11.42, 84.52) 
Wakiso 61.40 (35.44, 80.63) 84.52 (56.46, 96.29) 83.85 (56.49, 95.89) 
Yumbe 18.69 (1.01, 54.70) 52.78 (8.80, 88.26) 49.87 (9.76, 87.12) 
Bushenyi 18.26 (-0.63, 52.44) 63.54 (16.61, 92.75) 60.61 (13.20, 91.06) 
Busia 8.56 (-2.33, 31.31) 53.00 (10.75, 89.77) 34.47 (2.34, 79.72) 
Gulu 48.20 (27.08, 71.42) 86.48 (65.52, 96.04) 41.21 (4.79, 81.63) 
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An unprecedented reduction of the under-five mortality rate (U5MR) between 1990 and 2018 
was achieved in the sub-Sahara African, as pre-school mortality fell from 182 deaths per 
thousand live births to 78 deaths. Most of this reduction is attributed to the scaling-up of 
preventative and curative health interventions against some of the leading causes of under-
mortality, which were implemented particularly towards the end of the Millennium 
Development Goals era (MDGs). It is of great public health importance to understand which 
of these health interventions were associated with the changes in mortality risk that drove 
the reductions in the U5MR. We compiled data on under-five mortality, coverage of health 
interventions and of mortality-related risk factors from the Demographic and Health Surveys 
(DHS) for 21 sub-Sahara African countries that had data for two different time points, i.e. 
surveys. We employed a Bayesian geostatistical Weibull survival modelling approach in 
order to associate health interventions with changes in mortality risk for the two time points. 
Our results highlighted that Bacillus Calmette–Guérin (BCG) immunization, vitamin A 
supplementation and deworming medication were the health interventions mostly associated 
with the changes in all-cause under-five mortality in sub-Saharan Africa. Our results 
reflected the crucial role of vaccinations, micronutrient supplementation and treatments of 












Between 1990 and 2018, the world has experienced a remarkable reduction in the number 
of deaths for children below the age of five. The number of under-five deaths declined from 
12.5 million to 5.3 while the under-five mortality rate (U5MR), i.e. the probability for a child to 
die before its fifth birthday, fell from 93 deaths per thousand live births to 39 deaths (UN 
IGME, 2019). Most of these reductions took place between 2000 and 2015, hence during the 
Millennium Development Goals (MDGs) era. It has been estimated that the millennium 
commitment led to more than 50% reduction of the U5MR. Similar reductions were observed 
for the countries of sub-Saharan Africa (SSA), as the U5MR fell from 182 deaths per 
thousand live births in 1990 to 78 in 2018. This translates into an annual reduction rate of 
3% over these 28 years, albeit the highest annual rate was observed between 2000 and 
2018 at 3.8%. Yet, the African region remains the epicentre of the most under-five deaths 
worldwide and currently oversees pre-school mortality trends that the developed countries 
experienced two decades ago. Crucially, the SSA is home to five out of six countries with an 
U5MR that exceeds 100 deaths per thousand live births (WHO, 2019c).  
The scaling-up of preventative or curative health interventions mainly drove the reductions in 
the total number of deaths for under-five children during, and dynamically towards, the end 
of the MDGs period (Snow, 2015). Examples of changes in the distribution and usage of 
health interventions include the 30% increase in the ownership of Insecticide-Treated Nets 
(WHO, 2017a) (ITNs) and the changes in diphtheria-tetanus-pertussis-3 (DPT-3) vaccination 
from below 50% in the Africa region (Mosser, 2019) to 72.3% of second administrative unit6. 
These differences have substantially added to the protection of under-five children in SSA. 
Between 2000 and 2015, malaria control tools, championed by the use of ITNs to minimize 
the human-mosquito interaction, have been estimated to avert 663 million clinical malaria 
cases, by a Bayesian geostatistical model utilizing data from approximately 27000 
georeferenced clusters over a 19-year period until 2014 (Bhatt, 2015). The strong impact of 
vaccinations, improved hygiene facilities and oral rehydration solutions to the decline of 
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some of the leading causes of under-five mortality has been reported by international 
organisations such as the United Nations (UN IGME, 2019). A recent systematic review and 
meta-analysis indicated a 39% reduction of neonatal mortality risk in SSA with the presence 
of antenatal care visit that is conducted by a skilled provider (Tekelab, 2019). Despite the 
proven association between health interventions and under-five mortality in the African 
setting, there is a scarcity of studies taking a holistic approach and associating a large set of 
well proven for their effectiveness health interventions with under-five mortality, in order to 
take into account the synergistic effect of the scaling-up of multiple interventions. 
Additionally, to our knowledge, there are no studies yet that they have explicitly modelled 
impact of interventions, in terms of statistical associations, on the changes in mortality risk in 
Africa. An example of such a study has been conducted for the effect of health interventions 
on the changes in malaria parasitaemia risk for six SSA countries and reported the 
protective effect of ITNs against malaria risk (Giardina, 2014).  
Our geostatistical modelling study aims to associate well-proven, preventive or curative 
health interventions with changes in under-five mortality risk, between two time points, in 21 
SSA countries. To achieve that, we compiled and analysed health-related data coming from 
the Demographic and Health surveys (DHS), as well as climatic and environmental data 
from other open-access sources. We included only the countries with at least two DHS 
surveys and developed Bayesian geostatistical Weibull survival models to estimate the effect 
of health interventions on changes in under-five mortality risk across sub-Saharan Africa.  
We also implemented rigorous Bayesian variable selection procedures to select the best set 
of interventions for subsequent model fit.  
5.2 Methods 
Data sources 
The current study is primarily based on data coming from the cross-sectional, nationally and 
sub-nationally representative, household based DHS surveys. We compiled data from 21 
SSA countries that had at least two DHS surveys in order to estimate effect of interventions 
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on the changes in mortality over that two time points. Each survey consisted of a unique 
dataset that contained individual-level information for children less than the age of five. The 
key indicators incorporated in our study were as follows: the current or death age of each 
child, maternal characteristics (educational attainment of the mother of the child and her age 
at first birth), individual child characteristics (sex, delivered by caesarean section, birth order 
of the child), the socio-economic status of the family at which the child was a member and a 
classification of the type of region that the child was residing (rural or urban). The individual-
level morality data were geolocated, i.e. for each child we had available information for its 
residential coordinates. The set of curative or preventive health intervention available in the 
surveys included a wide range of health solutions, i.e. micronutrient supplementation, 
vaccinations, treatment of diseases, breastfeeding, malaria bednets, reproductive health and 
Water, Sanitation and Hygiene (WASH) practices. A full list of all interventions considered in 
our study is presented in Table 6.2. Importantly, the health interventions were modelled at 
cluster-level, since interventions are not reported by the DHS for the dead children therefore 
individual-level modelling for these indicators might have resulted on biased estimates.  
The DHS Program maintains strict standards for protecting the privacy of respondents and 
household members in all DHS surveys. Before each interview or biomarker test is 
conducted, an informed consent statement is read to the respondent, who may accept or 
decline to participate. In addition, verbal informed consent for each parasitaemia test is 
provided by the child’s parent/guardian/caregiver on behalf of children less than 5 years 
before the test is conducted. The interviewer requests verbal consent by reading a 
prescribed statement to the respondent and records in the questionnaire the reply from the 
respondent. The interviewer signs his or her name attesting to the fact that he/she read the 
consent statement to the respondent. Written consent is not included 
(https://dhsprogram.com/publications/publication-dhsm7-dhs-questionnaires-and-
manuals.cfm). 
In addition to the DHS surveys, we downloaded from open-access sources climatic and 
environmental data. The open-access sources from which we extracted our data were the 
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Global Rural and Urban Mapping Project (GRUMP), the Shuttle Radar Topography Mission 
(SRTM), the U.S. Geological Survey-Earth Resources Observation Systems (USGSS) Data 
portal and the Moderate Resolution Imaging Spectroradiometer (MODIS). We had available 
information on rainfall (USGSS), distance to the nearest water bodies (DWATER) (MODIS), 
altitude (SRTM), the normalized difference vegetation index (NDVI) (MODIS), the land 
surface temperature at night (LSTN) (MODIS) and the land surface temperature at day 
(LSTN) (MODIS) at cluster-level. We also had data on the land cover type of each cluster, 
i.e. cropland, grassland or forest (MODIS). Rural or urban classification for the residence of 
the children was based on the GRUMP project. A list of environmental and climatic data 
used in the study, together with their spatial resolution, is provided in the Appendix. 
Statistical analysis 
The core tool of our analysis is a specific type of spatial, mixed-effects model, namely the 
geostatistical model (Diggle, 1998). This approach assumes that the outcome of the model, 
in our case the under-five mortality, is correlated in space and the random intercept 
(geostatistical part) explains this feature of the data. The spatial random intercept was 
incorporated in the linear predictor as a cluster level Gaussian process with Matérn 
covariance matrix (Banerjee, 2014). Since the outcome of the model was the current or 
death age of each child, together with the corresponding censoring status, we assumed a 
Weibull lifetime distribution for the outcome and hence we resulted on a Weibull survival, 
geostatistical model. We employed Bayesian inference and hence we summarized 
regression coefficients by their posterior distribution. Assuming that the 95% Bayesian 
credible interval did not include zero, we interpreted and called the corresponding predictor 
as (statistically) important, which is equivalent to statistical significance under a frequentist 
approach. Model specification details can be found in the Appendix. 
We performed a bivariate geostatistical variable selection procedure by fitting for each 
country and health intervention, separately, a Bayesian geostatistical Weibull survival model 
in order to select interventions for subsequent model fit. The procedure involved only the 
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most recent DHS surveys for each country, as we did not use interventions data from the 
first-in-time surveys. For the set of selected variables, we used the variance inflation factor in 
order to exclude highly correlated predictors (O’Brien, 2007). In order to estimate the effects 
of health interventions on changes in under-five risk we followed a 3-step process. Initially, 
we fitted a Weibull survival geostatistical model for the first DHS survey of each country, 
using the climatic and environmental data as predictors. As a second step, we extracted the 
climatic and environmental data for the first survey year at the locations of the second survey 
and subsequently used these data to predict the outcome at the locations of the second 
survey. Under the assumption of a Weibull survival model, the linear predictor containing the 
fixed and random effects were linked to the scale parameter of the Weibull lifetime 
distribution and hence what we predicted in the second step is essentially the scale 
parameter at the locations of the second survey. The final steps involved modelling of the 
difference in scale parameters of the two Weibull survival distributions corresponding to the 
two time points, by fitting the geostatistical model for the second survey using the predicted 
scale from the first survey as an offset. The linear predictor of the last step incorporated the 
difference in the climatic data between the two time points, the selected health interventions 
at the second time point and a set of maternal, household and individual child covariates 
used as adjustments. The posterior coefficients of the health interventions were summarized 
in order to identify associations between interventions and changes in under-five mortality 
risk. A detailed description of the procedures and model formulation is provided in the 
Appendix. 
The analysis was performed in an integrated development environment of the R software (R 
Core Team (2019), 2019), i.e. the Rstudio (RStudio Team (2018), 2018). The bivariate 
geostatistical variable selection and the first two steps of the subsequent model fitting, i.e. 
fitting data from the first survey and predicting at locations of the second using the 
corresponding climatic and environmental data, were made using the Integrated Nested 
Laplace Approximation (Rue, 2009; Lindgren, 2011) (INLA) in order to conduct fast and 
reliable Bayesian Inference. The final step of the 3-process fitting was performed using the 
147 
 
STAN probabilistic programming language (Carpenter, 2017) and its interface with R called 
RStan (Stan Development Team, 2018). 
5.3 Results 
The DHS data compiled for this geostatistical analysis included cross-sectional information 
on 437,500 under-five children in 2 different time points and across 21 SSA countries. 
Almost equally split, 204,602 of these observations correspond to the surveys conducted at 
the first time point for each country. Accounting for all surveys, a total number of 20,172 
unique locations represented the clusters for which we had available information on pre-
school children. Nigeria, followed by Malawi, were the countries with the highest number of 
unique locations and observations in both sets of surveys, i.e. DHS that took place 
chronologically first and second. Benin and Sierra Leone were the only countries that were 
shown to have increased U5MR in their second DHS survey compared to their first, 
specifically from 70 to 96 deaths per thousand live deaths for Benin and from 140 to 156 
deaths for Sierra Leone. Contrarily, Mali experienced by far the largest decline in U5MR, i.e. 
from 191 deaths per thousand live births in 2006 to 95 deaths in 2012. The first in time DHS 
surveys were conducted between 2003 (Burkina Faso) and 2013 (Togo), while the surveys 
of the second set between 2010 (Burkina Faso) and 2017 (Benin and Togo). 
Results from the bivariate geostatistical variable selection presented useful patterns of which 
variables are most important for subsequent model fit. Preventative health interventions 
belonging to either the category of vaccinations or reproductive health were most frequently 
associated with all-cause under-five mortality. Specifically, Bacillus Calmette–Guérin (BCG), 
DPT and measles immunization were found to be statistically important in all 21 countries. 
Polio and Tetanus vaccinations were shown to be somewhat less associated with under-five 
mortality, as we found 19 and 16 important effects on mortality respectively. Reproductive 
health, taking the form of either antenatal care (ANC) for pregnant mothers from a skilled 
provider or frequent, at least four, ANC visiting during pregnancy, had a significant impact on 
pre-school mortality in at least 18 countries. Additionally, vitamin A supplementation and 
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deworming medication provided to children over the past 6 months that the DHS surveys 
took place, were almost everywhere associated with mortality. 
Our model-based estimates showed that approximately one out of three health interventions 
considered in this modelling study were associated with the changes in all-cause under-five 
mortality risk for at least one country. From all preventative or curative health interventions, 
the coverage of BCG vaccination was associated to mortality in 18 out of 21 countries, with 
the only exceptions of Ethiopia, Senegal and Togo. BCG immunization additionally had the 
strongest impact on the changes of mortality risk, in terms of posterior median estimates. 
Vitamin A supplementation followed BCG as it was found to be associated with changes in 
mortality in half of the countries. Deworming was statistically important in Benin, Burundi, 
Cameroon, Guinea, Malawi and Uganda. Sporadic associations between a small set of 
health interventions and pre-school mortality were found in a few countries, specifically for 
the following interventions: measles (Ghana, Mozambique and Zambia), immediate 
breastfeeding after birth for infants (Namibia and Nigeria), exclusive breastfeeding for 
children up to six months (Zambia), improved sanitation facilities in households (Togo) and 
use of ITNs from under-five children (Malawi).  
5.4 Discussion 
To our knowledge, this is the first study to assess the effect of preventive or curative health 
interventions on the changes in under-five mortality risk for 21 SSA countries, using routinely 
collected household survey data from the DHS program. We employed rigorous Bayesian 
variable selection procedures and fitted Bayesian geostatistical Weibull survival models to 
conduct our analysis. We included in the analysis countries with at least two DHS surveys 
that had available information on mortality, maternal, socio-economic and individual child 
characteristics. 
Our results highlight that BCG immunization, vitamin A supplementation and deworming 
medication are the interventions mostly associated with the changes in all-cause under-five 
mortality risk in sub-Saharan Africa. To role of vaccinations in Africa, for which BCG 
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immunization constitutes an important pillar, has been well documented in the literature. 
Reduced under-five mortality risk in areas of complete vaccination coverage, compared to 
regions with no immunization, was reported from a modelling study utilizing DHS data from 
149 countries (McGovern, 2015). The Global Alliance for Vaccines and Immunization (GAVI) 
reported that for the period 2000-2013, during which GAVI efforts helped the immunization of 
440 million children in low-income countries, six million deaths were averted due to 
vaccinations (Bustreo, 2015). In terms of the role of Vitamin A, a pooled analysis (Stevens, 
2015) of population-based surveys for 138 low-income and middle-income countries 
depicted that the African region is the most afflicted area globally in terms of vitamin A 
deficiencies, which in some countries like Mali could exceed 60%. Our analysis supports 
these results and demonstrates the crucial role that vitamin A supplementation can play in 
reducing under-five mortality risk.  
We assumed that the under-five mortality for the first survey period could be solely explained 
by environmental and climatic factors. This assumption also affected the prediction of the 
mortality risk, in terms of scale parameter for the Weibull lifetime distribution, at locations of 
the second survey for the first survey year. This hypothesis was because we did not have 
available DHS data at locations of the second surveys for the first time point. Consecutively, 
while fitting using more confounders could have been possible, we would not have available 
data for prediction. Contrarily, climatic and environmental data are available across all 
regions for all years and thus extraction of such information at locations of the second survey 
for the first time point was possible. Additionally, environmental and climatic data can be 
used as proxies of infectious and other related diseases and in doing so they account for 
some of the leading causes of mortality in sub-Saharan Africa. 
Our work uses statistical models to associate variables with mortality and does not imply 
causal relations. Instead, to establish such associations, a causal inference approach should 
have been rather used. The mortality data have been studied for a period of five years 
preceding the survey and our work did not take into account changes in the coverage of the 
health interventions over that period. This assumption might have resulted on 
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underestimation of the association between health interventions and changes in mortality 
risk. 
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Table 5.1: Descriptive analysis of the data in 21 sub-Saharan African countries, collected from the DHS programme. 


















Benin 2011 746 13336 70 2017 540 13262 96 
Burkina F. 2003 397 10575 184 2010 541 14159 129 
Burundi 2010 376 7742 96 2016 552 13135 78 
Cameroon 2004 461 8085 144 2011 577 11723 122 
Ethiopia 2011 571 11253 88 2016 622 10221 67 
Ghana 2008 401 2942 80 2014 423 5801 60 
Guinea 2005 291 6245 163 2012 300 7039 123 
Liberia 2007 291 5704 110 2013 322 7606 94 
Malawi 2010 827 19490 112 2015 850 17286 64 
Mali 2006 405 14194 191 2012 413 10326 95 
Mozambique 2003 11 10326 152 2011 609 11089 97 
Namibia 2006 486 5071 69 2013 537 5046 54 
Nigeria 2008 886 28647 157 2013 889 31225 128 
Rwanda 2010 492 9002 76 2014 492 7856 50 
Senegal 2010 385 12103 72 2016 214 6725 51 
Sierra Leone 2008 349 5590 140 2013 435 11938 156 
Tanzania 2010 458 7750 81 2015 608 10233 67 
Togo 2013 329 6979 88 2017 171 3415 73 
Uganda 2011 400 7795 90 2016 685 15276 64 
Zambia 2007 319 6401 119 2013 719 13412 75 
Zimbabwe 2010 393 5372 84 2015 399 6135 69 












Table 5.2: Description of health interventions. 
Intervention Description of Intervention 
Malaria bednets   
%H_1ITN Percentage of households with at least one Insecticide-Treated net (ITN) 
%H_1ITN2 Percentage of households with at least one ITN for every two people 
%P_ITNA Percentage of population with access to an ITN within their household 
%P_ITNS Percentage of population in a household that slept under an ITN the previous night before the survey 
%P_ITN5 Percentage of under-five children in a household who slept under an ITN the night before the survey 
%P_ITNU Percentage of existing ITNs used by the population in a household the previous night of the survey 
WASH  
Water Percentage of households with improved source of drinking water 
Sanitation Percentage of households with improved sanitation facilities 
Reproductive health  
ANC prov. Percentage of pregnant mothers receiving antenatal care (ANC) from a skilled provider 
4+ ANC Percentage of pregnant woman making at least four ANC visits during their pregnancy 
Fansidar Percentage of pregnant woman which received Fansidar during pregnancy 
Post. Care Percentage of new-borns receiving first postnatal check-up from a skilled provider within hours after delivery 
Breastfeeding   
Immediate  Percentage of infants which breastfed within one hour after birth 
Exclusive Percentage of infants which exclusively breastfed during the first six months after delivery 
Vaccinations  
Tetanus Percentage of last-born children protected against neonatal Tetanus 
BCG Percentage of children vaccinated against Bacillus Calmette–Guérin (BCG) 
DPT Percentage of children with complete  Diphtheria, Tetanus, and Pertussis (DPT) vaccination 
Polio Percentage of children with complete Polio vaccination 
Measles Percentage of children vaccinated against Measles 
Micronutrients  
Vitamin A Percentage of children which received vitamin A supplements in the past 6 months 
Iron Percentage of children which received iron supplements in the past 7 days 
Iodized salt Percentage of children which lived in a household with positive test for iodized salt 
Treatments  
ORS Percentage of children with diarrhoea given fluid from oral rehydration solution (ORS) 
ACT Percentage of children with fever during the two weeks prior to the survey which took Artemisinin-combination therapy (ACT) 










Table 5.3: Effect of health interventions on changes in under-five mortality risk across 21 countries in sub-Saharan Africa. 
 
 Benin Burkina Faso Burundi Cameroon Ethiopia Ghana Guinea 
H_1ITN X1 X X X X X  
H_1ITN2 X X X X X X X 
P_ITNA X X X X X X  
P_ITNS X X X X X X X 
P_ITN5 X X X X X  X 
P_ITNU X X X X X X X 
Water X  X X X X X 
Sanitation    X  X  
ANC prov.        
4+ ANC    X     
Fansidar  X X X X   
Post. Care X  X X X X X 
Immediate X X X   X X 
Exclusive X X X X X X X 
Tetanus   X     
BCG -1.44 (-2.47,-0.41) -3.75 (-4.80,-2.74) -3.36 (-4.98,-1.76) -2.95 (-3.84, -
2.09) 
 -5.30 (-6.89,-3.75) -2.15 (-3.15,-1.23) 
DPT        
Polio        
Measles      -1.55 (-2.88,-0.20)  
Vitamin A -0.55 (-0.98,-0.13) -0.45 (-0.82,-0.06) -0.73 (-1.36,-0.10)  -0.62 (-1.23,-0.01)   
Iron  X X  X X X 
Iodized 
Salt 
 X X X X X X 
ORS X X X  X X  
ACT X X X X X  X 
Deworming -0.67 (-1.34,-0.03)  -1.02 (-1.72,-0.33) -0.73 (-1.32,-0.15)   -1.27 (-2.21,-0.34) 










 Liberia Malawi Mali Mozambique Namibia Nigeria Rwanda 
H_1ITN X X X X X X  
H_1ITN2 X X X X X X X 
P_ITNA X X X X X X  
P_ITNS X   X X X X 
P_ITN5 X -0.93 (-1.77,-0.10)  X X X X 
P_ITNU X  X X X X X 
Water X X X X X  X 
Sanitation X X X X X  X 
ANC prov.        
4+ ANC         
Fansidar X  X  X  X 
Post. Care X X X X X  X 
Immediate X  X  -0.87 (-1.59,-0.15) -0.35 (-0.64,-0.05)  
Exclusive X X X X X X X 
Tetanus     X  X 
BCG -2.50 (-3.58,-1.44) -3.73 (-5.06,-2.42) -1.45 (-2.37,-0.55) -2.79 (-3.68,-1.95) -5.54 (-7.03,-4.10) -0.91 (-1.52,-0.31) -8.65 (-11.29,-
6.03) 
DPT        
Polio        
Measles    -1.32 (-2.17,-0.45)    
Vitamin A  -0.89 (-1.54,-0.27) -0.70 (-1.30,-0.09) -0.71 (-1.40,-0.03) -1.09 (-2.02,-0.14) -0.56 (-0.99,-0.12)  
Iron  X   X X X 
Iodized Salt X  X X X X X 
ORS X X X  X X X 
ACT X X X X X X X 











 Senegal Sierra Leone Tanzania Togo Uganda Zambia Zimbabwe 
H_1ITN X X X X  X X 
H_1ITN2 X X X X  X X 
P_ITNA X X X X  X X 
P_ITNS X X X X   X 
P_ITN5 X X X X   X 
P_ITNU  X X X X X X 
Water X X X  X X X 
Sanitation  X X -2.41 (-5.12,-0.02) X X X 
ANC prov.   X     
4+ ANC    X   X  
Fansidar  X X    X 
Post. Care  X X X X X X 
Immediate X X X  X   
Exclusive X X X X X -2.90 (-4.31,-1.53)  
Tetanus   X   X  
BCG  -4.04 (-5.15,-2.90) -2.71 (-4.19,-1.28)  -2.45 (-3.60,-1.36) -4.80 (-6.01,-3.62) -2.27 (-4.11,-
0.43) 
DPT        
Polio   X    X 
Measles      -1.27 (-2.19,-0.34)  
Vitamin A  -0.90 (-1.58,-0.22)      
Iron X  X X X X X 
Iodized Salt X  X X  X X 
ORS X X  X X X X 
ACT X X X X X X X 







The bivariate geostatistical variable selection, the model fitting of the climatic data for the 
first survey year and the subsequent prediction at the locations of the second survey were all 
conducted in INLA, while the final model fit for the effect of health interventions on changes 
in under-five mortality risk was performed in STAN. The two platforms follow a different 
parametrization for the Weibull survival distribution that we assumed for our mortality data. 
Specifically, while both parametrizations consider a fixed shape parameter 𝛼𝛼 for the Weibull 
distribution, INLA models a scale parameter lambda and STAN models a scale parameter 







That means that based on the choice of the scale parameter, i.e. lambda or sigma, the 
probability density function, the hazard function and all related equations of the Weibull 
survival distribution changed accordingly. Below, we provide details about the model 
formulation under both software and we provide further information on the 3-step process 
model fit to derive the changes in mortality specification. 
The Weibull formulation under INLA assumes that the scale parameter 𝜆𝜆 is reparametrized 
in terms of model parameters. We assumed that 𝛵𝛵𝑗𝑗𝑖𝑖 represents the age of a child, with 𝑗𝑗 
indicating each child and 𝐵𝐵 corresponding to one of the 𝐵𝐵 surveyed locations for which we 
had available data, i.e. 𝑠𝑠 = {𝑠𝑠1, 𝑠𝑠2, … , 𝑠𝑠𝑛𝑛}, 𝑠𝑠𝑖𝑖 ⊂ 𝑅𝑅2. Tau followed a Weibull lifetime distribution 
with fixed shape parameter alpha and scale parameter lambda that was linked with the linear 
predictor as follows: 
𝜆𝜆𝑗𝑗𝑖𝑖 = exp�𝜂𝜂𝑗𝑗𝑖𝑖�, 






To this equation, eta represented the linear predictor and the set of betas 𝛽𝛽 = (𝛽𝛽0,𝛽𝛽1, … ,𝛽𝛽𝜅𝜅)𝑇𝑇 
indicated the 𝛫𝛫 regression coefficients assigned to each predictor 𝑥𝑥𝑗𝑗𝑖𝑖𝜅𝜅, with 𝜅𝜅 representing 
the regression coefficient, 𝑗𝑗 each child and 𝐵𝐵 each location. The random vector 𝜉𝜉(𝑠𝑠) =
(𝜉𝜉1, 𝜉𝜉2, … , 𝜉𝜉𝑛𝑛)𝜏𝜏 corresponded to the value of geostatistical intercept at each location (cluster) 
at which we had available data. 𝜉𝜉(𝑠𝑠) followed a zero-mean, multivariate Gaussian 




, with 𝑠𝑠1 and 𝑠𝑠2 indicating two different locations, 𝑑𝑑(𝑠𝑠1, 𝑠𝑠2) being the 
distance between 𝑠𝑠1 and 𝑠𝑠2, 𝜅𝜅1 being the scaling parameter and 𝜎𝜎12 being the spatial process 
variance. Additionally, 𝛫𝛫𝜈𝜈 was the modified Bessel function of second kind and order 𝜈𝜈. The 
specification of the covariance matrix was completed with the spatial range parameter  𝑟𝑟1, 
which under the equation 𝑟𝑟1 =
√8
𝜅𝜅1
  particularly determines the distance at which the spatial 
correlation becomes negligible. In the case of bivariate variable selection, 𝛫𝛫 = 1 and we 
fitted each time, separately, one of the 25 health interventions considered in this study. In 
the case of the 3-step model fit, 𝛫𝛫 was equal to the number of selected health interventions 
plus all confounders and differences in climate. 
We compiled two different DHS surveys for each country and wanted to model the difference 
in mortality risk between the two time points. As the two different datasets derived from the 
surveys followed their own Weibull survival distribution, it followed that:  
𝜆𝜆1 = exp(𝜂𝜂1), 
𝜆𝜆2 = exp(𝜂𝜂2), 
with 𝜆𝜆1 and 𝜆𝜆2 representing the scale parameter of the first and second DHS survey 
respectively and eta being the corresponding linear predictor. By taking the logarithmic 
difference between the two equations, it followed that: 
log(𝜆𝜆2) − log(𝜆𝜆1) =  𝜂𝜂2 −  𝜂𝜂1  ⟹ log(𝜆𝜆2) = log(𝜆𝜆1) +  𝜂𝜂2 −  𝜂𝜂1  ⟹ 
𝜆𝜆2 = 𝜆𝜆1 exp(𝜂𝜂2 −  𝜂𝜂1). 
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To move towards the STAN specification we replaced 𝜆𝜆2 with its equivalent in STAN 




 and solved towards 𝜎𝜎2 in order to be able to get the equation 
needed for the STAN implementation: 





= 𝜆𝜆1 exp(𝜂𝜂2 −  𝜂𝜂1) ⟹ 𝛼𝛼2 log �
1
𝜎𝜎2
� = log(𝜆𝜆1) +  𝜂𝜂2 −  𝜂𝜂1 ⟹   




𝜂𝜂2 −  𝜂𝜂1
−𝛼𝛼2
⟹ 𝜎𝜎2
= exp (log (𝜆𝜆1
− 1𝛼𝛼2))exp (−
𝜂𝜂2 −  𝜂𝜂1
𝛼𝛼2
) ⟹ 
𝜎𝜎2 =  𝜆𝜆1
− 1𝛼𝛼2 exp �−
𝜂𝜂2 −  𝜂𝜂1
𝛼𝛼2
�. 
The last formula is what we explicitly modeled in STAN and consisted the last step (the 3rd 
step) of what we call a 3-step model fit. The first two steps of the model fit involved the 
spatial alignment of locations, as for a single country, the survey locations of the two DHS 
surveys were generally different. Therefore, in order to fit the last formula provided above in 
STAN, we had to fit (step1) 𝜆𝜆1 at the locations of the first DHS survey and subsequently 
predict (step2) 𝜆𝜆1 at the locations of the second DHS survey. Assuming that 𝑠𝑠 =
{𝑠𝑠1, 𝑠𝑠2, … , 𝑠𝑠𝑛𝑛}, 𝑠𝑠𝑖𝑖 ⊂ 𝑅𝑅2 are the locations of the first DHS survey and 𝑠𝑠∗ = {𝑠𝑠1∗, 𝑠𝑠2∗, … , 𝑠𝑠𝑛𝑛∗}, 𝑠𝑠𝑖𝑖∗ ⊂
𝑅𝑅2 are the locations of the second DHS survey that are generally different than 𝑠𝑠, the first 
step involved the model fitting for the first survey in INLA as described above, i.e.  
𝜆𝜆1(𝑠𝑠𝑖𝑖) = exp�𝜂𝜂1(𝑠𝑠𝑖𝑖)�. 
The second step involved the alignment of 𝜆𝜆1 at the second survey locations 𝑠𝑠∗ and 
therefore we derived the distribution 𝜆𝜆1(𝑠𝑠𝑖𝑖∗) conditionally on the spatial process and 
regression parameters as follows: 
𝜂𝜂1(𝑠𝑠𝑖𝑖∗) 𝛽𝛽1, 𝜉𝜉1(𝑠𝑠)⁄  ∼ 𝑁𝑁(𝛽𝛽1𝑋𝑋1(𝑠𝑠∗) + Σ𝑠𝑠∗𝑠𝑠Σ𝑠𝑠𝑠𝑠−1𝜉𝜉1(𝑠𝑠) , Σ𝑠𝑠∗𝑠𝑠∗ − Σ𝑠𝑠∗𝑠𝑠Σ𝑠𝑠𝑠𝑠−1Σ𝑠𝑠𝑠𝑠∗) 
𝜆𝜆1(𝑠𝑠𝑖𝑖∗) = exp�𝜂𝜂1(𝑠𝑠𝑖𝑖∗)�. 
In the above equations, 𝛽𝛽1 represents the estimated regression coefficients, 𝑋𝑋1(𝑠𝑠∗) is the set 
of climatic factors utilized in our analysis that were extracted at the locations of the latest 
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survey, 𝜉𝜉1(𝑠𝑠) is the spatial process and Σ represents the covariance matrix evaluated at the 
different set of locations 𝑠𝑠 and 𝑠𝑠∗. After having aligned (predicted) 𝜆𝜆1 at the second survey 
locations, we fitted the 3rd step of our analysis  
𝜎𝜎2(𝑠𝑠𝑖𝑖∗) =  𝜆𝜆1
− 1𝛼𝛼2(𝑠𝑠𝑖𝑖∗) exp�−




Environmental and climatic data 
Table 5.4: Sources of environmental and climatic data. 
Data Source Spatial resolution 
Annual average Normalised Difference 
Vegetation Index (NDVI) 
MODIS 1x1 km2  
Annual average Day and Night Land 
Surface Temperature (LST) 
MODIS 1x1 km2  
Land Cover Type (LC) MODIS 0·5x0·5 km2 
Distance from water bodies (DWATER) MODIS 0·5x0·5 km2 
Annual average Rainfall USGSS 8x8 km2 
Altitude (Digital Elevation model) SRTM 0·5x0·5 km2 
Urban rural extent GRUMP 1x1 km2 
MODIS: Moderate Resolution Imaging Spectroradiometer; USGSS: U.S. Geological Survey-Earth 
Resources Observation Systems; SRTM: Shuttle Radar Topographic Mission; GRUMP: Global Rural 













Table 5.5: Posterior estimates obtained from the bivariate geostatistical variable selection for the second DHS survey data of each country. We present posterior summaries (posterior median, 95% 
Bayesian Credible Interval) only for the statistically important associations between health interventions and under-five mortality. 
 
 Benin Burkina Faso Burundi Cameroon Ethiopia Ghana Guinea 
H_1ITN       -0.66 (-1.20,-0.13) 
H_1ITN2        
P_ITNA       -0.80 (-1.58,-0.02) 
P_ITNS        
P_ITN5      -0.73 (-1.42,-0.03)  
P_ITNU        
Water  -0.47 (-0.74,-0.20)      
Sanitation -1.00 (-1.57,-0.42) -0.74 (-1.19,-0.29) -0.70 (-1.07,-0.34)  -1.11 (-1.84,-0.37)  -0.89 (-1.40,-0.39) 
ANC prov. -0.90 (-1.39,-0.42) -0.68 (-1.01,-0.34) -2.22 (-3.25,-1.19) -1.12 (-1.63,-0.61) -0.97 (-1.38,-0.56) -2.42 (-3.57,-1.27) -0.99 (-1.43,-0.54) 
4+ ANC  -0.96 (-1.47,-0.46) -0.53 (-1.05,-0.01)  -1.30 (-1.78,-0.82) -1.29 (-1.79,-0.79) -1.27 (-2.11,-0.42) -1.08 (-1.61,-0.55) 
Fansidar -1.10 (-1.58,-0.62)     -1.87 (-2.81,-0.94) -0.61 (-1.20,-0.03) 
Post. Care  -0.65 (-1.21,-0.09)    -1.00 (-1.96,-0.04)  
Immediate    -0.38 (-0.77,0) -0.58 (-1.03,-0.13) -0.65 (-1.28,-0.03)  
Exclusive        
Tetanus -1.13 (-1.62,-0.64) -1.80 (-2.39,-1.21)  -1.30 (-1.86,-0.75) -1.15 (-1.62,-0.68) -1.72 (-2.74,-0.69) -1.30 (-1.84,-0.76) 
BCG -1.94 (-2.51,-1.38) -3.09 (-3.52,-2.66) -3.91 (-4.77,-3.04) -2.85 (-3.29,-2.42) -1.49 (-2.02,-0.96) -4.80 (-5.85,-3.76) -1.75 (-2.19,-1.30) 
DPT -1.61 (-2.15,-1.08) -2.02 (-2.40,-1.63) -3.56 (-4.40,-2.72) -1.64 (-2.00,-1.30) -1.36 (-1.91,-0.82) -2.43 (-3.29,-1.58) -0.93 (-1.36,-0.49) 
Polio -1.43 (-2.00,-0.87) -1.77 (-2.13,-1.41) -2.47 (-3.20,-1.74) -1.30 (-1.67,-0.93) -2.13 (-2.93,-1.33) -1.33 (-2.04,-0.64) -1.13 (-1.61,-0.66) 
Measles -1.52 (-2.15,-0.89) -2.39 (-2.81,-1.96) -2.87 (-3.67,-2.08) -2.19 (-2.61,-1.76) -1.57 (-2.21,-0.92) -3.61 (-4.62,-2.60) -1.33 (-1.80,-0.87) 
Vitamin A -0.74 (-1.09,-0.39) -1.00 (-1.31,-0.70) -1.55 (-2.02,-1.08) -0.88 (-1.32,-0.45) -1.20 (-1.66,-0.75) -1.13 (-1.83,-0.44) -0.79 (-1.25,-0.32) 
Iron -0.48 (-0.93,-0.02)   -1.40 (-2.38,-0.42)    
Iodized Salt -0.68 (-1.32,-0.05)       
ORS    -1.80 (-3.48,-0.12)   -1.78 (-3.42,-0.14) 
ACT      -0.61 (-1.02,-0.19)  











 Liberia Malawi Mali Mozambique Namibia Nigeria Rwanda 
H_1ITN       -0.77 (-1.53,-0.02) 
H_1ITN2        
P_ITNA       -0.72 (-1.45,0) 
P_ITNS  -0.59 (-1.06,-0.13) -0.96 (-1.68,-0.25)     
P_ITN5  -0.72 (-1.12,-0.33) -0.93 (-1.53,-0.33)     
P_ITNU  -0.56 (-1.01,-0.12)      
Water      -0.34 (-0.48,-0.20)  
Sanitation      -0.41 (-0.61,-0.22)  
ANC prov. -1.26 (-2.07,-0.45) -1.99 (-2.71,-1.27) -1.23 (-1.72,-0.74) -0.94 (-1.59,-0.28) -1.45 (-2.52,-0.38) -0.83 (-1.10,-0.56) -1.99 (-3.36,-0.63) 
4+ ANC  -0.78 (-1.38,-0.18) -0.90 (-1.45,-0.35) -1.51 (-2.13,-0.88) -0.78 (-1.35,-0.21) -1.01 (-1.85,-0.16) -0.80 (-1.09,-0.50) -1.50 (-2.38,-0.62) 
Fansidar  -1.94 (-2.63,-1.25)  -0.98 (-1.54,-0.42)  -0.93 (-1.35,-0.51)  
Post. Care      -1.72 (-2.34,-1.09)  
Immediate  -0.75 (-1.23,-0.27)  -0.62 (-1.09,-0.14) -0.90 (-1.66,-0.13) -0.71 (-0.98,-0.43) -1.45 (-2.33,-0.56) 
Exclusive        
Tetanus -1.15 (-1.82,-0.48) -1.56 (-2.19,-0.93) -1.08 (-1.64,-0.52) -0.81 (-1.38,-0.24)  -0.88 (-1.16,-0.59)  
BCG -1.94 (-2.46,-1.42) -2.79 (-3.52,-2.06) -1.40 (-1.82,-0.98) -3.08 (-3.61,-2.55) -5.89 (-7.01,-4.77) -1.11 (-1.33,-0.89) -8.26 (-9.56,-6.96) 
DPT -1.14 (-1.63,-0.65) -2.18 (-2.89,-1.47) -1.16 (-1.59,-0.73) -1.83 (-2.28,-1.40) -2.48 (-3.30,-1.66) -1.30 (-1.56,-1.05) -5.44 (-6.43,-4.44) 
Polio -0.79 (-1.32,-0.26) -0.99 (-1.59,-0.39) -0.96 (-1.52,-0.41) -1.44 (-1.85,-1.02) -1.59 (-2.36,-0.81) -1.40 (-1.73,-1.07) -2.81 (-3.53,-2.09) 
Measles -1.83 (-2.40,-1.26) -1.30 (-2.02,-0.58) -1.30 (-1.77,-0.83) -2.59 (-3.09,-2.09) -2.69 (-3.54,-1.83) -1.25 (-1.51,-0.99) -0.74 (-1.34,-0.14) 
Vitamin A -0.75 (-1.20,-0.30) -1.53 (-2.00,-1.06) -1.21 (-1.63,-0.79) -2.00 (-2.48,-1.53) -2.83 (-3.58,-2.08) -1.11 (-1.38,-0.84) -3.28 (-4.14,-2.42) 
Iron -0.70 (-1.39,-0.01)  -1.46 (-2.06,-0.86) -0.72 (-1.27,-0.17)    
Iodized Salt  -0.40 (-0.71,-0.09)      
ORS    -1.44 (-2.72,-0.15)    
ACT        












 Senegal Sierra Leone Tanzania Togo Uganda Zambia Zimbabwe 
H_1ITN     -0.95 (-1.45,-0.46)   
H_1ITN2     -0.70 (-1.15,-0.25)   
P_ITNA     -0.89 (-1.37,-0.42)   
P_ITNS     -0.69 (-1.15,-0.22) -0.60 (-1.13,-0.06)  
P_ITN5     -0.59 (-1.01,-0.18) -0.51 (-0.94,-0.08)  
P_ITNU -0.69 (-1.28,-0.10)       
Water    -0.42 (-0.74,-0.09)    
Sanitation -0.83 (-1.32,-0.34)   -1.66 (-2.69,-0.64)    
ANC prov. -1.84 (-2.96,-0.72) -1.02 (-1.91,-0.12)  -0.83 (-1.30,-0.37) -1.40 (-2.19,-0.60) -1.05 (-1.78,-0.33) -2.38 (-3.10,-1.66) 
4+ ANC  -2.35 (-3.26,-1.45) -0.76 (-1.29,-0.22)  -1.09 (-1.76,-0.42) -0.78 (-1.38,-0.18)  -1.81 (-2.60,-1.03) 
Fansidar -1.91 (-2.93,-0.89)   -1.60 (-2.22,-0.97) -1.04 (-1.68,-0.40) -0.92 (-1.57,-0.28)  
Post. Care -1.91 (-2.65,-1.18)       
Immediate    -0.64 (-1.08,-0.20)  -0.48 (-0.91,-0.05) -0.77 (-1.49,-0.06) 
Exclusive      -1.76 (-3.03,-0.49) -1.56 (-2.41,-0.70) 
Tetanus -1.69 (-2.76,-0.61) -1.20 (-2.05,-0.35)  -1.47 (-2.23,-0.71) -1.12 (-1.79,-0.46)  -2.23 (-3.02,-1.45) 
BCG -2.33 (-3.20,-1.46) -3.46 (-4.05,-2.86) -1.93 (-2.77,-1.08) -3.80 (-4.54,-3.07) -2.76 (-3.54,-1.98) -4.58 (-5.25,-3.91) -1.68 (-2.61,-0.75) 
DPT -2.13 (-2.86,-1.40) -1.46 (-1.90,-1.03) -1.13 (-1.88,-0.38) -1.97 (-2.52,-1.43) -2.16 (-2.82,-1.50) -2.32 (-2.84,-1.80) -1.06 (-2.01,-0.10) 
Polio -1.38 (-2.03,-0.73) -1.41 (-1.84,-0.98)  -1.60 (-2.21,-0.99) -1.81 (-2.46,-1.16) -0.66 (-1.12,-0.20)  
Measles -2.13 (-2.90,-1.37) -2.22 (-2.79,-1.66) -1.15 (-1.99,-0.31) -2.18 (-2.85,-1.51) -1.78 (-2.51,-1.06) -3.42 (-4.02,-2.81) -1.82 (-2.87,-0.78) 
Vitamin A -2.23 (-3.14,-1.33) -1.77 (-2.25,-1.30) -0.85 (-1.42,-0.29) -2.63 (-3.22,-2.03) -0.96 (-1.39,-0.52) -2.05 (-2.55,-1.54) -1.37 (-2.05,-0.69) 
Iron  -0.90 (-1.39,-0.41)      
Iodized Salt  -0.40 (-0.72,-0.08)   -0.90 (-1.70,-0.11)   
ORS   -1.92 (-3.57,-0.28)     
ACT        














Bayesian variable selection methods for spatially 
varying coefficient models 
 
Isidoros Papaioannou1,2, Jürg Utzinger1,2, Penelope Vounatsou1,2 
 
Affiliations: 
1Swiss Tropical and Public Health Institute, Basel, Switzerland 



















In the African setting, control programmes and decision makers are interested in assessing 
the effects of health interventions on child mortality risk and identifying potential subnational 
differences of their effects. Geostatistical models provide a modelling framework for 
determining such associations and incorporating in the analysis distance-dependent spatial 
correlations between pairs of locations in which the observed data are measured. These 
models can be extended to include spatially varying coefficients, so that the dependency 
between the outcome and predictors is additionally studied over regions of interest. In the 
Bayesian approach, the conditional autoregressive (CAR) structure has been extensively 
used to model the covariance matrix of the spatially varying coefficients. As CAR-structured 
models are highly parameterized, variable selection procedures could be employed in order 
to reduce the parameter space, improve prediction accuracy and overall offer faster 
statistical analysis. Stochastic search variable selection (SSVS) augments the parameter 
space with latent inclusion-indicator variables and their posterior distribution is used for 
variable selection inference. For spatially varying coefficients, either global methods, 
suggesting the form of predictors across the whole spatial study area, or local methods 
exploring regional effects could be employed. We designed a simulation study and analysed 
data stemming from the Burundi 2016 Demographic and Health survey, in order to assess 
the performance of SSVS for geostatistical models and to compare three different selection 
methods for CAR-structured spatially varying coefficient models. We further studied the 
sensitivity of SSVS method when an additional selection procedure for varying coefficients is 
simultaneously employed. Our analysis showed that SSVS is able to accurately separate the 
statistically important predictors from the parameter space and is not influenced by the 
simultaneous implementation of another selection method. Results from the three spatially 
varying coefficient selection methods were relatively inconclusive, albeit one of them, the 
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Global selection method was able to correctly identify the true varying coefficients with 70 
per cent success probability.  
6.1 Introduction 
In the era of Sustainable Development Goals (SDGs) under-five mortality still remains a 
highly relevant public health issue, with only 57 countries globally having met the Millennium 
Development Goals (MDGs). In Africa, despite large reductions in child mortality rates, it is 
estimated that multiple sites need an annual reduction of as much as 8.8%, so that the SDG 
3.2 target for under-5 mortality is to be met (Golding, 2017). Relevantly, health interventions 
provide an important pillar against pre-school mortality (Shoo, 2007). In the absence of 
developed civil registration systems in most African countries, the Demographic and Health 
Surveys (DHS) have been developed and employed in order to measure and provide key 
information on health-related indicators, such as of child and maternal health, malaria, 
nutrition, household and other characteristics. Model-based studies are commonly utilizing 
the cross-sectional DHS datasets to associate the effects of health interventions and 
prevalence of diseases with child mortality and explore possible subnational variation of 
these effects (Papaioannou, 2019; Giardina, 2014; Millogo, 2019; Nambuusi, 2019). Given 
the wealth of the health indicators measured by data sources such as the DHS, variable 
selection techniques could be implemented to identify the most relevant indicators for 
subsequent model fitting. 
Variable selection methods have been traditionally utilized to perform faster statistical 
analysis and improve prediction accuracy (Reunanen, 2003). This is achieved by selecting a 
subset of all predictors which are initially considered for model fit, based on some criteria 
that each variable selection method sets. In Bayesian analysis, most of the Bayesian 
variable selection (BVS) methods can be classified as either model choice-specific or 
variable-specific. The former refers to methods which use information criteria for model 
selection, while the latter refers to methods which support inclusion of variables based on 
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posterior inclusion probabilities (O’Hara, 2009). The variable-specific procedures can be 
implemented to both fixed and random components of a model (Frühwirth-Schnatter, 2010). 
Variable-specific selection methods can be classified into four categories (O’Hara, 2009): 
stochastic search variable selection (SSVS), indicator model selection, adaptive shrinkage 
and model space approach. SSVS (George, 1993) was the first BVS procedure to introduce 
the choice of variables for the fixed effects of a model. SSVS proposed to augment the 
parameter space of a model with latent variables which would act as indicators of whether a 
predictor should be included in a final model fit. Specifically, the latent variables were 
incorporated in the prior distribution of each regression coefficient and, based on their 
posterior marginal distribution, inference for selecting the corresponding predictor could be 
made. The term stochastic search refers to how the model space is explored (Peng, 2013). 
Extensions of SSVS were later proposed (Brown, 1998; George, 1997). Other notable 
stochastic search methods include: the Kuo and Mallick method (Kuo, 1998) (indicator 
model selection), the Gibbs variable selection (Dellaportas, 2002) (indicator model 
selection), Jeffreys’ prior (Xu, 2003) (adaptive shrinkage) and the Reversible jump MCMC 
(Green, 1995) (Model space approach) method. A recent review8 of numerous BVS 
procedures still argued for the usefulness of the SSVS method. Applications of stochastic 
search methods can be found, among others, in schistosomiasis (Chammartin, 2013) and 
malaria modelling (Giardina, 2014), Biology (García‐Díaz, 2015), cancer research 
(Newcombe, 2014), genetics (Srivastana, 2009) and clinical research (Whitlock, 2014). 
BVS procedures have also been developed for the random effects of a model (Kinney, 2007; 
Tüchler, 2008; Yang, 2011; Chen, 2003; Wagner, 2012). Spatially varying coefficient models 
constitute a subclass of all random effect models and their specification allows coefficients to 
vary in space, so that dependency between the outcome and predictors is better explained 
over a region of interest (Gelfand, 2003). One approach to BVS for this type of models, is the 
introduction of indicators which would specify one of the following forms for each predictor: 
exclusion of predictor, inclusion as fixed effect or inclusion as a spatially varying coefficient 
(Reich, 2010).  The previous method can be characterized as “global” selection method, 
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since the proposed form of predictors is not determined at subregional (local) level but rather 
across the whole spatial study area. Contrarily, an approach for local BVS is to assume 
independent inclusion indicators for each coefficient and subregion, while imposing a spatial 
structure to the coefficient via a Gaussian copula (Boehm Vock, 2015). Another example of 
local BVS is to directly modify the covariance matrix of each regression coefficient, by left 
and right multiplication with a diagonal matrix, which holds an indicator vector in its main 
diagonal (Zhang, 2016). Recent efforts have introduced the spatial dependency directly to 
the selection indicators (Choi, 2016), for instance by imposing a spatial autologistic Besag 
model to each indicator of a coefficient and region. 
Geostatistical models are a class of mixed models which assume spatial dependency in the 
response across a set of locations. Typically, a zero-mean Gaussian distributed random 
intercept is added to linear predictor, which assumes a spatially structured covariance matrix 
(Brown, 2015). A distance-dependent covariance matrix is usually considered. Additionally, 
in the case of geostatistical modelling with spatially varying coefficients, the vector of varying 
effects for a single coefficient usually follows a multivariate Normal distribution and is fully 
characterized by its covariance matrix (Finley, 2011). Among other specifications, conditional 
autoregression (CAR) modelling of the spatially varying components has been extensively 
used for spatial data analysis (Gelfand, 2003b). Despite the relatively recent proposals of 
new variable selection methods for spatially varying coefficient models, studies assessing 
the sensitivity of the methods under different assumptions are rather few. 
The aim of this article is threefold: to assess the performance of SSVS for geostatistical 
models, to compare three different BVS methods for CAR-structured spatially varying 
coefficient models and to assess the sensitivity of SSVS when is co-implemented with a 
spatially varying coefficient selection method. In section 2 we provide an overview of the 
data, methodology and models utilized in this study. In section 3 we present details from the 
simulation study which we designed and conducted for all the proposed methods, while in 
section 4 we specify all relevant information from the application of the methods to the 
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Burundi DHS dataset. In section 5, we provide a detailed discussion of the simulation and 
application results.  
6.2 Methods 
Data sources 
We extracted data stemming from the Burundi DHS which took place between October 2016 
and March 2017. The rational of the survey was to provide a platform for measuring and 
updating key indicators on basic health and demographics. Data collection was based on a 
stratified, two-stage analysis and four different forms of questionnaires, i.e. household, 
individual woman, male and biomarker were utilized. We obtained data on individual child, 
maternal and household characteristics, malaria interventions, vaccinations, breastfeeding, 
macronutrients and reproductive health. The data were geolocated, i.e. latitude and 
longitude information was available for each observation. A detail summary of the survey 
methodology and data outcomes can be found on the Burundi DHS final report. 
Environmental and climatic data were downloaded from open access and remote sensing 
sources. We obtained from Moderate Resolution Imaging Spectroradiometer (MODIS) 
information on the land surface temperature (LST), the normalized difference vegetation 
index (NDVI) and the type of land cover (LC). We classified all observations to belong to a 
forest, grassland or cropland area based on the corresponding coordinates and LC type of a 
particular observation. The U.S. Geological Survey-Earth Resources Observation Systems 
(USGSS) Data Portal and the Shuttle Radar Topography Mission (SRTM) provided the 
portals through which rainfall and altitude data were correspondingly extracted. 
Statistical models 
Let 𝑠𝑠 = {𝑠𝑠1, 𝑠𝑠2, … , 𝑠𝑠𝑛𝑛}, 𝑠𝑠𝑖𝑖 ⊂ 𝑅𝑅2 be a set of locations at which the outcome and predictors were 
observed. The response variable was defined as 𝛵𝛵𝑖𝑖 and represented time to death for the 𝐵𝐵-
th under-five child observed at the 𝑠𝑠𝑖𝑖 location. Under the Weibull survival regression, the 
outcome 𝛵𝛵𝑖𝑖 followed a Weibull distribution for which the shape parameter 𝛼𝛼 was considered 
fixed and the scale 𝜆𝜆 was reparameterised in terms of predictors and regression coefficients. 
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By defining as 𝐵𝐵 = 1, … ,𝑁𝑁 the number of observations, 𝑝𝑝 = 1, … ,𝑃𝑃 the number of fixed effect 
parameters of the model and 𝜂𝜂𝑖𝑖 the linear predictor corresponding to the 𝐵𝐵-th observation, 
the Weibull survival geostatistical model was formulated as: 
𝛵𝛵𝑖𝑖~𝑊𝑊𝑊𝑊𝐵𝐵𝑏𝑏𝑊𝑊𝑙𝑙𝑙𝑙(𝛼𝛼, 𝜆𝜆𝑖𝑖), 
𝜆𝜆𝑖𝑖 = exp(𝜂𝜂𝑖𝑖), 




where 𝛽𝛽0 is the constant term, 𝜷𝜷 = (𝛽𝛽1, … ,𝛽𝛽𝑝𝑝) is the vector of fixed effects, 𝑿𝑿𝑁𝑁𝑁𝑁𝑃𝑃 the design 
matrix and 𝒘𝒘0 the geostatistical intercept. We used a 𝑁𝑁-dimensional, zero-mean Gaussian 
distribution 𝒘𝒘0 ∕ 𝜮𝜮0~𝛮𝛮𝛮𝛮(𝟎𝟎,𝜮𝜮0) to model the location effects. The geostatistical intercept can 
be fully characterized by its covariance matrix with exponential correlation function 
𝜮𝜮0�𝑠𝑠𝑖𝑖, 𝑠𝑠𝑗𝑗� = 𝜎𝜎02𝑊𝑊𝑥𝑥𝑝𝑝�−𝜑𝜑𝜆𝜆𝑖𝑖𝑗𝑗�, where 𝜎𝜎02 is the variance of the Gaussian process, 𝜑𝜑 the spatial 
decay parameter and 𝜦𝜦 a distance matrix storing the kilometre distance 𝜆𝜆𝑖𝑖𝑗𝑗 between 𝑠𝑠𝑖𝑖 and 
𝑠𝑠𝑗𝑗 locations. 
The above geostatistical model was further extended to include spatially varying effects. By 
assuming 𝑘𝑘 = 1, … ,𝐾𝐾 varying coefficients at 𝑚𝑚 = 1, … ,𝑀𝑀 locations, the linear predictor of the 
spatially varying coefficient model was defined as: 
𝜂𝜂𝑖𝑖 = 𝛽𝛽0 + �𝛽𝛽𝑝𝑝𝑥𝑥𝑖𝑖𝑝𝑝
𝑃𝑃
𝑝𝑝=1





where 𝑫𝑫𝑁𝑁𝑁𝑁𝐾𝐾 is the design matrix for the varying components of the model and 𝑤𝑤𝑚𝑚𝑘𝑘 
represents the 𝑘𝑘-th varying coefficient at province 𝑚𝑚. The term 𝐵𝐵 ∈ 𝑚𝑚 describes at which 
province the 𝐵𝐵-th observation belongs to and ensures that the 𝐷𝐷𝑖𝑖𝑘𝑘𝑤𝑤𝑚𝑚𝑘𝑘 multiplication is 
compatible, as only one out of all 𝑀𝑀 provinces corresponds to each observation. The varying 
effect 𝒘𝒘𝑘𝑘, 𝑘𝑘 = 1, … ,𝐾𝐾 is 𝑀𝑀-dimensional and represents the province-specific effect for 
covariate 𝑘𝑘. We could have obtained 𝐾𝐾 = 𝑃𝑃 if all fixed effects 𝑃𝑃 had a spatially varying 
component. The local varying effects were realizations of a Gaussian process, i.e. 
𝑤𝑤𝑘𝑘 𝛽𝛽𝑘𝑘⁄ ,𝛴𝛴𝜅𝜅~𝛮𝛮𝛭𝛭(𝜷𝜷𝜅𝜅 ,𝛴𝛴𝜅𝜅) with 𝜷𝜷𝜅𝜅 being a 𝑀𝑀-dimensional vector of the fixed effect 𝛽𝛽𝑘𝑘 and 𝛴𝛴𝜅𝜅 the 
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corresponding covariance matrix. For the covariance matrix 𝛴𝛴𝜅𝜅 we imposed a CAR structure, 
i.e. 𝛴𝛴𝑘𝑘−1 = 𝜎𝜎𝑘𝑘−2(𝑅𝑅 − 𝜌𝜌𝑘𝑘𝛺𝛺), with 𝑅𝑅 being a diagonal matrix with entries the sum of neighbours 
for each province and 𝛺𝛺 a proximity matrix which reflected the neighbouring structure 
between the provinces. 
We completed the Bayesian formulation with the assignment of suitable priors for each 
model parameter. We selected an inverse gamma 𝐼𝐼𝐼𝐼(2,1) distribution for all variance 
parameters and a gamma 𝐼𝐼(1,1) for the shape of Weibull distribution. The spatial decay 
parameter phi followed a fragmented gamma distribution with shape and scale parameters 
equal to 1 and 0.5 respectively. Phi was restricted based on the rule that −log (0.05)
𝜑𝜑
 
determines the distance at which correlation drops to 0.05 and it is considered as negligible. 
The spatial association measure of CAR model 𝜌𝜌𝑘𝑘 ensures that 𝑅𝑅 − 𝜌𝜌𝑘𝑘𝛺𝛺 is a non-singular 
matrix (Banerjee, 2014) and thus followed a uniform distribution, bounded by the inverse of 
the minimum and maximum of the ordered eigenvalues of the matrix 𝑅𝑅−1/2𝛺𝛺𝑅𝑅−1/2.  
Bayesian Variable Selection 
Stochastic search variable selection was implemented by the introduction of a spike and slab 
prior for each regression coefficient 𝛽𝛽𝑝𝑝, 𝑝𝑝 = 1, … ,𝑃𝑃, which means, in precision terms for the 
Normal distribution, that 𝛽𝛽𝑝𝑝 𝛿𝛿𝑝𝑝⁄ , 𝜏𝜏2~𝑁𝑁(0, 𝛿𝛿𝑝𝑝𝜏𝜏2 + (1 − 𝛿𝛿𝑝𝑝)𝑊𝑊0𝜏𝜏2). The indicator 𝛿𝛿𝑝𝑝 had a 
Bernoulli prior with 0.5 successes probability and dictated whether the corresponding 
coefficient 𝛽𝛽𝑝𝑝 would be included in the model. When 𝛿𝛿𝑝𝑝 implied inclusion the prior distribution 
of 𝛽𝛽𝑝𝑝 was transformed into 𝑁𝑁(0, 𝜏𝜏2) with an inverse gamma distribution imposed on the 
variance, while otherwise the shrinkage factor 𝑊𝑊0 would concentrate the 𝛽𝛽𝑝𝑝 prior around 0. 
We fixed 𝑊𝑊0 equal to 0.001.  
For the spatially varying coefficient models we considered a global BVS method, which 
determined whether a predictor should be included in a model and if so to either have a fixed 
or random slope. The global selection method introduced the vector indicator 𝛾𝛾𝑘𝑘 = �𝛾𝛾1𝑘𝑘𝛾𝛾2𝑘𝑘�, 
which was sampled from a categorical distribution with three equally probable cases. These 
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three cases corresponded to exclusion of predictor from the model, inclusion as fixed effect 
and inclusion as a spatially varying coefficient, which translated into 𝛾𝛾𝑘𝑘 taking the form �00�, 
�10� and �
1
1� respectively. The indicators 𝛾𝛾1𝑘𝑘 and 𝛾𝛾2𝑘𝑘 were incorporated as spike and slab 
priors in the regression coefficients 𝛽𝛽𝑘𝑘 and the variance 𝜎𝜎𝑘𝑘2 of the CAR model, i.e. 
𝛽𝛽𝑘𝑘 𝛾𝛾1𝑘𝑘⁄ , 𝜏𝜏2~𝑁𝑁(0, 𝛾𝛾1𝑘𝑘𝜏𝜏2 + (1 − 𝛾𝛾1𝑘𝑘)𝑊𝑊0𝜏𝜏2) and 𝜎𝜎𝑘𝑘2 𝛾𝛾2𝑘𝑘⁄ ,𝜎𝜎𝑘𝑘�
2 = 𝛾𝛾2𝑘𝑘𝜎𝜎𝑘𝑘�2 + (1 − 𝛾𝛾2𝑘𝑘)𝑊𝑊0𝜎𝜎𝑘𝑘�2. We 
assigned 0 prior probability to the outcome �01�, as a predictor cannot have a spatially varying 
component without being included in the model at least as a fixed effect. 
We also considered two alternatives to the global BVS method in order to allow variable 
selection indicators to vary locally in space. The main difference between global and local 
procedures was that local methods did not jointly define the spatially varying coefficient 𝑤𝑤𝑘𝑘 
with the aid of a single indicator 𝛾𝛾2𝑘𝑘, but instead each of the elements of a varying coefficient 
(𝑤𝑤𝑚𝑚𝑘𝑘) was conditionally defined based on a province-specific indicator 𝛾𝛾𝑚𝑚𝑘𝑘 ,𝑚𝑚 = 1, … ,𝑀𝑀. 
Hence, under local selection strategies, the prior of the varying coefficient on the 𝑚𝑚-th 
province was 𝑤𝑤𝑚𝑚𝑘𝑘 𝛾𝛾𝑚𝑚𝑘𝑘⁄ ,𝛽𝛽𝑘𝑘 ,𝜎𝜎𝑘𝑘2 ∼ 𝑁𝑁(𝛾𝛾𝑚𝑚𝑘𝑘𝛽𝛽𝑘𝑘, 𝛾𝛾𝑚𝑚𝑘𝑘𝜎𝜎𝑘𝑘2 + (1 − 𝛾𝛾𝑚𝑚𝑘𝑘)𝑊𝑊0𝜎𝜎𝑘𝑘2). Additionally, a Bernoulli 
distribution was assigned as prior on the indicators 𝛾𝛾𝑚𝑚𝑘𝑘. The two proposed local procedures 
differed on how the CAR model was imposed on the priors. The first strategy used a local 
success probability for the Bernoulli prior, that is 𝛾𝛾𝑚𝑚𝑘𝑘 ∼ 𝐵𝐵(𝑝𝑝𝑚𝑚𝑘𝑘), and adopted the probit link 
to impose a CAR structure on 𝑝𝑝𝑚𝑚𝑘𝑘, i.e. 𝛷𝛷−1(𝑝𝑝𝑚𝑚𝑘𝑘) = 𝜀𝜀𝑚𝑚𝑘𝑘 and 𝜺𝜺𝑘𝑘 ∼ 𝑁𝑁𝑀𝑀(𝟎𝟎,𝜮𝜮𝑘𝑘). The second 
strategy assigned a global probability of success for the Bernoulli prior, 𝑝𝑝𝑘𝑘 ∼ 𝑈𝑈(0,1) and 
imposed a CAR model through a Gaussian copula on each 𝑤𝑤𝑚𝑚𝑘𝑘. The copula specification 
was achieved by augmenting the parameter space with latent variables 𝜃𝜃𝑚𝑚𝑘𝑘 and by utilizing 
the cumulative distribution function of the standard normal distribution, so that 𝜃𝜃𝑘𝑘 ∕ 𝜌𝜌𝑘𝑘 ∼
𝑁𝑁𝑀𝑀(𝟎𝟎,𝜮𝜮𝑘𝑘), with 𝛴𝛴𝑘𝑘−1 = 𝜎𝜎𝑘𝑘−2(𝑅𝑅 − 𝜌𝜌𝑘𝑘𝛺𝛺) and 𝜃𝜃𝑚𝑚𝑘𝑘 = 𝛷𝛷−1(𝑃𝑃(𝑤𝑤𝑚𝑚𝑘𝑘)). Since the copula model 
hypothesized on sampling from a great number of variables (133 in total) and in order to 




A summary of all model formulations is provided in Table 6.1. The analysis was conducted in 
Just Another Gibbs Sampler (Plummer, 2003) (JAGS). Throughout the analysis we used 2 
chains, which had thinning equal to 10, and we discarded initial iterations as burn-in which 
were equivalent to 5 per cent of the iterations we utilized in each chain. We selected the 
following number of updates for each case: 1 million for the simulation, 300 thousand for the 
application of SSVS and BVS on Burundi DHS and finally 100 thousand in order to get 
posterior summaries and compare between models for the selected covariates of our 
application. We assumed that mean posterior probability greater than 50 per cent favours 
inclusion of a predictor in a model or, when applicable, highlights an important varying effect 
for the specific province. Model comparisons were made based on the Watanabe-Akaike 
information criterion (Watanabe, 2010) (WAIC). 
6.3 Simulation study 
Overview 
Our simulation study focused on the performance of: SSVS for geostatistical models, global 
and local BVS methods for spatially varying coefficient models and models combining the 
SSVS method with one of the BVS methods. To achieve that, we simulated 20 datasets 
based on a Weibull survival geostatistical model which was specified having 𝑃𝑃 = 10 
regressors, the first three of which were selected to be CAR-structured spatially varying. We 
hypothesized that our coefficients vary in an area of  𝑀𝑀 = 5 polygons, e.g. provinces, and 















































We assumed 500 observations of under-five children as outcome and georeferenced our 
data by assuming a sample size of ten at each location. The 50 unique locations used were 
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extracted from the Cote d'ivoire DHS 2011. Across all 20 simulations the values of the 
parameter space were held fixed and variability arose for each simulation from sampling for 
the following components: the 𝑿𝑿𝑁𝑁𝑁𝑁𝑃𝑃 design matrix, the geostatistical term 𝒘𝒘0, the spatially 
varying parts 𝑤𝑤𝑚𝑚𝑘𝑘 and finally the generation of Weibull outcomes based on the linear 
predictor that we in each case had. 
Our simulation study was designed so that only the first six regressors are statistically 
important, from which the first three vary in space. Yet, we tested the performance of the 
BVS methods assuming that the second, third and fourth coefficients were spatially varying. 
This specification is the common rule in practice as researchers do not have any prior 
knowledge about which regressors may vary in space and thus any reliable variable 
selection method should be able to separate true varying effects, which in our case 
translates into methods supporting inclusion as varying effect (global BVS) or associating 
important province effects (local BVS) only to the second and third regressors. Further 
details about the parameter values used to generate our simulations, the sampling 
distributions and the initial values we provided for sampling in JAGS are provided in the 
Appendix. 
Results 
Our simulation study indicated that the SSVS method was always able to identify correctly 
the statistically important coefficients and to support their inclusion in the model, with 
posterior mean probabilities exceeding 90 per cent.  In geostatistical settings, only in one 
simulation study the SSVS wrongly proposed the inclusion of the last regression coefficient 
(𝛽𝛽10). When we added 3 spatially varying components to the geostatistical model (models 3 
and 4) SSVS wrongly supported twice the inclusion of the last predictor and also in one 
occasion the inclusion of 𝛽𝛽8. We obtained the same results when SSVS was coupled with 
the global BVS method. The addition of local BVS procedures to the stochastic search 
doubled the mistaken inclusion of 𝛽𝛽8. A summary of results is presented in Table 6.2. 
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Global BVS method was able to identify correctly that all three regression coefficients 𝛽𝛽2, 𝛽𝛽3 
and 𝛽𝛽4 should be, at least as fixed effects, included in the model. It also hinted in seven out 
of ten times that 𝛽𝛽2 is a coefficient that varies in space, while the results regarding the form 
of inclusion for 𝛽𝛽3 and 𝛽𝛽4 were inconclusive. Yet, by comparing the posterior summaries of 
the spatially varying effects for all 20 simulations for model 5, we were able to identify that in 
14 out of 20 cases we found statistically important province effects for the true varying 
coefficients, i.e. 𝛽𝛽2 and 𝛽𝛽3, while not for 𝛽𝛽4. When the global BVS was combined with a 
SSVS (model 6), the prior observation number was reduced to 12 cases. 
Both local selection methods, which utilized the probit link and a Gaussian copula to impose 
a CAR spatial structure on the varying effects, failed to separate the true local varying 
coefficients and to correctly identify statistical important effects only on these regressors. By 
observing separately the outcomes of each simulation, in most occasions the local methods 
wrongly identify important local effects for 𝛽𝛽4 which was designed to have only a fixed 
component. A summary of posterior inclusions for the spatially varying coefficients 𝛽𝛽2, 𝛽𝛽3 
and 𝛽𝛽4 and their local effects, stratified by variable selection, is presented in Table 6.3. 
Tables in Appendix summarize the results from the local BVS methods and specifically 
provide, for each simulation, all the indicators with posterior mean inclusion probability 
greater than 50 per cent. 
6.4 Application 
Overview 
We applied SSVS and BVS procedures to select and analyse the effects of a set of child, 
maternal and household interventions on all-cause under-five mortality in Burundi. A 
description of the interventions coverage indicators can be found in Table 6.4. All models 
were adjusted for the cluster-level climatic conditions, as well as the rural-urban 
classification, at the geolocations of each observation, a socio-economic proxy based on the 
asset index of the family (classified as poorest or poorer), the sex, place of delivery and birth 
order for a child, the age at birth and live births of the mother as well as her educational 
175 
 
level. All intervention and adjustments were considered as fixed effects and thus the 
stochastic search analysed all of them. Additionally, in models 3 to 10 we imposed the CAR-
structured spatially varying component to the following covariates: use of insecticide-treated 
nets (ITNs) by under-five children, antimalarial medication for children with fever and 
breastfeeding within 24 hours after birth. 
Our application included 12’853 observations of under-five children across 540 unique 
locations, inside the 17 provinces of Burundi. An initial fit of all 10 models was performed in 
order to obtain the outcomes from the selection methods. We re-fitted all models based on 
the selected set of fixed effects and the type of inclusion that the BVS methods proposed for 
the varying variables. The latter meant for the local selection methods that in variables we 
found at least one local effect we re-fitted the model with a spatially varying component for 
the corresponding variable, otherwise it was considered as a fixed effect predictor. We 
estimated, for all the re-fitted models, the pointwise out-of-sample prediction accuracy using 
the WAIC. The goal of our application was not to analyse the effects of all health 
interventions on all-cause under-five mortality but rather utilize this publicly available dataset 
to encapsulate the advantages and drawbacks of the methods discuss in this article. 
Results 
Across all models imposing a SSVS method we found, similarly to our simulation, consistent 
results about which variables should be considered for the final model. Specifically, the use 
of ITNs from under-five children, antimalarial medication, breastfeeding of new-borns within 
24 hours after birth, DPT vaccination, vitamin A supplementation, improved sanitation 
facilities, the birth order of a child, the number of live births from a mother and the asset 
index of a family were all highlighted for model inclusion with high posterior probabilities. 
Measles vaccination was the only predictor with mean values for the inclusion indicator just 
above 50 per cent and in one case (model 8) failed to surpass that threshold. A summary of 
results is presented in Table 6.5.  
176 
 
Greater variability of results was presented from the initial fit of the BVS methods. The use of 
ITNs from under-five children (𝛽𝛽2) was mostly proposed as a fixed effect, albeit the probit 
local selection method combined with SSVS (model 8) identified multiple important regional 
effects and thus implied inclusion of the predictor as a spatially varying coefficient. For 
antimalarial medication (𝛽𝛽3), all the local methods identified an important subregional effect 
in the Gitega province of Burundi. Contrarily, the Global BVS suggested that 𝛽𝛽3 should be 
incorporated as either a fixed effect (model 6) or being excluded from the final model (model 
5). For breastfeeding of new-borns, all models hinted inclusion as a fixed effect, except from 
model 6 which proposed the addition of a spatially varying component. A summary of results 
is presented in Table 6.6.  
The initial analysis resulted on final models which were fitted to assess the effect of selected 
predictors on under-five mortality. Models A and B corresponded to the final form of the 
geostatistical and three-term (𝛽𝛽2, 𝛽𝛽3 and 𝛽𝛽4) spatially varying coefficient models. Model C 
derived from model 5 and included only fixed effects, with antimalarial medication not taken 
into account. Model D placed a varying coefficient on 𝛽𝛽4 while model F on both 𝛽𝛽2 and 𝛽𝛽3. 
Models E and G had models 7 and 9–10 as their parent models and while both imposed a 
varying part on 𝛽𝛽3, model E had one less fixed effect component (measles vaccination).  
Results across all final models showed that DPT3 vaccination, vitamin A supplementation, 
improved sanitation facilities and higher birth order bring about reduced mortality risk. 
Differently, poor asset index status for a family and many live births for a mother increase 
the mortality risk. The use of ITNs by under-five children showed relatively high negative 
mean posterior effects, but was identified as statistically important only in models C and F. 
Breastfeeding and measles vaccination were the only two predictors for which none of the 
models presented a statistically important association with the outcome and, from the set of 
variables included in the model, they were the two with the lowest inclusion posterior 
probabilities. Model D had the lowest WAIC and thus is seen as the best model fit, albeit 
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differences of WAIC between the models were relatively small and thus could be considered 
as negligible.  
6.5 Discussion 
To our knowledge, this is the first study to assess the performance of Bayesian variable 
selection methods for CAR-structured spatially varying coefficients, coupled with the 
stochastic search variable selection method. We also assessed the effects of specific child, 
maternal and household interventions on all-cause under-five mortality. Our simulation study 
revealed that SSVS is reliable for identifying suitable predictors from a candidate set, 
irrespective of the presence of other BVS methods. In terms of varying coefficients, the 
results were inconclusive about the usefulness of the methods, albeit we observed that the 
Global BVS method hints true varying coefficients with 70 per cent probability of success. 
DPT3 vaccination, vitamin A supplementation, improved sanitation facilities and higher birth 
order were shown to be associated with reduced mortality risk. 
The utilization of a CAR parameterization with the additional parameter 𝜌𝜌𝜅𝜅 revealed that a 
lighter framework such as an exchangeable structure might be more appropriate, when the 
discussed methods are implemented. A modelling study (Boehm Vock, 2015) proposing the 
copula framework argued for the usefulness of the method, yet it proposed an exponential 
spatial correlation compared to the CAR structure. Similarly, a Bayesian probit model with 
regional selection (Zhang, 2016) tested its proposed method based on simulation studies 
which generating values, for the simulated regression coefficients, assuming either 
independence or an exponential correlation function.  
Different assumptions about the choice of prior distributions and the corresponding values of 
the hyperparameters may have yielded dissimilar results. For the global selection method, 
we assumed a 3-dimensional categorical distribution for the inclusion indicator gamma, 
assigning a 34 per cent prior probability for the case of exclusion of the corresponding 
variable and 33 per cent probabilities for inclusion as fixed component or as varying 
coefficient. The aforementioned values hypothesized that the two forms of inclusion were 
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separate and equally probable, albeit together summed up to 66 per cent and thus left just 1 
out of 3 chances for the exclusion case. In that sence, our choice of hyperparameters 
encouraged inclusion of variables. Another approach could have assumed 50 per cent prior 
probability for exclusion and 25 per cent for each of the two inclusion forms.  Additionally, the 
categorical distribution could have been replaced by defining a joint prior for 𝛾𝛾1𝑘𝑘 and 𝛾𝛾2𝑘𝑘 
which would rely on Beta distributed hyperprior probabilities (Reich, 2010). For the local 
selection method using the probit link, rather the logit link could have been employed. The 
use of inverse Gamma distributed priors for all variance terms could have been replaced by 
half-Cauchy, half-Normal or Uniform distributions, as supported by the corresponding 
literature (Gelman, 2006; Polson, 2012). 
The selection of 50 per cent as an absolute cut-off of inclusion or exclusion of predictors 
from the linear part of the model, or as a measure which reveals which subregional effects 
were considered as statistically important, influenced our inference. Whereas very high or 
low mean posterior probabilities for the inclusion indicators lead to stronger conclusions, it is 
relatively unclear if variables with mean posterior indicators of 49 or 51 per cent should be 
explicitly removed or incorporated in a future model. For instance, SSVS showed that 
measles vaccination exceeded fractionally the cut-off, yet posterior summaries from the final 
models presented no association with the under-five mortality. Hence, a slightly harder 
inclusion cut-off of 55 per cent could have correctly prevented the use of measles 
vaccination from a predictor in the final models, assuming that the goal of inference from 
such methods is to result on a final model which incorporates only statistically important 
coefficients and facilitates a parameter space reduced to minimum. Contrarily, the delivery 
place of children achieved mean posterior values greater than 40 per cent, reaching in one 
occasion a value equal to 49, albeit the predictor was ultimately excluded from all final 
models. Analogously, the probit local selection method estimated a 49 per cent mean 
posterior value for the effect of breastfeeding in the Bururi province, but the effect was 
considered as not important.    
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The selection methods discussed in this study have also been extended to include temporal 
terms. The global selection method facilitated additional random temporal effects with the 
augmentation of the analogous set of inclusion indicators and forms through which a 
predictor was selected to be incorporated in the model (Cai, 2013). A modelling study 
associating the sea surface temperature, the latent heat flux and the occurrences of tropical 
cyclones (Cordoba, 2018) extended the Gaussian copula method to a spatio-temporal 
framework. Similarly, a spatially varying auto-regressive model was developed (Teng, 2018), 
to extent the idea of modelling brain voxels with homogeneous auto-regressive (AR) orders, 
with spatially varying AR orders which are additionally selected using a spike-and-slab prior 
at each voxel. The local BVS method assigning Bernoulli-prior indicators to local effects was 
recently enriched with Bernoulli distributed priors that are multiplied with temporally varying 
parameters of AR(1) structure (Choi, 2018). 
The identification of health interventions and related risk factors which are associated with a 
decreased under-five mortality risk is crucial for decision makers. Additionally, the 
exploration of the geographical variation of such associations could assist in resource 
allocation, planning and implementation of health interventions. In our application we 
analysed a subset of all health interventions and verified their protective attribute across the 
whole spatial study area of Burundi. Routine intervention administration could benefit from 
variable selection schemes, such as those presented in our study, in an effort to identify 
areas in which successful implementation of health interventions has been achieved. 
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Table 6.1: Summary of model formulations. Normal distribution is presented in precision terms.  
Model Fixed effects Random effects Inclusion indicators Interpretation 
1 𝛽𝛽𝑝𝑝~𝒩𝒩(0, 0.1), 𝑝𝑝 = 1, … ,10 𝒘𝒘𝟎𝟎~𝒩𝒩𝑁𝑁(𝟎𝟎, (𝜎𝜎02exp (−𝜑𝜑𝜦𝜦))−1) - Geostatistical model 
2 𝛽𝛽𝑝𝑝 𝛿𝛿𝑝𝑝⁄ , 𝜏𝜏2~𝑁𝑁(0, 𝛿𝛿𝑝𝑝𝜏𝜏2 + (1 − 𝛿𝛿𝑝𝑝)𝑊𝑊0𝜏𝜏2), 
𝑝𝑝 = 1, … ,10 
𝒘𝒘𝟎𝟎~𝒩𝒩𝑁𝑁(𝟎𝟎, (𝜎𝜎02exp (−𝜑𝜑𝜦𝜦))−1) 𝛿𝛿𝑝𝑝 ∼  ℬ(0.5), 𝑝𝑝 = 1, … ,10 Model 1 with SSVS 
imposed on fixed effects 
3 𝛽𝛽𝑝𝑝~𝒩𝒩(0, 0.1), 𝑝𝑝 = 1, … ,10 𝒘𝒘𝟎𝟎~𝒩𝒩𝑁𝑁(𝟎𝟎, (𝜎𝜎02exp (−𝜑𝜑𝜦𝜦))−1) 





4 𝛽𝛽𝑘𝑘~𝒩𝒩(0, 0.1), 𝑘𝑘 = 2,3,4 
𝛽𝛽𝑝𝑝 𝛿𝛿𝑝𝑝⁄ , 𝜏𝜏2~𝑁𝑁(0, 𝛿𝛿𝑝𝑝𝜏𝜏2 + (1 − 𝛿𝛿𝑝𝑝)𝑊𝑊0𝜏𝜏2), 
𝑝𝑝 = 1,5, … ,10 
𝒘𝒘𝟎𝟎~𝒩𝒩𝑁𝑁(𝟎𝟎, (𝜎𝜎02exp (−𝜑𝜑𝜦𝜦))−1) 
𝒘𝒘𝒌𝒌 ∕ 𝛽𝛽𝑘𝑘,𝜎𝜎𝑘𝑘2,𝜌𝜌𝑘𝑘~𝒩𝒩𝑀𝑀(𝜷𝜷𝒌𝒌,𝜎𝜎𝑘𝑘−2(𝑹𝑹 − 𝜌𝜌𝑘𝑘𝜴𝜴)), 𝑘𝑘 = 2,3,4 
𝛿𝛿𝑝𝑝 ∼  ℬ(0.5), 𝑝𝑝 = 1,5, … ,10 Model 3 with SSVS 
imposed on fixed effects 
5 𝛽𝛽𝑝𝑝~𝒩𝒩(0, 0.1), 𝑝𝑝 = 1,5, … ,10 
𝛽𝛽𝑘𝑘 𝛾𝛾1𝑘𝑘⁄ , 𝜏𝜏2~𝒩𝒩(0, 𝛾𝛾1𝑘𝑘𝜏𝜏2 + (1 − 𝛾𝛾1𝑘𝑘)𝑊𝑊0𝜏𝜏2), 
𝑘𝑘 = 2, 3,4 
𝒘𝒘𝟎𝟎~𝒩𝒩𝑁𝑁(𝟎𝟎, (𝜎𝜎02exp (−𝜑𝜑𝜦𝜦))−1) 
𝒘𝒘𝒌𝒌 ∕ 𝛾𝛾2𝑘𝑘,𝛽𝛽𝑘𝑘 ,𝜎𝜎𝑘𝑘2,𝜌𝜌𝑘𝑘~𝒩𝒩𝑀𝑀(𝜷𝜷𝒌𝒌,𝜎𝜎𝑘𝑘−2(𝑹𝑹 − 𝜌𝜌𝑘𝑘𝜴𝜴)), 
𝜎𝜎𝑘𝑘2 𝛾𝛾2𝑘𝑘⁄ ,𝜎𝜎𝑘𝑘�
2 = 𝛾𝛾2𝑘𝑘𝜎𝜎𝑘𝑘�2 + (1 − 𝛾𝛾2𝑘𝑘)𝑊𝑊0𝜎𝜎𝑘𝑘�2, 𝑘𝑘 = 2,3,4 
 
𝛾𝛾 = �𝛾𝛾1𝑘𝑘𝛾𝛾2𝑘𝑘� ∼ 𝒞𝒞(0.34,0.33,0.33), 𝑘𝑘 =
2,3,4 
Global BVS method for 
spatially varying 
coefficients 
6 𝛽𝛽𝑝𝑝 𝛿𝛿𝑝𝑝⁄ , 𝜏𝜏2~𝑁𝑁(0, 𝛿𝛿𝑝𝑝𝜏𝜏2 + (1 − 𝛿𝛿𝑝𝑝)𝑊𝑊0𝜏𝜏2), 
𝑝𝑝 = 1,5, … ,10 
𝛽𝛽𝑘𝑘 𝛾𝛾1𝑘𝑘⁄ , 𝜏𝜏2~𝒩𝒩(0, 𝛾𝛾1𝑘𝑘𝜏𝜏2 + (1 − 𝛾𝛾1𝑘𝑘)𝑊𝑊0𝜏𝜏2), 
𝑘𝑘 = 2, 3,4 
𝒘𝒘𝟎𝟎~𝒩𝒩𝑁𝑁(𝟎𝟎, (𝜎𝜎02exp (−𝜑𝜑𝜦𝜦))−1) 
𝒘𝒘𝒌𝒌 ∕ 𝛾𝛾2𝑘𝑘,𝛽𝛽𝑘𝑘 ,𝜎𝜎𝑘𝑘2,𝜌𝜌𝑘𝑘~𝒩𝒩𝑀𝑀(𝜷𝜷𝒌𝒌,𝜎𝜎𝑘𝑘−2(𝑹𝑹 − 𝜌𝜌𝑘𝑘𝜴𝜴)), 
𝜎𝜎𝑘𝑘2 𝛾𝛾2𝑘𝑘⁄ ,𝜎𝜎𝑘𝑘�
2 = 𝛾𝛾2𝑘𝑘𝜎𝜎𝑘𝑘�2 + (1 − 𝛾𝛾2𝑘𝑘)𝑊𝑊0𝜎𝜎𝑘𝑘�2, 𝑘𝑘 = 2,3,4 
𝛾𝛾 = �𝛾𝛾1𝑘𝑘𝛾𝛾2𝑘𝑘� ∼ 𝒞𝒞(0.34,0.33,0.33), 𝑘𝑘 =
2,3,4 
𝛿𝛿𝑝𝑝 ∼  ℬ(0.5), 𝑝𝑝 = 1,5, … ,10  
Model 5 with SSVS 
imposed on fixed effects 
7 𝛽𝛽𝑝𝑝~𝒩𝒩(0, 0.1), 𝑝𝑝 = 1, … ,10 𝒘𝒘𝟎𝟎~𝒩𝒩𝑁𝑁(𝟎𝟎, (𝜎𝜎02exp (−𝜑𝜑𝜦𝜦))−1) 
𝑤𝑤𝑚𝑚𝑘𝑘 𝛾𝛾𝑚𝑚𝑘𝑘⁄ ,𝛽𝛽𝑘𝑘,𝜎𝜎𝑘𝑘2 ∼ 𝑁𝑁(𝛾𝛾𝑚𝑚𝑘𝑘𝛽𝛽𝑘𝑘, 𝛾𝛾𝑚𝑚𝑘𝑘𝜎𝜎𝑘𝑘2 + (1 − 𝛾𝛾𝑚𝑚𝑘𝑘)𝑊𝑊0𝜎𝜎𝑘𝑘2), 
𝑘𝑘 = 2,3,4, 𝑚𝑚 = 1, … ,5 
𝛾𝛾𝑚𝑚𝑘𝑘 ∕ 𝑝𝑝𝑚𝑚𝑘𝑘 ∼ ℬ(𝑝𝑝𝑚𝑚𝑘𝑘), 
𝛷𝛷−1(𝑝𝑝𝑚𝑚𝑘𝑘) = 𝜀𝜀𝑚𝑚𝑘𝑘, 
𝜺𝜺𝒌𝒌 ∕ 𝜎𝜎𝑘𝑘2,𝜌𝜌𝑘𝑘 ∼ 𝒩𝒩𝑀𝑀(𝟎𝟎,𝜎𝜎𝑘𝑘−2(𝑹𝑹 − 𝜌𝜌𝑘𝑘𝜴𝜴)), 
𝑘𝑘 = 2,3,4, 𝑚𝑚 = 1, … ,5 
Local BVS method 
utilizing the probit link 
8 𝛽𝛽𝑘𝑘~𝒩𝒩(0, 0.1), 𝑘𝑘 = 2,3,4 
𝛽𝛽𝑝𝑝 𝛿𝛿𝑝𝑝⁄ , 𝜏𝜏2~𝑁𝑁(0, 𝛿𝛿𝑝𝑝𝜏𝜏2 + (1 − 𝛿𝛿𝑝𝑝)𝑊𝑊0𝜏𝜏2), 
𝑝𝑝 = 1,5, … ,10 
𝒘𝒘𝟎𝟎~𝒩𝒩𝑁𝑁(𝟎𝟎, (𝜎𝜎02exp (−𝜑𝜑𝜦𝜦))−1) 
𝑤𝑤𝑚𝑚𝑘𝑘 𝛾𝛾𝑚𝑚𝑘𝑘⁄ ,𝛽𝛽𝑘𝑘,𝜎𝜎𝑘𝑘2 ∼ 𝑁𝑁(𝛾𝛾𝑚𝑚𝑘𝑘𝛽𝛽𝑘𝑘, 𝛾𝛾𝑚𝑚𝑘𝑘𝜎𝜎𝑘𝑘2 + (1 − 𝛾𝛾𝑚𝑚𝑘𝑘)𝑊𝑊0𝜎𝜎𝑘𝑘2), 
𝑘𝑘 = 2,3,4, 𝑚𝑚 = 1, … ,5 
𝛾𝛾𝑚𝑚𝑘𝑘 ∕ 𝑝𝑝𝑚𝑚𝑘𝑘 ∼ ℬ(𝑝𝑝𝑚𝑚𝑘𝑘), 
𝛷𝛷−1(𝑝𝑝𝑚𝑚𝑘𝑘) = 𝜀𝜀𝑚𝑚𝑘𝑘, 
𝜺𝜺𝒌𝒌 ∕ 𝜎𝜎𝑘𝑘2,𝜌𝜌𝑘𝑘 ∼ 𝒩𝒩𝑀𝑀(𝟎𝟎,𝜎𝜎𝑘𝑘−2(𝑹𝑹 − 𝜌𝜌𝑘𝑘𝜴𝜴)), 
𝑘𝑘 = 2,3,4, 𝑚𝑚 = 1, … ,5 
Model 7 with SSVS 
imposed on fixed effects 
9 𝛽𝛽𝑝𝑝~𝒩𝒩(0, 0.1), 𝑝𝑝 = 1, … ,10 𝒘𝒘𝟎𝟎~𝒩𝒩𝑁𝑁(𝟎𝟎, (𝜎𝜎02exp (−𝜑𝜑𝜦𝜦))−1) 
𝑤𝑤𝑚𝑚𝑘𝑘 𝛾𝛾𝑚𝑚𝑘𝑘⁄ ,𝛽𝛽𝑘𝑘,𝜎𝜎𝑘𝑘2 ∼ 𝑁𝑁(𝛾𝛾𝑚𝑚𝑘𝑘𝛽𝛽𝑘𝑘, 𝛾𝛾𝑚𝑚𝑘𝑘𝜎𝜎𝑘𝑘2 + (1 − 𝛾𝛾𝑚𝑚𝑘𝑘)𝑊𝑊0𝜎𝜎𝑘𝑘2),  
𝑤𝑤𝑚𝑚𝑘𝑘 = 𝑃𝑃−1(𝛷𝛷(𝜃𝜃𝑚𝑚𝑘𝑘)), 𝜃𝜃𝑘𝑘 ∕ 𝜌𝜌𝑘𝑘 ∼ 𝒩𝒩𝑀𝑀(𝟎𝟎,𝑹𝑹 − 𝜌𝜌𝑘𝑘𝜴𝜴), 𝑘𝑘 =
2,3,4, 𝑚𝑚 = 1, … ,5 
𝛾𝛾𝑚𝑚𝑘𝑘 ∕ 𝑝𝑝𝑘𝑘 ∼ ℬ(𝑝𝑝𝑘𝑘), 𝑝𝑝𝑘𝑘 ∼ 𝒰𝒰(0,1), 𝑘𝑘 =
2,3,4, 𝑚𝑚 = 1, … ,5 
Local BVS method 
utilizing the a Gaussian 
copula 
10 𝛽𝛽𝑘𝑘~𝒩𝒩(0, 0.1), 𝑘𝑘 = 2,3,4 
𝛽𝛽𝑝𝑝 𝛿𝛿𝑝𝑝⁄ , 𝜏𝜏2~𝑁𝑁(0, 𝛿𝛿𝑝𝑝𝜏𝜏2 + (1 − 𝛿𝛿𝑝𝑝)𝑊𝑊0𝜏𝜏2), 
𝑝𝑝 = 1,5, … ,10 
𝒘𝒘𝟎𝟎~𝒩𝒩𝑁𝑁(𝟎𝟎, (𝜎𝜎02exp (−𝜑𝜑𝜦𝜦))−1) 
𝑤𝑤𝑚𝑚𝑘𝑘 𝛾𝛾𝑚𝑚𝑘𝑘⁄ ,𝛽𝛽𝑘𝑘,𝜎𝜎𝑘𝑘2 ∼ 𝑁𝑁(𝛾𝛾𝑚𝑚𝑘𝑘𝛽𝛽𝑘𝑘, 𝛾𝛾𝑚𝑚𝑘𝑘𝜎𝜎𝑘𝑘2 + (1 − 𝛾𝛾𝑚𝑚𝑘𝑘)𝑊𝑊0𝜎𝜎𝑘𝑘2),  
𝑤𝑤𝑚𝑚𝑘𝑘 = 𝑃𝑃−1(𝛷𝛷(𝜃𝜃𝑚𝑚𝑘𝑘)), 𝜃𝜃𝑘𝑘 ∕ 𝜌𝜌𝑘𝑘 ∼ 𝒩𝒩𝑀𝑀(𝟎𝟎,𝑹𝑹 − 𝜌𝜌𝑘𝑘𝜴𝜴), 𝑘𝑘 =
2,3,4, 𝑚𝑚 = 1, … ,5 
𝛾𝛾𝑚𝑚𝑘𝑘 ∕ 𝑝𝑝𝑘𝑘 ∼ ℬ(𝑝𝑝𝑘𝑘), 𝑝𝑝𝑘𝑘 ∼ 𝒰𝒰(0,1), 𝑘𝑘 =
2,3,4, 𝑚𝑚 = 1, … ,5 
Model 9 with SSVS 







Table 6.2: Proportional inclusion of the fix components for models 1-10, based on SSVS. Results were derived from 20 simulations. 
Fixed effects Model 2 Model 4 Model 6 Model 8 Model 10 
𝛽𝛽1 100% 100% 100% 100% 100% 
𝛽𝛽2 100% * * * * 
𝛽𝛽3 100% * * * * 
𝛽𝛽4 100% * * * * 
𝛽𝛽5 100% 100% 100% 100% 100% 
𝛽𝛽6 100% 100% 100% 100% 100% 
𝛽𝛽7 0% 0% 0% 0% 0% 
𝛽𝛽8 0% 5% 5% 10% 10% 
𝛽𝛽9 0% 0% 0% 0% 0% 
𝛽𝛽10 5% 10% 10% 10% 10% 
* Variables not included in SSVS.  
 
Table 6.3: Proportional posterior inclusions for the spatially varying coefficients 𝜷𝜷𝟐𝟐, 𝜷𝜷𝟑𝟑 and 𝜷𝜷𝟒𝟒 and their local effects, stratified by variable selection. Results were derived from 20 simulations. 
 
Indicator 
𝛽𝛽2 (𝑘𝑘 = 2) 𝛽𝛽3 (𝑘𝑘 = 3) 𝛽𝛽4 (𝑘𝑘 = 4) 












� 70% 65%     45% 40%     60% 50%     
𝛾𝛾1𝑘𝑘   50% 45% 25% 30%   50% 45% 30% 30%   30% 30% 25% 25% 
𝛾𝛾2𝑘𝑘   35% 35% 25% 20%   35% 35% 25% 20%   15% 20% 10% 15% 
𝛾𝛾3𝑘𝑘   60% 60% 40% 45%   55% 60% 35% 40%   0% 0% 5% 0% 
𝛾𝛾4𝑘𝑘   60% 60% 30% 35%   60% 65% 40% 30%   0% 0% 10% 10% 
𝛾𝛾5𝑘𝑘   30% 20% 15% 10%   30% 25% 10% 10%   45% 45% 45% 45% 






Table 6.4: Description of child, maternal and household interventions coverage indicators utilized in the application.  
Interventions Definition 
Use of ITNs from under-five children Proportion of under the age of five children who slept under an ITN the night before 
the survey 
Antimalarial medication Proportion of under the age of five children with fever who received any antimalarial 
medication 
Breastfeeding within 24 hours Proportion of new-born children which was breastfed within one day after birth  
Postnatal check Proportion of postnatal check-up for infants within two months after birth 
Measles immunization Proportion of children vaccinated against measles 
DPT3 immunization Proportion of children which was vaccinated against measles 
Vitamin A supplementation Proportion of children which was vaccinated with DPT3 
Improved sanitation Proportion of household using improved sanitation facilities 
Table 6.5: Posterior mean inclusion probabilities for each variable and model applied on the Burundi DHS data. Asterisk (*) indicates no SSVS for the corresponding covariates. 
Variable (indicator) Model 2 Model 4 Model 6 Model 8 Model 10 
Sex (𝛿𝛿1) 0.30 0.31 0.31 0.29 0.30 
Use of ITNs (𝛿𝛿2) 0.74 * * * * 
Antimalarial (𝛿𝛿3) 0.80 * * * * 
Breastfeeding (𝛿𝛿4) 0.59 * * * * 
Postnatal check (𝛿𝛿5) 0.37 0.37 0.36 0.36 0.37 
Measles (𝛿𝛿6) 0.51 0.53 0.55 0.46 0.53 
DPT3 (𝛿𝛿7) 1 1 1 1 1 
Vitamin A (𝛿𝛿8) 1 1 1 1 1 
Improved Sanitation (𝛿𝛿9) 0.88 0.66 0.65 0.61 0.87 
Rural-urban (𝛿𝛿10) 0.12 0.14 0.13 0.13 0.12 
Delivery place (𝛿𝛿11) 0.49 0.41 0.44 0.42 0.45 
Birth order (𝛿𝛿12)  0.78 0.79 0.82 0.85 0.80 
Mothers age (𝛿𝛿13) 0.32 0.34 0.34 0.34 0.34 
Mothers live births (𝛿𝛿14) 0.88 0.90 0.92 0.93 0.91 
Mothers educ. level (𝛿𝛿15) 0.08 0.09 0.09 0.09 0.09 
Asset Index  (𝛿𝛿16) 0.96 0.97 0.97 0.96 0.96 
Altitude (𝛿𝛿17) 0.09 0.09 0.09 0.08 0.08 
NDVI (𝛿𝛿18) 0.08 0.08 0.09 0.08 0.07 
LSTN (𝛿𝛿19) 0.11 0.09 0.11 0.09 0.08 
LSTD (𝛿𝛿20) 0.33 0.22 0.28 0.21 0.17 
Rainfall (𝛿𝛿21) 0.05 0.06 0.06 0.06 0.06 
Forests (𝛿𝛿22) 0.42 0.43 0.43 0.41 0.42 
Grasslands (𝛿𝛿23) 0.44 0.44 0.44 0.44 0.43 




Table 6.6: Posterior mean inclusion probabilities for the spatially varying coefficients 𝜷𝜷𝟐𝟐, 𝜷𝜷𝟑𝟑 and 𝜷𝜷𝟒𝟒 and their local effects, stratified by variable selection. Results were derived from the initial fit to 




𝛽𝛽2 (𝑘𝑘 = 2) 𝛽𝛽3 (𝑘𝑘 = 3) 𝛽𝛽4 (𝑘𝑘 = 4) 












� 0 0     0 0     0 1     
Bubanza 
(𝛾𝛾1𝑘𝑘) 
  0.46 0.52 0.12 0.07   0.42 0.38 0.14 0.09   0.48 0.41 0.05 0.05 
Bujumbura 
Mairie (𝛾𝛾2𝑘𝑘) 
  0.43 0.53 0.07 0.05   0.45 0.41 0.12 0.07   0.48 0.40 0.04 0.05 
Bujumbura 
Rural (𝛾𝛾3𝑘𝑘) 
  0.44 0.52 0.11 0.07   0.42 0.46 0.16 0.09   0.46 0.42 0.04 0.06 
Bururi (𝛾𝛾4𝑘𝑘)   0.42 0.56 0.10 0.05   0.42 0.46 0.13 0.08   0.49 0.47 0.06 0.05 
Cankuzo 
(𝛾𝛾5𝑘𝑘) 
  0.40 0.53 0.09 0.05   0.39 0.40 0.13 0.10   0.37 0.38 0.04 0.03 
Cibitoke 
(𝛾𝛾6𝑘𝑘) 
  0.34 0.52 0.08 0.04   0.39 0.39 0.10 0.07   0.34 0.33 0.02 0.02 
Gitega (𝛾𝛾7𝑘𝑘)   0.46 0.60 0.12 0.16   0.53 0.51 0.56 0.64   0.41 0.38 0.16 0.12 
Karuzi (𝛾𝛾8𝑘𝑘)   0.37 0.51 0.08 0.06   0.31 0.40 0.11 0.06   0.37 0.32 0.03 0.05 
Kayanza 
(𝛾𝛾9𝑘𝑘) 
  0.35 0.50 0.08 0.06   0.41 0.37 0.13 0.07   0.35 0.36 0.03 0.05 
Kirundo 
(𝛾𝛾10𝑘𝑘) 
  0.39 0.48 0.09 0.06   0.40 0.44 0.12 0.10   0.36 0.37 0.03 0.03 
Makamba 
(𝛾𝛾11𝑘𝑘) 
  0.38 0.51 0.08 0.04   0.39 0.43 0.09 0.09   0.45 0.43 0.05 0.05 
Muramvya 
(𝛾𝛾12𝑘𝑘) 
  0.41 0.54 0.14 0.12   0.47 0.43 0.26 0.19   0.45 0.37 0.05 0.07 
Muyinga 
(𝛾𝛾13𝑘𝑘) 
  0.34 0.48 0.08 0.03   0.34 0.40 0.12 0.07   0.35 0.32 0.02 0.02 
Mwaro 
(𝛾𝛾14𝑘𝑘) 
  0.43 0.51 0.13 0.08   0.46 0.44 0.16 0.10   0.42 0.46 0.09 0.08 
Ngozi (𝛾𝛾15𝑘𝑘)   0.35 0.48 0.08 0.05   0.36 0.38 0.13 0.09   0.39 0.37 0.04 0.04 
Rutana 
(𝛾𝛾16𝑘𝑘) 
  0.44 0.51 0.11 0.06   0.41 0.42 0.15 0.08   0.47 0.41 0.04 0.09 
Ruyigi (𝛾𝛾17𝑘𝑘)   0.45 0.58 0.25 0.15   0.46 0.39 0.22 0.13   0.48 0.42 0.12 0.13 




Table 6.7: Posterior summaries of regression coefficients. Results are derived from the re-fit on the Burundi DHS 2016 data, based on the variables selected from the SSVS. 
 Model A Model B Model C Model D Model E Model F Model G 






































































































































WAIC 8619.5 8624.6 8623.7 8616.0 8618.2 8620.1 8619.1 
Parent models 1 – 2 3 – 4  5 6 7 8 9 – 10 











Table 6.8: Pre-determined parameter values and distributions used to generate our simulation (part I).  
 𝑝𝑝 = 0 𝑝𝑝 = 1 𝑝𝑝 = 2 𝑝𝑝 = 3 𝑝𝑝 = 4 𝑝𝑝 = 5 𝑝𝑝 = 6 𝑝𝑝 = 7 𝑝𝑝 = 8 𝑝𝑝 = 9 𝑝𝑝 = 10 
𝛽𝛽𝑝𝑝 -0.80 0.80 -1 -1.10 0.50 1 0.70 0 0 0 0 
𝑥𝑥𝑖𝑖𝑝𝑝 1 𝒩𝒩(0,0.50) 𝒩𝒩(0,0.50) 𝒩𝒩(0,0.50) ℬ(0.5) ℬ(0.5) 𝒩𝒩(1,0.50) 𝒩𝒩(−1,2) ℬ(0.5) 𝒩𝒩(1,2) ℬ(0.5) 
𝒩𝒩 stands for Normal distribution; ℬ stands for Bernoulli distribution.  
 
Table 6.9: Pre-determined parameter values used to generate our simulation (part II). 

















Value 1 1 0.20 2 0.50 2.5 0.70 2 0.60 
GP stands for Gaussian process. 
 
Table 6.10: Initial values used for the two chains of the MCMC. 
 Chain 1 Chain 2  Chain 1 Chain 2 
𝛽𝛽1 0.80 1 𝛽𝛽0 -0.80 0.50 
𝛽𝛽2 -1 1 𝛼𝛼 1 1 
𝛽𝛽3 -1.10 1 𝜎𝜎02 1 0.33 
𝛽𝛽4 0.50 1 𝜑𝜑 0.20 5 
𝛽𝛽5 1 1 𝜎𝜎2−2 2.5 1 
𝛽𝛽6 0.70 1 𝜌𝜌2 0.70 0.90 
𝛽𝛽7 0 1 𝜎𝜎3−2 2 1.5 
𝛽𝛽8 0 1 𝜌𝜌3 0.60 0.40 
𝛽𝛽9 0 1 𝜎𝜎4−2 1 3 







Table 6.11: Proportional inclusion of the fix components for models 1-10, based on SSVS. Results were derived from 20 simulations. 
Fixed effects Model 2 Model 4 Model 6 Model 8 Model 10 
𝛽𝛽1 20/20 20/20 20/20 20/20 20/20 
𝛽𝛽2 20/20 * * * * 
𝛽𝛽3 20/20 * * * * 
𝛽𝛽4 20/20 * * * * 
𝛽𝛽5 20/20 20/20 20/20 20/20 20/20 
𝛽𝛽6 20/20 20/20 20/20 20/20 20/20 
𝛽𝛽7 0/20 0/20 0/20 0/20 0/20 
𝛽𝛽8 0/20 1/20 1/20 2/20 2/20 
𝛽𝛽9 0/20 0/20 0/20 0/20 0/20 
𝛽𝛽10 1/20 2/20 2/20 2/20 2/20 
* Variables not included in SSVS.  
 
Table 6.12: Proportional posterior inclusion for the spatially varying coefficients 𝜷𝜷𝟐𝟐, 𝜷𝜷𝟑𝟑 and 𝜷𝜷𝟒𝟒 and their local effects, stratified by variable selection. Results were derived from 20 simulations. 
 
Indicator 
𝛽𝛽2 𝛽𝛽3 𝛽𝛽4 












� 14/20 13/20     9/20 8/20     12/20 10/20     
𝛾𝛾1𝑘𝑘   10/20 9/20 5/20 6/20   10/20 9/20 6/20 6/20   6/20 6/20 5/20 5/20 
𝛾𝛾2𝑘𝑘   7/20 7/20 5/20 4/20   7/20 7/20 5/20 4/20   3/20 4/20 2/20 3/20 
𝛾𝛾3𝑘𝑘   12/20 12/20 8/20 9/20   11/20 12/20 7/20 8/20   0/20 0/20 1/20 0/20 
𝛾𝛾4𝑘𝑘   12/20 12/20 6/20 7/20   12/20 13/20 8/20 6/20   0/20 0/20 2/20 2/20 
𝛾𝛾5𝑘𝑘   6/20 4/20 3/20 2/20   6/20 5/20 2/20 2/20   9/20 9/20 9/20 9/20 







Table 6.13: Summary of indicators derived from the local BVS methods with posterior mean inclusion probability greater than 50%.  
Sim* Model 3 Model 4 Model 7 Model 8 Model 9 Model 10 








2 𝛾𝛾23, 𝛾𝛾33, 𝛾𝛾43 𝛾𝛾22, 𝛾𝛾23 - - - - 










5 - - 𝛾𝛾12,𝛾𝛾32,𝛾𝛾42,𝛾𝛾13,
𝛾𝛾33,𝛾𝛾43,𝛾𝛾24,𝛾𝛾54 
𝛾𝛾12,𝛾𝛾32,𝛾𝛾42,𝛾𝛾13,
𝛾𝛾33, 𝛾𝛾43,𝛾𝛾24, 𝛾𝛾54 
𝛾𝛾12,𝛾𝛾32,𝛾𝛾42,𝛾𝛾52,
𝛾𝛾13,𝛾𝛾33,𝛾𝛾43,
𝛾𝛾24, 𝛾𝛾34,𝛾𝛾44, 𝛾𝛾54 
𝛾𝛾12,𝛾𝛾32,𝛾𝛾42,𝛾𝛾13,
𝛾𝛾33, 𝛾𝛾43,𝛾𝛾24, 𝛾𝛾54 





7 𝛾𝛾43 𝛾𝛾43 𝛾𝛾52,𝛾𝛾53,𝛾𝛾24 𝛾𝛾43,𝛾𝛾24 - - 











































𝛾𝛾32,𝛾𝛾33,𝛾𝛾43,𝛾𝛾14 𝛾𝛾32,𝛾𝛾33, 𝛾𝛾14 
14 𝛾𝛾52,𝛾𝛾53 𝛾𝛾22,𝛾𝛾52,𝛾𝛾23,𝛾𝛾53 𝛾𝛾52,𝛾𝛾53,𝛾𝛾14 𝛾𝛾52,𝛾𝛾53,𝛾𝛾14 𝛾𝛾52,𝛾𝛾53 𝛾𝛾52,𝛾𝛾53 
15 𝛾𝛾23 𝛾𝛾23 𝛾𝛾12,𝛾𝛾22,𝛾𝛾13,𝛾𝛾23  𝛾𝛾12,𝛾𝛾22,𝛾𝛾13,𝛾𝛾23 𝛾𝛾22,𝛾𝛾23 𝛾𝛾22,𝛾𝛾23 































20 𝛾𝛾22,𝛾𝛾42, 𝛾𝛾43 𝛾𝛾22,𝛾𝛾42,𝛾𝛾43 𝛾𝛾42,𝛾𝛾43 𝛾𝛾42,𝛾𝛾43 - - 
* Simulation 




Table 6.14: Posterior summaries of regression coefficients and the shape parameter alpha of Weibull lifetime distribution. Results are derived from the initial fit to Burundi DHS 2016. 
 Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 Model 9 Model 10 





















































































































































































































































































































































































































































































































































































































The present PhD thesis has been committed to the spatio-temporal modelling of under-five 
mortality data in the African setting using primarily routinely collected, cross-sectional, 
household-based survey data coming from the Demographic and Health surveys program. In 
the absence of improved vital registration systems and strong health infrastructure, as well 
as having the world’s highest under-five mortality burden, our aim was to contribute to the 
scientific fields of Epidemiology and Statistics by modelling and analysing preschool 
mortality data for most of the African countries. A list of key achievements succeeded by this 
PhD thesis are as follows:  
(1) We proposed a novel indicator, namely the malaria-anemia comorbidity prevalence 
indicator, in its capacity to estimate malaria-related mortality for under the age of five 
children in sub-Saharan Africa.  
(2) We obtained maps at high spatial resolution of the malaria-anemia comorbidity effect on 
all-cause under-five mortality. 
(3) We assessed the sensitivity of Bayesian variable selection methods for geostatistical 
models with spatially varying coefficients. 
(4) We associated important preventative or curative health interventions with all-cause 
under-five mortality and identified health inequities between and within countries in the 
African continent, based on the geographical difference of intervention effects. 
(5) We quantified the geographical distribution of the contribution of the leading causes of 
under-five mortality in Africa with febrile response. 
(6) We developed a novel model formulation to estimate the impact of health interventions 
on the temporal changes in under-five mortality risk for 21 African countries. 
Detailed information on the backgrounds, methods, analysis and discussions of the 
aforementioned achievements can be found in Chapters 2–6. The role of this section is to 
provide an overview of the main outcomes of our work, assess its limitations and provide 




7.1 Major contributions of the work 
7.1.1 Epidemiology 
One of the most significant outcomes of the present PhD thesis is the proposed malaria-
anemia comorbidity prevalence indicator as a novel measure to quantify malaria-related 
mortality in Africa. A global renewed interest on malaria control and elimination essentially 
started in 1998 when the Roll Back Malaria (RBM), currently RBM Partnership to end 
malaria, was launched with a goal to halve the malaria burden by 2010 and eliminate malaria 
by 2030. Roughly at the same time, the Mapping Malaria risk in Africa/Atlas du Risqué de la 
Malaria en Afrique (MARA/ARMA) project was initiated with a mandate to collect malaria 
infection prevalence data, entomological inoculation rates, case-incidence information and 
data on An. Gambiae and An. Funestus malaria vectors. Following the establishment of the 
RBM and MARA projects, several studies utilized different approaches and data sources in 
order to quantify and map malaria-related mortality in the African setting. All of these studies 
contributed to the scientific knowledge on malaria burden and provided key information to 
decision makers. Yet, given that most of these studies utilized survey data for their analysis, 
they faced a double challenge: firstly, finding a statistically important malaria-mortality 
association using the parasitaemia prevalence as an indicator to explain the malaria-
mortality association and secondly, completely overlooked indirect causes of malaria 
mortality. The latter is a very important, as, for instance, one of the main outcomes of 
Plasmodium infection is anemia that leads to a serious life-threatening form of disease, i.e. 
severe malarial anemia, which is considered responsible for around one third of malaria 
deaths (Kai, 2008; Haldar, 2009). Additionally, malaria parasitaemia prevalence takes into 
account patients that experience, for example, uncomplicated malaria (presence of parasites 
without experiencing a life-threatening situation) and thus from a modelling perspective, 
many of the positives accounted in prevalence are not linked with mortality. Our work 
contributed to the development, proposal and validation of a novel indicator for quantifying 
malaria-mortality using survey data, which overcomes the above difficulties. Our main 
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conclusions were that malaria burden in sub-Saharan Africa is considerably underestimated 
when anemia in not taken into account and that the malaria-anemia comorbidity prevalence 
provides a useful measure of the malaria-related deaths. As the understanding of malaria-
related, mortality provides insights in monitoring and evaluation of malaria control and 
elimination efforts, as well as in the planning of interventions, our work has the potential to 
impact key decisions made by policy makers. Further details are provided in Chapter 2. 
Another key result of the present PhD thesis is the modelling, mapping and presentation of 
health inequities at sub-national level in the African continent, due to variation in the 
association of preventative or curative health interventions with all-cause under-five 
mortality. Overall, Africa has seen a remarkable reduction in under-five deaths between 
1990 and 2015, as the number of global deaths was nearly halved. Most of these gains were 
accomplished during the Millennium Development Goals era, especially towards the final 
half of that period when the scaling-up of preventative and curative health interventions took 
place. Modelling studies, field data and reports from local and international organisations 
have all pointed out that this particular increase in coverage of health interventions, 
accompanied by the profound effect of such interventions when properly implemented, 
constitute the reason of the unprecedented decline in pre-school mortality. However, it has 
recently attracted strong attention if there is an equal and fair distribution and effectiveness 
of such interventions across all areas covered by a country. For instance, a crucial question 
is if people leaving in remote or neglected areas of a given country experience health 
inequities compared to other subsets of the population residing in more well-off, urban areas. 
To this regard, several studies and national reports have described strong disparities in the 
under-five mortality rate, coverage of health interventions and some have raised the point of 
differences in the effectiveness of health interventions across various regions. In this thesis, 
we developed the first model-based estimates of sub-national health inequities due to the 
variation in the association of health interventions with all-cause under-five mortality over 
large scale in SSA. Based on the associations found, we provided a continental map 
highlighting these inequities at administrative level 1 for 28 countries in Africa. At the heart of 
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the Sustainable Development Goals is the reduction of inequalities and hence our work 
provides a roadmap on how to address these issues. Additionally, our work can inform 
decision makers about the areas of highest need, in terms of effectiveness of health 
interventions, and in doing so assist in malaria control and elimination efforts. Further details 
are provided in Chapter 3. 
Results of our work inform about the contribution of the leading causes of under-five 
mortality in Africa on febrile response. One of the most common outcomes of inflammatory 
disease or infection is fever, albeit the identification of its cause is difficult. This is an 
important issue, as due to the large number of its potential causes, there are relatively high 
chances for wrong treatment of fever cases. Additionally, in the African setting, fever can be 
triggered by the leading causes of under-five mortality, i.e. acute respiratory infection, 
diarrhoea and malaria. Another crucial aspect of fever is that it is generally so strongly 
associated with malaria in endemic countries that often malaria is over-diagnosed and over-
treated among under-five children with fever. Observational studies have reported that 
malaria can be the root-cause for less than one out of four children with fever. The current 
PhD thesis presents the first modelling study on the contribution of the leading causes of 
mortality on febrile response using routinely collected survey data for 16 sub-Saharan 
African countries. Our estimates confirm the strong contribution of diarrhoea and acute 
respiratory infection on fever and account only one out of five cases to malaria. These 
findings are of great public health significance, as they highlight the need for comprehensive 
testing before malaria is diagnosed and treated in endemic countries. Further details are 
provided in Chapter 4. 
Chapter 5 provides information on the effect of 21 preventative or curative health 
interventions on changes in under-five mortality risk in 21 African countries. Since the 
remarkable reduction in the number of deaths for children below the age of five during the 
millennium Development Goals era, it is of major public health important to identify which 
interventions contributed the most on the decline of the under-five mortality risk. While 
several studies tried to estimate the effect of individual interventions on mortality, there is a 
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scarcity of studies taking a holistic approach and associating a large set of well-proven for 
their effectiveness health interventions with under-five mortality. Additionally, our study does 
not look at the effect of interventions in a cross-sectional fashion, but rather focuses on the 
difference in mortality risk between two distinct time points. Our results reflected the crucial 
role of vaccinations, micronutrient supplementation and treatments of diseases in the 
reduction of under-five mortality risk in the African setting. 
Apart from the key take-home conclusions derived from this PhD thesis, as presented 
above, our work has contributed to the field of Epidemiology through several other aspects. 
At Chapter 2, we present high spatial resolution, i.e. 2x2 km2, model-based risk map 
surfaces for the malaria-anemia comorbidity prevalence (both moderate and severe), 
malaria parasitaemia, at least moderate anemia and severe anemia for 16 sub-Saharan 
Africa countries. These estimates were derived using the latest DHS surveys for each 
country and hence are of great public health importance, in the context of identifying areas of 
severe disease. Chapter 3 contains an up-to-date, under-five mortality rate map of the 
African continent, presented at administrative level 1, again using data from the latest DHS 
surveys. Crucially, in that Chapter we present sets of continental and national maps with the 
spatially varying effect of 25 health interventions on all-cause, under-five mortality at sub-
national level for 28 African countries. As with the disease maps, these are valuable 
cartographic efforts in terms of identifying subnational areas in which there is no statistical 
association between interventions and mortality. At chapter 4, we present continental maps 
with the geographical distribution of the association of acute respiratory infection, diarrhoea 
and malaria with fever. These maps show vividly the strong contribution of acute respiratory 
infection and diarrhoea to fever, while they highlight the varying effect of malaria to fever 
across different areas. 
7.1.2 Statistics 
This thesis contributed to the areas of statistics and data science through the development, 
implementation and interpretation of Bayesian geostatistical Weibull-survival and logistic-
197 
 
regression models and their extensions to include spatially varying coefficients. The varying 
coefficient specification was implemented using three different specifications. In Chapters 3–
6 we employed either an exchangeable or a conditional autoregressive structure for the 
province-level (Administrative level 1) effect of the varying coefficients. The exchangeable 
structure assumed that the province-level effects deviate from their national average 
independently, while the conditional autoregressive Gaussian process for the varying 
coefficients introduced spatial dependence among provinces based on their neighbouring 
structure. An interesting feature of our work is presented at Chapter 2, in which we fitted a 
varying coefficient model using a spatially continuous Gaussian process, on the malaria-
anemia comorbidity effect, with Matérn covariance function. This specification allowed us to 
estimate the spatially varying effect at lower resolution, i.e. pixel-level. At chapter 6, we 
assessed the performance of stochastic search variable selection for the fixed effects of 
geostatistical models and compared three different Bayesian variable selection methods for 
spatially varying coefficients with a conditional autoregressive Gaussian process imposed on 
the varying part of the models. Additionally, we assessed the co-implementation of 
stochastic search variable selection with the selection processes for the spatially varying 
coefficients. Our work followed a recent renewed interest in Bayesian variable selection 
methods for mixed-effect spatial models. Our results are of great importance to the field of 
Bayesian modelling, as spatial models are computationally expensive and to this regard, 
selection methods that can reduce the parameter space and therefore the computation time 
for model fitting and prediction are of great interest. At Chapter 5, we provide a novel 
methodology to model the effect of a set of covariates on the changes in mortality risk 
between two survey time-points. A methodological issue was the difference in locations at 
which we had available data for the two time-points. We fitted and predicted the mortality risk 
at locations of the second survey and subsequently modelled the logarithmic difference of 
the Weibull scale parameters corresponding to each survey dataset. The presented 
methodology is valuable to modellers aiming to assess the impact of diseases or health 
interventions on the changes in mortality risk in Africa, as cross-sectional, survey data 
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constitute the primary source of information in the absence of improved vital registration 
systems.  
7.2 Study limitations 
The work presented in this PhD thesis was based on a number of assumptions and 
limitations that have, to some extent, influenced the results, and therefore the conclusions 
presented. One key point is that our work is based on statistical models that establish 
associations and do not imply causal relations. For instance, it is biologically proven that the 
malaria-anemia comorbidity leads to mortality and yet our analysis presented in Chapter 2 
could not claim any causal associations. To establish such relations, a causal inference 
approach should have been rather used. We treated under-five mortality as the main 
outcome in most of our modelling efforts and it should be carefully noted that these survival 
data reflect a five years period preceding the time at which the DHS surveys took place. 
Contrarily, the biomarker tests from which we extracted the data concerning the childhood 
diseases, e.g. malaria and anemia, were performed only for the alive children exactly when 
the DHS surveys were conducted. The same issue concerns the health interventions 
considered in our studies. This assumption is particularly strong for data stemming from the 
most recent DHS surveys, when the scaling up of health interventions had already taken 
place. Further, the structure of the data rendered impossible to use individual level diseases 
or interventions data. Another limitation concerning Chapter 2 is that children with severe 
malaria anemia are less likely to participate in DHS or MIS, leading to underestimation of 
corresponding effect in our analysis. A crucial point is also that throughout our work we 
considered that climatic and environmental factors can be used as proxies of vector-borne 
diseases and that socio-economic status can account for poverty-related conditions, for 
instance malnutrition. The latter is a noteworthy assumption, as the WHO has reported that 
malnutrition is linked to 1 out of 3 under-five deaths. At Chapter 5, we assumed that 
environmental and climatic factors could solely explain all-cause, under-five mortality. This 
hypothesis was because we did not have available DHS data at locations of the second 
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surveys for the first time point and hence we relied solely on climatic data, which were 
available for all sites and time points. This was a rather strong assumption that might have 
led to underestimation of the effect of health interventions on changes in mortality risk. 
Concerning chapter 6, our analysis did not take into account methods for spatio-temporal 
varying coefficients. We also focused solely on CAR-structured varying coefficients while 
other specifications were also available and perhaps less parameter-heavy.  
7.3 Future research recommendations 
The malaria-anemia comorbidity indicator is a novel approach to measure malaria-related 
mortality but was only tested using all-cause mortality data from cross-sectional surveys. 
Future research should further evaluate the use of the comorbidity indicator in estimating 
deaths for under-five children using malaria-specific mortality data or information stemming 
from different sources than the DHS. Additionally, future studies should try to quantify the 
anemia attributed to malaria infection, as our study did not explore the causal agent for 
anemia in individuals classified to experience malaria-anemia comorbidity. Furthermore, 
further insights from the under-five mortality could be achieved by modelling childhood 
diseases with all-cause, under-five mortality. Causal modelling procedures for the effects of 
the leading causes of under-five mortality with fever would greatly improve our 
understanding of febrile response in Africa. As the introduction of a new health intervention 
could result in better equity outcomes, it is worth studying the potential contribution of the 
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